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Anuttoma Ray, Ph.D.
University of Nebraska, 2018
Supervisor: Parmender P. Mehta, Ph.D.
Gap junctions (GJ)s are conglomeration of several cell-cell channels at cell-tocell contact sites involved in the direct intercellular exchange of small growth regulatory
molecules. Defects in assembly of GJ-forming proteins, called connexins (Cxs), are
observed in many cancers, yet the molecular basis of this defect remains unknown.
Connexin32 (Cx32) is expressed by the polarized cells in epithelia.

The carboxyl-

terminal tail (CT) of Cx32, although not required to initiate GJ formation, orchestrates
several aspects of GJ dynamics, function and growth. Our studies have discovered that
the CT of Cx32 harbors a tyrosine-based [YXXØ]-type and two dileucine-based
[DE]XXXL[LI]-type motifs, which govern the intracellular sorting and endocytosis of
transmembrane proteins.

We explored their role in regulating endocytosis and GJ-

forming ability of Cx32. One dileucine motif, designated as LI, was located near the
juxtamembrane domain, whereas another, designated as LL, was located distally. We
also discovered a non-canonical motif, designated as LR. Our results showed that the
LL and LR motifs regulated the endocytosis of Cx32 by the clathrin-mediated pathway.
Rendering the LI motif nonfunctional inhibited GJ assembly by augmenting Cx32
endocytosis via the LL and LR motifs. We also found that the tyrosine-based motif,
acted as a possible endocytic motif. Moreover, our studies showed that the LI motif
regulates basolateral sorting of Cx32 from the Golgi to the cell surface in polarized cells
only. We also found that the CT of Cx32 harbored three cysteines. These cysteines
were likely to be modified by palmitoylation, and two of them were part of a CAAX box
motif, known to be modified by prenylation. Our studies have shown for the first time
that cysteine 217 of Cx32 was palmitoylated. However, we found that mutating these
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cysteines singly affected neither the trafficking nor the ability of Cx32 to assemble into
GJs. Intriguingly, we discovered that mutating all cysteines together or cysteine 280 and
283 in combination, blocked the transport of Cx32 from the Golgi to the cell surface.
Overall, our studies here show that the trafficking, endocytosis, and assembly of Cx32
are modulated in a complex manner by different regulatory motifs found on its CT.
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Chapter I

Introduction
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1. CELL JUNCTIONS
The polarized state of epithelial cells is maintained by cell-cell and cell-matrix
junctions, such as adherens junctions and tight junctions, gap junctions (GJ)s,
desmosomes and hemi-desmosomes, and focal adhesions (Figure 1.1).

These

junctions play diverse roles in regulating aspects of cell-cell adhesion, intercellular
signaling, communication, differentiation, permeability, polarity, and development (Bryant
& Mostov, 2008). Among the various junctions, GJs are unique in that they provide a
direct pathway for intercellular communication (Saez et al., 2003).

2. CELL-CELL COMMUNICATION
The first clue of a possible existence of a pathway for direct cell-to-cell
communication came from the work of Weidmann (Weidmann, 1952). He found that in
myocardial strips, for a single Purkinje fiber, the space constant for the spread of current
extended beyond the expected value; thereby suggesting that this phenomenon might
be accounted for by the existence of a low-resistance intercellular pathway. Further
support to the existence of such a pathway was provided by the discovery of electrical
transmission at the giant crayfish motor synapses (Furshpan & Potter, 1959). Later, this
type of pathway was found to exist in other excitable and non-excitable cell types (Saez
et al., 2003). Seminal findings by Kanno and Loewenstein (Kanno & Loewenstein, 1964)
showed that not only small inorganic ions, which carry current, but also a large
hydrophilic molecule like fluorescein, molecular weight (MW) approximately 330 daltons
(Da), traverse this intercellular pathway. In the next few years, several other fluorescent
tracers, with MW up to 1000 Da were shown to be able to traverse this pathway (Kanno
& Loewenstein, 1966). These findings suggested that these molecules passed through
channels of the plasma membrane (PM) between the two adjacent cells, and thus
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differed from the ordinary ion channels.

These studies pointed to the existence of

distinct pathways of direct cell-cell communication (Loewenstein, 1981). Later studies
were directed at elucidating the structural and functional components of this specialized
intercellular pathway, which are discussed in the next sections.

3. GAP JUNCTIONS
a) Structural organization
Gap junctions are conglomerations of several cell-cell channels that provide a
direct pathway of communication between two adjacent cells by linking their cytoplasmic
interiors.

The first evidence of their structure came from transmission electron

microscopic studies in mouse liver and heart tissues (Revel & Karnovsky, 1967). A
combination of lanthanum tracing and uranium staining revealed a septalaminar
structure where the stain was excluded by the hydrophobic lipid bilayer, and
accumulated in the extracellular space and the cytoplasmic faces (Figure 1.2, Inset A).
Because of this, a narrow gap of 20 Å was observed between the outer leaflets of
apposed plasma membranes. This led to their name as ‘gap junctions’.

Tangential

sections through a junctional area in the mouse heart revealed closely packed arrays of
a hexagonal pattern, with an electron opaque core, and an electron transparent wall,
with a 90 Å center-to-center spacing of the hexagonal subunits. Electron micrographs of
freeze-fracture replicas of vertebrate GJs showed a similar hexagonal lattice structure
consisting of several particles, each particle corresponding to a channel (Figure 1.2,
Inset B) (Goodenough & Paul, 2009).
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b) Gap junction forming proteins: Connexins
i)

Connexin nomenclature and isoforms
The constituent proteins of vertebrate GJs are called connexins (Cxs), which

belong to a multigene family of transmembrane proteins. Initially, it was proposed to
subdivide Cxs into two classes: α and β.

This classification was based on the

observation that each class had a number of common features, and also taking into
account evolutionary considerations for the limited number of sequences available at
that time. Thus, for example, the members of the α class, had the motif K-X-X-X-E
whereas the members of the β class had the motif R-X-X-X-E in the transmembrane
domain, lining the channel. This motif could be used to classify them into two classes
(Kumar & Gilula, 1992). As more Cx genes were identified later, this system provided
ambiguous results. A standard nomenclature system was then proposed. This system
uses the word connexin (abbreviated as Cx) followed by a suffix, indicating the predicted
molecular mass of the polypeptide, a Cx, in kilodaltons (kDa). To indicate the species of
origin, a prefix is added. So for example, rCx32 indicates a Cx of 32 kDa isolated from
rat. Sometimes, a decimal point is used to distinguish two or more Cxs with similar
molecular masses (e.g., mCx30.3 or mCx31.1) (Beyer et al., 1990; Saez et al., 2003).
To date, 21 members of the Cx family of proteins have been identified in humans, and
20 members in mice (Goodenough & Paul, 2009; Sohl & Willecke, 2004). Some Cxs are
expressed ubiquitously, whereas some are expressed in a tissue-specific manner. A
schematic diagram showing redundant and tissue specific expression of various Cxs is
shown (Figure 1.3).
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ii)

Topology of connexins and their molecular organization into gap
junction channels

The Cx topologies were originally predicted from hydropathy plots of the cloned
sequences and further supported by mapping of regions using site-directed antibodies
and proteolysis studies (Milks et al., 1988). Later, determination of the crystal structures
of Cxs lent further credence to the predicted topological models as discussed below.
Cxs are multi-pass integral membrane proteins containing four transmembrane
domains (TM1-TM4), N- and C-termini, and a cytoplasmic loop, all of which face the
cytoplasmic side, and two extracellular loops (EC1 and EC2) between TM1-TM2 and
TM3-TM4, respectively (Figure 1.4). The four TM segments were predicted to be αhelices based on the number and nature of the constituting amino acids in each segment
(Sosinsky & Nicholson, 2005). Sequence alignment studies have shown that the two EC
loops are the most conserved among all Cx family members, with considerable variation
in the CL and the carboxy-terminal tail (CT). Whereas trans-membrane domains TM1,
TM2 and TM4 mainly harbor hydrophobic residues, TM3 has both hydrophobic and
charged amino acid residues (Saez et al., 2003).
Cxs first hexamerize and move to the cell surface. The site of Cx oligomerization
will be discussed in the next section.

This hexamer is termed connexon or a

hemichannel. Docking of two connexons from apposing cells leads to formation of an
intact channel between two contiguous cells. A significant step towards discovering the
secondary structure and molecular organization of the GJ came from the electron
crystallographic studies of the connexon (Perkins et al., 1997) and the intact channel
(Unger et al., 1997, 1999). Using a mutant of Cx43 that lacks most of the CT (truncated
from residue 263), Unger et al. showed the dodecameric structure of the channel at 7 Å
resolution in the membrane plane and 21 Å in the vertical direction. Cx43 has 382
amino acid residues. Each connexon was seen to contain 24 α-helices corresponding to
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the four transmembrane domains of the six protein subunits. The amphipathic α-helical
structure in TM3 is proposed to form the lining of the channel pore.
The first X-ray structure of GJ channel at 3.5 Å resolution was determined for
human Cx26 GJ channel that describes the open conformation of the channel. The
structure revealed the N-terminal (NT) structure ‘‘pore funnel’’, which describes how the
NT regions of the six Cx subunits line the pore entrance and form a funnel-like structure,
restricting the diameter at pore entrance to 14 Å (Maeda et al., 2009).

Electron

crystallographic analysis of the Cx26 M34A mutant (Cx26M34A) revealed large density
in the pore at the level of the two membranes; this density was interpreted as a plug
blocking the channel. The structure of Cx26M34A was assumed to show the channel in
a closed state (Oshima et al., 2007). Together, these two findings suggested that the
Cx26 NT region can undergo conformational change and plays a key role in opening and
closing of the GJ channel.
Site-directed mutagenesis studies of the EC loops revealed that three inter-loop
disulfide bonds are formed between conserved cysteines in the EC loops of each Cx
(Figure 1.4). Thus an antiparallel β-sheet arrangement resulting in concentric β-barrels
is formed from the 24 extracellular loops in an intact channel (Foote et al., 1998;
Rahman & Evans, 1991). Docking between two apposing connexons to form an intact
channel requires a 30° rotation between them to ensure a tight seal. This ensures there
is no leakage of current and other conduits between the channel lumen and the
extracellular space (Perkins et al., 1998).

The outer diameter of the connexon

decreases from 70 Å at the intracellular region to 50 Å at the extracellular region,
thereby resulting in an hour glass shape of the intact channel. The diameter of the
channel pore narrows from 40 Å at the cytoplasmic side to 15 Å at the extracellular side
and then widens to 25 Å in the extracellular region (Saez et al., 2003; Unger et al.,
1999).
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When a cell expresses more than one Cx isoform, connexons can be assembled
from a single isoform (called a homomeric connexon) or more than one isoform (called a
heteromeric connexon). Furthermore, an intact cell-cell channel can be composed of
two identical homomeric connexons (termed as a homotypic cell-cell channel) or two
connexons of different heteromeric or homomeric composition (termed as a heterotypic
cell-cell channel) (Kumar & Gilula, 1996) (Figure 1.5).

iii)

Biosynthesis and site of oligomerization of connexins
Studies using cell-free translation systems have shown that Cxs, similar to other

classical integral membrane proteins, co-translationally insert into the endoplasmic
reticulum (ER) membrane and lumen (Falk et al., 1994; Zhang et al., 1996). The only
exception to this is Cx26 which is both co- and post-translationally inserted into the ER
membrane and lumen (Ahmad et al., 1999; Laird, 2006). After membrane insertion, Cxs
achieve their native folded topology in the ER. Cxs are not glycosylated and no specific
chaperones have been found to assist in their folding while in the ER. This is followed
by oligomerization of Cxs to form hexameric connexons.

Unlike other multimeric

proteins, for which oligomerization in the ER is a prerequisite to ER exit, not all Cxs
oligomerize in the ER.

For Cxs, the site of oligomerization varies among different

members. While oligomerization of Cx26 occurs in the ER (Das Sarma et al., 2002;
Kumar et al., 1995), Cx32 oligomerization commences in the ER-Golgi intermediate
compartment (ERGIC) (Ahmad et al., 1999). Cx43 and Cx46 oligomerization have been
shown to occur in the trans-Golgi network (TGN) (Koval et al., 1997; Musil &
Goodenough, 1993).

Despite the above differences, oligomerization of Cxs into

connexons is necessary for their further trafficking to the cell surface.

8
As discussed earlier, connexons can be assembled from a single Cx isoform
(called a homomeric connexon) or more than one Cx (called a heteromeric connexon).
However, association between different Cxs is restricted.

For example, Cx43 can

hetero-oligomerize with Cx37, Cx40 or Cx46, but not with Cx32. On the other hand,
Cx32 can hetero-oligomerize with Cx26 (Laird, 2006; Saez et al., 2003; Stauffer, 1995).
Studies have revealed that a pair of amino acids in the N-terminal domain (amino acid
residues 12 and 13) of Cxs dictate the oligomerization compatibility between Cx43 and
Cx32, which belong to α and β groups of Cxs, respectively (Lagree et al., 2003). This
ability of Cxs to hetero-oligomerize with different members explains a higher level of
specificity towards charge, size and other characteristics of molecules that can
permeate; thereby allowing connexons to function as molecular sieves to finely regulate
the function of cells in which these heteromeric connexons are expressed

iv)

Trafficking of connexins
Integral membrane proteins follow the conventional secretory pathway on their

way to the cell surface. Proteins are synthesized in the ER and then transported to the
Golgi, from where they are sorted and directed to the PM, lysosome or secretory
vesicles (Pfeffer & Rothman, 1987). Cxs also follow this same secretory pathway (Koval
et al., 1997; Musil & Goodenough, 1993; VanSlyke et al., 2000). However, Cx26 is an
exception to this rule, wherein it has been shown to traverse to the cell surface directly
from the ER, bypassing the Golgi (Diez et al., 1999; George et al., 1999).
Studies in live cells using time-lapse microscopy of fluorescent protein-tagged
Cxs have shown that they were transported in 100-150 nm vesicles to the PM after
exiting the Golgi. These pleiomorphic vesicles were seen to emanate from the TGN
(Gaietta et al., 2002; Lauf et al., 2002).

Studies have also shown that connexons
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comprised of Cx43, Cx32 or Cx26 are transported to the PM via vesicular transport
along microtubules (MTs).

Additionally, Cx26 transport is also dependent on actin

microfilaments (George et al., 1999; Thomas et al., 2001). Recently, consortin, a transGolgi network cargo receptor has been shown to play a role in the PM targeting of Cxs
through interaction with GGA clathrin adaptor proteins (del Castillo et al., 2010).

c) Gap junction assembly
After the connexons are delivered to the cell surface, they dock with other
connexons from an apposing cell to form intact cell-cell channels. Clustering of several
such cell-cell channels gives rise to a GJ at the cell surface often called a GJ plaque
(Figure 1.6).

The number of channels in a GJ plaque can vary between few to

thousands, and depending upon the number of channels present, the diameter of a
plaque can range from few hundred nanometers to several micrometers. Docking is
facilitated by interaction between the extracellular loops of apposing connexons (Foote
et al., 1998; Sosinsky & Nicholson, 2005).
Three possibilities exist by which newly formed connexons are recruited to GJs.
Connexon carrying transport vesicles may (1) be delivered to the PM near or within the
plaques directly; (2) fuse with the PM at the periphery of the plaques; and/or (3) fuse
with nonjunctional PMs away from the plaque and the connexons then drift laterally in
the PMs to the plaques where they can dock to form intact GJ channels (Lauf et al.,
2002). A key study, using a novel tetracysteine epitope tagged Cx43 along with the use
of two optically distinct ligands covalently bound to the tetracysteine epitope was used in
a pulse-chase experiment which showed that GJs were assembled from the outer edges
of the plaques, whereas aged channels were localized to the central core of the plaques,
from where they were removed (Gaietta et al., 2002; Laird, 2006). These findings were
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confirmed subsequently by studies using live cell imaging of GFP-tagged Cx43 and
FRAP (fluorescent recovery after photobleaching), which showed that newly synthesized
connexons were first delivered to the nonjunctional PM, from where they moved laterally
in the plane of the PM and accrued to the outer margins of existing GJ plaques, resulting
in growth of these plaques (Lauf et al., 2002) (Figure 1.7A). Incorporation of connexons
into GJ plaques renders them resistant to solubilization by non-ionic detergents such as
Triton-X-100 (TX100), whereas connexons en route to the cell surface or in the nonjunctional plasma membrane are detergent soluble as shown by biochemical studies
(Musil & Goodenough, 1991).

d) Internalization of gap junctions
Endocytosis or cellular uptake is characterized by the internalization of molecules
from the cell surface into internal membrane compartments, and endocytic trafficking
can be classified into two main pathways — the classic, clathrin-mediated endocytic
pathway and the non-classic, clathrin-independent, but lipid-raft dependent endocytic
route (Bonifacino & Lippincott-Schwartz, 2003; Nichols, 2003) (Figure 1.8).

The

internalization of GJs and/or Cxs has been an area of considerable research. Cxs have
a very short half-life between 2-5 h in vivo and in vitro (Beardslee et al., 1998; Fallon &
Goodenough, 1981). As a result, GJs are highly dynamic structures involving constant
replenishment of the Cx pool degraded from the cell surface.

Earlier studies using

electron microscopy identified large double-membrane vesicular structures termed
‘annular gap junctions’ (AGJs) which were thought to be formed as a result of one cell
internalizing either the entire GJ between two cells or a fragment of it (Naus et al., 1993)
(Figure 1.7B). Studies using anti-Cx43 antibody microinjection, together with live cell
imaging of GFP-tagged Cx43, showed that the AGJs originated from pre-existing GJ
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plaques at cell-cell contact surfaces (Jordan et al., 2001; Laird, 2006). Detailed studies
about whether Cxs are endocytosed by clathrin-dependent or -independent pathways
are ongoing. In a study examining epidermal growth factor-induced loss of GJs from the
cell surface, the clathrin-mediated internalization pathway for Cx43 was proposed
(Leithe & Rivedal, 2004). Studies by Piehl et al. (Piehl et al., 2007) demonstrated that
AGJs too are internalized by the clathrin-dependent pathway.

Some Cxs, including

Cx43 and Cx32, have been found to colocalize with caveolin-1 and to be targeted to lipid
rafts, thereby suggesting that caveolae-dependent pathways may also play a role in GJ
internalization (Schubert et al., 2002).
In summary, GJs are turned over in at least two different ways:
1) A relatively slow (20- to 60-min range) internalization of large portions or entire GJ
plaques that generates AGJ vesicles (0.5-5 μm in diameter) (Piehl et al., 2007); and 2) a
continuous and fast (few seconds) internalization of small (0.18-0.27 μm in diameter) GJ
vesicles which bud out from central regions of the plaques (Falk et al., 2009). This
continuous internalization of small GJ vesicles correlates with previous studies where it
was shown that newer channels accumulate at the periphery of the plaque, and older
channels are pinched off from the center (Gaietta et al., 2002; Lauf et al., 2002).

e) Degradation of gap junctions
Earlier studies showed that similar to other integral membrane proteins, Cxs and
GJs are degraded via the lysosomal pathway (Laird, 2006). Later, in the mid-1990s,
strong evidence highlighted the role of the proteasomal pathway as another candidate
pathway involved in degradation of Cxs where studies using inhibitors of proteasome
showed reduced Cx degradation and increased GJ assembly of Cx43 (Musil et al.,
2000). Cx43 is a known substrate for ubiquitin ligases and mono-ubiquitination of Cx43
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has been found to serve as an internalization signal for the degradation of Cxs (Leithe &
Rivedal, 2004). Recent studies, using biochemical and structural approaches, support
the involvement of autophagy in degradation of GJs upon internalization (Bejarano et al.,
2012; Fong et al., 2012; Hesketh et al., 2010).

f) Pathophysiology aspects
Gap junctional communication has been postulated to play an important role in
regulation of cell growth and proliferation through direct intercellular exchange of
cytoplasmic molecules (Loewenstein, 1981; Saez et al., 2003). Eight distinct human
diseases have been definitively linked to germline mutations in Cxs.

Diseases

associated with Cxs include demyelinating neuropathies, deafness, epidermal diseases,
and lens cataracts; thus highlighting the importance of gap junctional intercellular
communication (GJIC) in diverse physiological processes (Laird, 2006). The first Cxlinked human disease to be discovered was the chromosome X-linked Charcot-MarieTooth (CMTX) disease. Study of diseases associated with mutations and knockouts of
Cx genes in mice have provided valuable insights on Cx function and have brought
forward the significance of GJIC in maintaining tissue homeostasis (Saez et al., 2003).
Diseases associated with Cx32 are detailed in the next section. Mutational and knockout
(KO) studies with some Cxs have been discussed here. The most frequent phenotype
of Cx-linked diseases is nonsyndromic deafness which is associated with mutations in
Cx26, Cx30 and Cx31, which are primarily expressed in the skin and cochlea. Also,
some mutations in Cx26 and Cx31 can lead to syndromic deafness [i.e., deafness
accompanied by skin disorders like keratitis and ichthyosis]. Mutations of Cx46 and
Cx50, which are present in the lens, are among the genetic reasons for the development
of zonular pulverulent cataracts. Mutations in Cx43, which is expressed ubiquitously,
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cause the rare oculodentodigital dysplasia (ODDD).

Almost 30 different mutations,

including point mutations, codon duplications, and a frameshift mutation in the Cx43
coding DNA, have been reported to cause ODDD. As many as nine recessive mutations
in the Cx47 gene, a Cx expressed in the central nervous system (CNS), is known to
cause

Pelizaeus-Merzbacher–like

disease,

which

is

a

neuropathic

disorder.

(Dobrowolski & Willecke, 2009).
During the last 25 years, many Cx mouse models that lack the coding region (null
mutated mice) or express a point-mutated Cx gene have been generated, which have
provided important mechanistic insights into understanding the molecular biology of
some human disorders. Some of them are discussed here. Female mice lacking Cx37,
which is expressed in the oocytes, are infertile because ovulation does not occur. Cx37
is required for bidirectional signaling between oocytes and granulosa cells, which
regulate ovum maturation (Simon et al., 1997).
(Laird, 2006).

Cx43 is found in almost all organs

A targeted disruption of the Cx43 gene resulted in a dramatic

malformation at the origin of the pulmonary artery involving the development of
labyrinthine, anomalous septae which partially or completely block the right ventricular
outflow to the lungs.

As a result, animals are not able to oxygenate their blood,

independently of the placenta, and so they die postnatally of asphyxiation.

This

sensitivity of the developing heart to the lack of Cx43 is due to changes in the migratory
behavior of neural crest cells that express Cx43 and participate in the development of
the outflow pathway (Reaume et al., 1995). KO of Cx26 in mice results in lethality at
embryonic day 11, and they die in utero.

This failure to survive was explained by

postulating a role for junctional communication in transplacental movement of nutrients.
Cx26 is required for transport of glucose between the two syncytiotrophoblast layers in
mouse placenta. In KOs, this exchange of glucose between placental and fetal blood is
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inhibited (Gabriel et al., 1998). However, mutations in the human Cx26 gene result in
hereditary deafness, not embryonic lethality. This is because the human placenta
contains only one syncytiotrophoblast cell layer rather than two layers connected by
Cx26, as in mice. As a result, there is no placental transport defects in humans (White &
Paul, 1999).
Apart from playing a role in genetic diseases, defects in the expression,
trafficking and assembly of Cxs into GJs have also been observed during progression of
many carcinomas (Naus & Laird, 2010).

A seminal study published in 1966

(Loewenstein & Kanno, 1966) demonstrated that the electrical coupling was lost in liver
tumor cells as compared to healthy hepatocytes. Later, additional studies supported this
hypothesis that loss of direct intercellular communication was a characteristic of cancer
cells. Cx overexpression in tumor cells has been shown to attenuate their malignant
phenotype and also induce differentiation (Naus & Laird, 2010). These and many other
studies support the notion that Cxs act as tumor suppressors.

However, recent

evidence suggest that in some types of tumors Cxs may promote tumor progression at
specific stages through both junctional and non-junctional signaling pathways (Aasen et
al., 2016).

4. CONNEXIN32
a) Distribution
Cx32 is not ubiquitously expressed and shows a tissue-specific expression. It is
present in the polarized acinar cells of exocrine glands like the pancreas, lacrimal
glands, salivary glands, as well as liver hepatocytes, alveolar cells of mammary glands,
Sertoli cells of testis, and parietal cells of gastric glands in the stomach (Figure 1.9).
The only endocrine cells expressing Cx32 are the follicular cells of the thyroid, where it is
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co-expressed with Cx26 and Cx43 (Guerrier et al., 1995; Michon et al., 2005). Cx32 is
also abundantly expressed in cells of the CNS and peripheral nervous system (PNS).
Immunolocalization studies reveal that myelinating Schwann cells of the PNS express
Cx32 at the paranodal regions and at the incisures of Schmidt-Lanterman.

This

distribution suggests a unique functional role of Cx32 in Schwann cells, where GJs
formed of Cx32 possibly provide a shorter, radial pathway for diffusion of
nutrients/signals, directly connecting adjacent wraps of myelin at incisures and
paranodal membranes (Bergoffen et al., 1993; White & Paul, 1999). In CNS, Cx32 is
found in the cell bodies and processes of oligodendrocytes but not in compact myelin.
Some studies showed that Cx32 played an important role in the biology of myelinforming cells like Schwann cells and oligodendrocytes as it is expressed as part of their
myelinating phenotype. However, it is localized to different parts of each cell (Scherer et
al., 1995).

b) Transcription
The GJB1 gene encoding for Cx32 is located on chromosome Xq13.1. The gene
for Cx32 in humans consists of three exons that are alternatively spliced to produce
mRNAs with different 5'-untranslated regions (UTRs). Transcription is initiated from two
tissue-specific promoters. In liver and pancreas, promoter P1, located more than 8 kb
upstream of the translation start codon, is used and the transcript is processed to
remove a large intron. In contrast, in nerve cells, transcription is initiated from promoter
P2, located 497 bp upstream from the translation start codon, and the transcript is
processed to remove a small 355 bp intron. The downstream exon which includes the
entire coding sequence, is shared by both mRNAs. CMTX1 patients with a normal
coding region are expected to have mutations in this promoter P2, rather than the known
promoter P1, as P2 is a nerve specific promoter (Neuhaus et al., 1995).
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Mist1, a basic helix-loop-helix transcription factor, is a positive regulator of Cx32
gene expression in acinar cells of the exocrine pancreas. Mist1 KO mice exhibit a highly
disorganized cellular architecture and function of pancreatic acini, accompanied by
severe transcriptional down-regulation of the GJB1 gene, which codes for Cx32.
Moreover, there is no compensatory increase in Cx26 expression, which is also
expressed by these acinar cells. Intriguingly, KO of Cx32 reduced the assembly of Cx26
into GJ plaques resulting in a complete lack of intercellular communication pathways
among these acinar cells. (Rukstalis et al., 2003).

c) Pathophysiology
i)

Secretion
It is well documented that GJs connect a variety of secretory cells, both

endocrine and exocrine in nature, and GJIC is instrumental for fine regulation of the
biosynthesis, storage and release of many secretory products.

Secretory cells of

exocrine glands express Cx26 and Cx32 but usually not Cx43.

Cx43 is primarily

expressed in endocrine cells (Meda et al., 1993; Michon et al., 2005). The importance of
Cx32 expression to secretory function has been implicated from various KO studies in
mice. In the pancreas, loss of Cx32, did not affect the acinar architecture. However, it
increased basal amylase secretion, almost up to two-fold.

The results showing an

alteration in the in vivo function of the exocrine pancreas due to loss of Cx32 protein
suggested that the communication observed normally between acinar cells mediates an
inhibitory effect that downregulates the number of acinar cells recruited for amylase
secretion (Chanson et al., 1998). In the liver, Cx32 KO mice showed an altered hepatic
function, whereby after stimulation of the hepatic nerves, their livers released
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significantly less glucose from glycogen as well as reduced bile secretion, as compared
to their wild type littermates. In the thyroid, a mutation in the cytoplasmic loop of Cx32
resulted in a 60% truncated protein, which led to uncoupling between thyroid epithelial
cells and decreased thyroxine release (Michon et al., 2005).

ii)

Charcot-Marie-Tooth disease

The first discovered Cx-linked human disease was chromosome-X-linked CharcotMarie-Tooth disease (CMTX). Linkage studies placed the locus of an X-linked form of
CMTX near the map location assigned to Cx32 on the X chromosome (Xq13.1). To
date, more than 270 mutations in Cx32 have been linked to CMTX. Most of them are
point mutations spread throughout the coding region that result in aberrant Cx32
trafficking, misassembly of GJ channels, or abnormal gating properties. The clinical
manifestations of CMTX include progressive demyelination of peripheral axons,
abnormally low nerve conduction velocities and chronic weakness with progressive
muscular atrophy and sensory loss of the distal extremities.

Because of X-linked

inheritance of the mutated GJB1 allele, disease severity is observed more in males than
females (Bergoffen et al., 1993; Laird, 2006). CMTX has also been observed in cases
which harbor no mutations in the Cx32 coding region.

In these cases, mutation is

present in the untranslated or regulatory portion of this gene (Neuhaus et al., 1995). As
compared to the CMTX phenotype in the human, Cx32-null mutated mice express a lateonset neuropathy, characterized by abnormal thin myelin sheets and a slight decrease in
nerve coupling. However, the behavior of Cx32-null mutated mice appeared similar to
that of wild-type mice and hence differs from the human CMTX phenotype.

These

differences in human and mouse phenotypes could be due to anatomic differences of
myelinated tissue (Dobrowolski & Willecke, 2009). Cx32 expression in the PNS provides
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a radial pathway for passage of small molecules, almost 300-fold shorter than the
circumferential pathway within the Schwann cell cytoplasm. This allows transfer of
metabolites around the compact myelin to the inner layers, thus providing sustenance to
the axon. This would explain the combination of myelin disruption and axonal
degeneration that occurs with Cx32 mutations (Bergoffen et al., 1993; Kleopa et al.,
2012).
Many studies have been directed at elucidating the molecular mechanisms of
how CMTX mutations of Cx32 affect its subcellular fate and cause pathogenesis.
Studies in HeLa cells and transgenic mice have shown that some Cx32 mutants
associated with CMTX act in a dominant-negative (DN) manner to the wild-type and form
non-functional heteromeric connexons, which are not properly inserted into the
membrane (Kleopa et al., 2012; Omori et al., 1996). Studies with PC12 cells showed
that some of the CMTX mutations affected the intracellular trafficking of Cx32 from the
Golgi to the cell surface as heteromeric connexons of wild-type and mutant Cx32 were
unable to form connexons (Deschenes et al., 1997).

iii)

Cancer
As discussed earlier, attenuated Cx expression, trafficking and assembly has

been observed during the pathogenesis of many cancers (Naus & Laird, 2010). Most
studies point to a tumor-suppressive role for Cxs (Aasen et al., 2016). Studies have
shown that forced expression of Cx32 in Cx-deficient human prostate cancer cell line,
LNCaP, retarded tumorigenicity and induced differentiation, and these effects were
contingent upon the restoration of GJ assembly. However, upon several passages, the
growth suppressive effect of GJ formation was overridden (Mehta et al., 1999). In in vivo
studies, where athymic nude mice were injected with Cx32 expressing clones of
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communication-deficient human tumor cells (SKHepl), a reduction in tumor growth rate
was observed (Eghbali et al., 1991). The above studies implicated that tumorigeneis is
negatively correlated with intercellular communication. Cx32 KO mice showed a higher
incidence of spontaneous and chemically-induced liver tumors (Temme et al., 1997). An
increased susceptibility to chemically-induced hepatocarcinogenesis was also observed
in a transgenic mutant mouse model expressing a DN mutant (V139M) of Cx32 that
caused a loss of channel function in the liver (Aasen et al., 2016).
In Cx32 KO mice, X-ray irradiation also greatly enhanced liver tumorigenesis
compared to the wild-type mice, as well as increased tumor formation in the lung,
adrenal gland, lymph nodes and small intestine accompanied with activation of the
MAPK pathway in these tumors (King & Lampe, 2004, 2004). Interestingly, in a double
KO study in which both the Cx32 and the p27 tumor suppressors were ablated,
radiation-exposed mice exhibited an increase in tumor formation in the intestine, adrenal
gland and pituitary over that of the Cx32 KO, but had reduced numbers of liver and lung
tumors. This suggests that the mechanism by which Cx32 acts as a tumor suppressor in
liver and lungs crosstalks with p27 (King et al., 2005).

Collectively, these studies

strongly suggest that Cx32 is a tumor suppressor, at least in the context of the liver and
lungs (Naus & Laird, 2010). Investigation into the molecular mechanisms regulating the
trafficking and assembly of Cxs into GJs in cancer cells is thus essential to enhance our
understanding about the pathogenesis of different types of cancers.

d) Role of carboxyl tail of Cx32
Our knowledge of the molecular events leading to the nucleation of a GJ plaque,
the identity of molecular players involved in the trafficking of Cxs along the secretory
pathway and their assembly into GJs, the degradation of GJs along the endocytic
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pathway, as well as the physiological stimuli that orchestrate these events has remained
scant. Previous studies have documented the role of the two EC loop domains of Cxs in
the docking and formation of cell-to-cell channels as well as of the CTs in regulating the
opening and closing of cell-cell channels (Foote et al., 1998; Sosinsky & Nicholson,
2005). The CT is the most divergent in sequence among different Cxs. CTs of Cxs
interact directly or indirectly with several proteins. In case of Cx32, its CT interacts with
calmodulin, ZO-1, occludin, claudin and disks large homolog 1 (Dlgh1) (Herve et al.,
2012). These interactions might play a role in regulating GJ assembly; however, the
underlying molecular mechanisms are yet to be elucidated.
Previous studies from our group showed that retrovirus-mediated expression of
Cx32 in Cx-null, and androgen-sensitive prostate cancer cell line, LNCaP, induced the
formation of GJs, restored GJIC, suppressed growth in vitro, and attenuated malignant
behavior in vivo (Mehta et.al. 1999). Earlier studies showed that Cx32 is expressed in
the luminal cells of the prostate whereas Cx43 in the basal cells (Habermann et al.,
2002). Analysis of the distribution of Cx32 in 23 normal prostates, 43 benign prostatic
hyperplasia specimens, 60 primary and 20 metastatic prostate tumors in archival and
frozen sections showed that in invasive tumors, Cx32 remained intracellular whereas in
well-differentiated tumors it was inefficiently assembled into GJs. These studies formed
the basis of investigating the molecular mechanisms involved in the assembly of Cx32
into GJs.
Our previous study with cadherin-null human squamous carcinoma cells showed
that acquisition of a partially polarized state facilitated the assembly of Cx32 into GJs
and CT of Cx32 (Cx32-CT) was required to initiate the formation of a GJ plaque and/or
its subsequent growth in these cells (Chakraborty et al., 2010). Our subsequent study
has directly explored the role of Cx32-CT in the assembly of GJs, where we found that
compared with the full-length Cx32, the CT-deleted Cx32 is assembled into smaller GJs
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in human pancreatic and prostatic cancer cells. Our results suggest that Cx32-CT was
neither required for the trafficking nor for initiating GJ assembly, but regulated the
recruitment of connexons to nascent GJ plaques and controlled GJ size by stabilizing
connexons at the plaque periphery or permitting clustering of cell-cell channels (Katoch
et al., 2015).

Collectively, the above studies indicate that Cx32-CT may harbor

important regulatory motifs that dictate Cx32’s stability and/or its recruitment and
incorporation into GJ plaques. These motifs may interact with different kinases and
scaffolding proteins to affect GJ assembly and dynamics.
The importance of GJs in maintaining tissue homeostasis by regulating growth
and proliferation of cells is well established. Disruption of Cx32 mediated GJIC leads to
pathogenesis of several diseases including cancer. Hence, it is important to determine
what extrinsic and intrinsic factors might regulate the assembly, size and disassembly of
Cx32 into GJs. The studies reported here are the logical extension of earlier studies
initiated in our laboratory regarding the mechanisms by which the CT of Cx32 might
regulate GJ assembly.

OBJECTIVES

The two major questions addressed in my dissertation are:
1) Which motifs in the C-terminal tail of Cx32 govern its basolateral sorting and
endocytosis?
2) How are basolateral sorting and endocytosis linked to the assembly of Cx32 into
GJs?
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Figure 1.1. Cell junctions maintain the polarized state of epithelia. Organization of
different junctional complexes within a polarized epithelial cell is shown. Tight junctions
are localized towards the apical region and serve a barrier function to maintain the
apico-basolateral polarity of the cell. Adherens junctions and desmosomes localize to
the basolateral domain and link the cell with adjacent cells by linkage through the
cytoskeletal filaments, actin and intermediate filaments, respectively. GJs link the
cytoplasmic interiors of adjacent cells directly. Focal adhesions and hemidesmosomes
localize to the basal domain of the cell, linking it to the extracellular matrix through
attachment with the cytoskeletal filaments, actin and intermediate filaments, respectively.
Adapted from (Mehta, 2007)
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Figure 1.2. Electron microscopy of gap junctions in mouse hepatocytes. A GJ is
seen as an area of close PM apposition, distinct from the tight junction (TJ) joining these
cells. Inset A. A high magnification view of a GJ plaque revealing the 2-3 nm
“gap”(white arrows) between the PMs and showing a septalaminar structure, where the
hydrophobic domains of the lipid bilayer exclude the stain whereas the extracellular gap
and cytoplasmic faces accumulate the stain (electron dense). Inset B. A freeze-fracture
replica of a GJ plaque showing the characteristic particles on the protoplasmic (P)
fracture face and pits on the ectoplasmic (E) fracture face. The particles and pits have
an average 90 Å center-to-center spacing.
Adapted from (Goodenough & Paul, 2009)
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Figure 1.3. Different members of the connexin gene family. The Cx gene family
consist of 21 distinct members. Cxs are expressed redundantly and also in a tissuespecific manner. For example, Cx43 is expressed in most tissues, whereas Cx36 is
expressed in a tissue-specific manner in the pancreas as illustrated.
Figure Courtesy: Dr. Mehta
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Figure 1.4. Schematic diagram showing the topology of Cx32. TM1-TM4 are the
transmembrane domains. EC1 and EC2 are the extracellular loop domains, which are
linked by disulfide bonds, as shown by pink lines. The NH2 and COOH are the amino
and the carboxyl termini, respectively. CL denotes the cytoplasmic loop. Both the Nand C-termini as well as the CL face the cytoplasm. A single letter denotes an amino
acid.
Figure Courtesy: Dr. Mehta

29

30
Figure 1.5. Schematic diagram of the various possible arrangements of connexin
isoforms to form connexons and gap junction channels. Connexons consisting of
six Cx subunits are depicted in different configurations. Connexons may be homomeric
(composed of six identical Cx isoforms) or heteromeric (composed of more than one
isoform of Cx). Two connexons dock with one another end to end to form a double
membrane GJ channel. The channel maybe homotypic (formed by two identical
connexons) or heterotypic (formed by two non-identical connexons).
Adapted and modified from (Mehta, 2007)
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Figure 1.6. Schematic overview of gap junction formation. A single Cx (red or
green cylinders) first hexamerizes to form a connexon. This oligomerization occurs in
the ER or Golgi. The connexon then traffics to the PM, where it docks with another
connexon from an apposing cell. This gives rise to a GJ channel. Clustering of several
such channels gives rise to a GJ plaque. A GJ plaque can be formed of connexons
containing different Cx isoforms (red and green cylinders).
Adapted from (Mehta, 2007)
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Figure 1.7. Schematic representation of gap junction assembly and disassembly. A. Cxs

after being co-translationally synthesized in the ER, move along the secretory pathway,
where they oligomerize in the ER or Golgi to form connexons. These connexons then
traffic to the PM in vesicles of 100-150 nm in diameter. New connexons (termed as
juvenile here) are recruited to the periphery of an existing GJ plaque, from where they
laterally diffuse in it. Older connexons (termed as senile here) are removed from the
center of the plaque by endocytosis. Undocked connexons can also be endocytosed.
The half-life of a Cx is 2-5 hours; hence, GJs are highly dynamic structures. Once
endocytosed, these connexons are degraded in the lysosomes. B. Sometimes the
entire GJ plaque can be endocytosed into either cell. These large double membrane
structures are termed annular GJs.
Adapted and modified from (Mehta, 2007)
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Figure 1.8. Schematic overview of endocytosis. Endocytosis can be broadly
classified into clathrin-dependent and clathrin-independent pathways. Clathrindependent endocytosis depends on clathrin recognition of the cargo protein via its
adaptor protein (AP) complex AP-2. Clathrin-independent endocytosis, on the other
hand, is mediated by caveolin-1, a molecular component of caveolae. After endocytosis
by either pathway, the cargo is delivered to the early endosomes, which then sorts the
cargo either to the recycling pathway via the recycling endosomes for transport back to
the PM or to the late endosomes for degradation in the lysosomes.
Figure Courtesy: Dr. Mehta
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Figure 1.9.
Expression of connexin32 in polarized tissues. Schematic
representation of cross-sections of prostatic and pancreatic acini. The highly
differentiated and polarized cells of the prostatic acini (luminal cells) and pancreatic acini
(acinar cells) express Cx32 (depicted by red arrows). Defects in Cx32 assembly or
expression in these tissues results in abnormal functioning of these glands.
Figure Courtesy: Dr. Mehta
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Chapter II
Materials and Methods
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1) Materials
Cell culture media (DMEM and RPMI) were obtained from GIBCO (Carlsbad,
CA). Fetal bovine sera were obtained from Hyclone Laboratory (Logan, UT) and Atlanta
Biologicals (Flower Branch, GA).

Tissue culture plastic ware were obtained from

Sarstedt (Newton, NJ). Geneticin (G418) was obtained from GIBCO, and puromycin
from InvivoGen (San Deigo, CA).

The mounting medium SlowFade antifade was

obtained from Thermo Fisher Scientific (Lenexa, KS).

Alexa 488 and Alexa 594

conjugated fluorescent antibodies were from Jackson ImmunoResearch Laboratories
(West Grove, PA). Alexa 488 and Alexa 594 fluorescent tracers were from Molecular
Probes (Eugene, OR).

The BCA reagent protein estimation kit, SuperSignal West

Femto Maximum Sensitivity Substrate, EZ-LinkTM Sulpho-NHS-SS Biotin reagent and
Streptavidin-conjugated agarose beads were from Pierce (Rockford, IL). The plasmid
purification, gel purification and PCR-cleanup kits were obtained from Qiagen (Valencia,
CA). Restriction endonucleases, prestained protein molecular weight markers, Deep
Vent DNA polymerase, DNA ligase, dNTPs and DNA molecular weight markers were
obtained from New England Biolabs (Beverly, MA).

Ampicillin, protease inhibitor

cocktail, sodium orthovanadate (Na3VO4), N-ethylmaleimide (NEM) and iodoacetamide
were obtained from Sigma Aldrich (St. Louis, MO). The primers for PCR were obtained
from Integrated DNA Technologies (IDT, Coralville, IA). DNA sequencing analyses were
also performed by ACGT Inc Sequencing Facility (Wheeling, IL).

Point mutations

produced in Cx32 were generated using QuikChange kit from Stratagene (La Jolla, CA).
2) Cell Culture
Human pancreatic cancer cell lines, BxPC3 (ATCC CRL-1687) and Capan-1
(HTB-79), and prostate cancer cell line, LNCaP (ATCC CRL-1740), were purchased
from the American Type Culture Collection (ATCC, Manassas, VA). These cells were
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grown in RPMI 1640 (GIBCO) containing 5% fetal bovine serum in an atmosphere of 5%
CO2 at 37°C as described previously (Johnson et al., 2013; Katoch et al., 2015; Mitra et
al., 2006).

EcoPack and PTi67, the two retroviral packaging cell lines, were also

obtained from ATCC and were grown as described previously (Mehta et al., 1999; Mitra
et al., 2006).

BxPC3 and LNCaP cells were infected with various recombinant

retroviruses and pooled polyclonal cultures from approximately 2000 colonies were
grown and maintained in RPMI containing G418 (200 µg/ml) (see Recombinant DNA
Constructs and Retrovirus Production and Infection).
3) Recombinant DNA Constructs and Retrovirus Production and Infection
The source of the retroviral vector LXSN has been described in our earlier
studies (Chakraborty et al., 2010; Mitra et al., 2006). Wild-type rat Cx32 and its various
mutants were cloned into pcDNA3.1 and pLXSN using PCR cloning and standard
recombinant DNA protocols. Site-directed mutagenesis was used to generate mutants
by QuikChange kit according to manufacturer’s instructions. To generate wild-type Cx32
and its various mutants tagged in-frame with monomeric green fluorescent protein
(GFP), we used plasmid pAcGFP-N1 (Clontech) and employed the strategies described
in our earlier studies (Johnson et al., 2013; Katoch et al., 2015). To generate wild-type
Cx32 and its various mutants tagged in-frame with Myc, the coding sequence for the
Myc tag was incorporated in the reverse primer for Cx32 by PCR-based cloning.
Recombinant DNA constructs were verified by DNA sequencing (ACGT Inc). Rab4,
Rab5, Rab11 and their constitutively active mutants tagged with GFP, were a gift from
Dr. Steve Caplan (Department of Biochemistry and Molecular Biology, University of
Nebraska Medical Center).

LXSN vectors encoding cysteine mutants of Cx32;

designated here as Cx32-C217A. Cx32-C280A, Cx32-C283A, Cx32-2CA and Cx32-3CA
were a gift from Dr. Keith R. Johnson (Department of Oral Biology, University of
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Nebraska Medical Center). Recombinant retroviruses were produced in EcoPack and
PTi67 packaging cell lines. BxPC3 and LNCaP cells were multiply (2-4 times) infected
with various recombinant retroviruses produced from PTi67 cells and selected in G418
(400 μg/ml) as described (Chakraborty et al., 2010; Govindarajan et al., 2010; Mehta et
al., 1999). Pooled cultures from about 2000 colonies obtained from 2-4 dishes were
expanded, frozen, and maintained in selection media containing G418 (200 µg/ml).
Pooled polyclonal cultures were used within 3-5 passages for immunocytochemical and
biochemical analyses.
4) Antibodies and Immunostaining
A mouse hybridoma M12.13 secreting monoclonal antibody against rat Cx32
(Goodenough et al., 1988) was a gift from Dr. Dan Goodenough (Harvard University).
This monoclonal antibody recognizes residues 111-125 in the CL of rat, mouse and
human Cx32.

In some experiments, we also used two rabbit polyclonal antibodies

raised against residues 106-124 in the CL and residues 262-279 in the CT of Cx32
(Sigma; C-3595 and C-3470). The primary antibodies used in this study are listed in
Table 2.1. Various chemicals, drugs and inhibitors used are described in Table 2.2.
Most of the antibodies were diluted 1:1 (v/v) in glycerol and stored at -20 °C.

For

immunostaining 3 x105 BxPC3 or 3 x105 LNCaP cells were seeded on glass cover slips
in six-well clusters and allowed to grow for 72 h, after which they were fixed with 2%
paraformaldehyde and immunostained as described previously (Chakraborty et al.,
2010; Govindarajan et al., 2010; Johnson et al., 2013; Katoch et al., 2015). Anti-rabbit
and anti-mouse secondary antibodies, conjugated with Alexa 488 or Alexa 594 (Jackson
ImmunoResearch Laboratories), were used as appropriate.
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5) Microscopy
Fluorescent images of immunostained cells were acquired with a Leica DMRIE
microscope (Leica Microsystems, Wetzler, Germany) using a 63x oil objective (NA 1.35).
This microscope is also equipped with a Hamamatsu ORCA-ER2 CCD camera
(Hamamatsu City, Japan). Co-localization was measured in z-stacked images taken 0.3
µm apart using the commercial image analysis program Volocity 6.0.1 (Improvision,
Lexington, MA) as described previously (Chakraborty et al., 2010; Govindarajan et al.,
2010; Johnson et al., 2013; Katoch et al., 2015). Saturation of the detector, which would
alter background adjustment, was prevented by minimizing exposure of each
fluorescently-tagged antibody during acquisition.

A background-corrected Pearson’s

correlation coefficient was used to determine fluorescence co-localization as described
(Barlow et al., 2010). For Structured Illumination Microscopy (SIM), we used an ELYRA
PS.1 Super Resolution System (Carl Zeiss) with a 63x oil objective (NA 1.4). Images
were captured with a Z-plane thickness of 90 nm and processed with the Zen Blue
software (Carl Zeiss). The processed images were imported into Volocity, cropped as
appropriate, and exported as TIFF files.
6) Gap Junction Size Measurement
The surface area of a GJ plaque was measured as follows.

After acquiring

images of immunostained cells, serial z-sections (0.5 µm) were collected and subjected
to

iterative

(Improvision).

volume

deconvolution

using

Volocity

image-processing

software

The de-convolved images of single optical sections were used for

measuring GJ size.

Each distinct fluorescent punctum at the cell-cell contact site,

delineated by E-cadherin immunostaining, was considered as one GJ plaque. The area
of each GJ plaque was calculated by drawing an ROI around each punctum using the
free hand ROI tool of the “Measurement” module of Volocity. The area of each GJ is
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represented as “pixel count” where one pixel corresponded to 0.01 μm2.

In each

captured image, 3-5 puncta were randomly chosen for the measurement of area and 515 images were used. We used the “Extended focus” display option, which merges all
captured z planes, for determining the number of GJ plaques per cell-cell interface. The
number of distinct visible puncta along the cell-cell interfaces of two adjoining cells were
then counted.

We chose only distinct interfaces at random to avoid ambiguity in

localization of the puncta.

Typically, 60-70 interfaces were measured from three

independent experiments.
7) Detergent Extraction and Western Blot Analysis
BxPC3 (3x106) and LNCaP (2x106) cells, seeded in replicate 10 cm dishes in 10
ml of complete medium, were grown to 80% confluence. Cell lysis, detergent-solubility
in 1% Triton X-100 (TX100), and Western blot analysis were performed as described
previously (Chakraborty et al., 2010; Govindarajan et al., 2010; Katoch et al., 2015; Mitra
et al., 2006).

Normalization was based on equal cell number for the analysis of

detergent-soluble and -insoluble fractions by SDS-PAGE analysis of cell lysates.
8) Cell Surface Biotinylation Assay
For cell surface biotinylation, BxPC3 (5x105) and LNCaP (4x105) cells expressing
Cx32-WT or various mutants were seeded in 6 cm dishes in replicates and grown to 7080% confluence. The biotinylation reaction was carried out at 4°C for 1 h with freshly
prepared EZ-LinkSulfo-NHS-SS Biotin reagent (Pierce) at 0.5 mg/ml in phosphate
buffered saline (PBS) supplemented with 1 mM CaCl2 and 1 mM MgCl2. The affinity
precipitation of biotinylated proteins was from 200 μg of total protein using 100 µl of
streptavidin-agarose beads (Pierce) on a rotator overnight at 4°C. SDS-PAGE followed
by Western blotting was used to resolve the streptavidin-bound biotinylated proteins
after elution as described previously (Chakraborty et al., 2010; Govindarajan et al., 2010;
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Govindarajan et al., 2002). The kinetics of degradation of cell-surface-associated Cx32WT and mutants was determined as follows: After biotinylation, washing and quenching
biotin, biotinylated proteins were chased at 37°C for various times before affinity
precipitation with streptavidin as described previously (Govindarajan et al., 2010;
Johnson et al., 2013; Katoch et al., 2015). The protein concentration was determined
using the BCA reagent (Pierce).
9) Immunoprecipitation
For co-immunoprecipitation experiments, HEK293T cells were grown in 6-cm
dishes to 80% confluence and transfected with 5 µg of each plasmid for co-transfection
studies. Twenty-four hours post-transfection, the cells were harvested and lysed in a
non-denaturing Tris-NP40 lysis buffer (10 mM Tris-HCl, pH 8.0, 0.5 % NP-40, 1 mM
EDTA) supplemented with 1 mM PMSF, 2 mM Na3VO4, 1 mM NaF, and a protease
inhibitor cocktail. Following lysis and protein estimation, 500 µg of total protein was
incubated with antibodies and mixed overnight at 4°C. Next day, anti-mouse (Sigma) or
anti-rabbit IgG affinity gel (MP Biomedicals) was washed with Tris-NP40 buffer once.
The cell extract-antibody mix was incubated with IgG affinity gel and mixed at 4°C for 2
h. The immune complexes were washed 4 times with the wash buffer (10 mM Tris-HCl,
pH 7.5, 150 mM NaCl, and 0.25% Tween 20). After the final wash, the beads were
suspended in 2X Laemmli sample buffer and incubated at 37ºC for 45 min to elute
bound proteins. Proteins were then analyzed by SDS-PAGE and Western blotting.

10)

Cell Transfection

BxPC3 (4x105) or LNCaP (5x105) cells were seeded on glass cover slips in 6well clusters 24 h prior to transfection. Cells were transfected with various plasmids in
duplicate using XtremeGENE (Roche Diagnostics) according to the manufacturer’s
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instructions. Two μg of plasmid DNA per well was used for transfection. When cells
were to be co-transfected with two plasmids, one µg of each plasmid was used.
Expression was analyzed 24 h post-transfection after fixing and immunostaining cells
with the desired antibodies as described previously (Govindarajan et al., 2010; Johnson
et al., 2013; Katoch et al., 2015; Mitra et al., 2006). For transfection of HEK293T for
immunoprecipitation studies, 6 cm dishes were transfected with 5 µg of two plasmids
and cells were lysed and relevant antigens were immunoprecipitated as described
above.
11) Hypertonic Sucrose Treatment and K+ depletion
For hypertonic sucrose and K+ depletion treatments, 3x105 BxPC3 cells
expressing Cx32-WT or Cx32-LI were seeded on glass cover slips in six-well clusters
and allowed to grow to confluence for 72 h. Cells were incubated for 1 h at 37ºC in
starvation medium (RPMI, 0.5 % BSA, 30 mM HEPES, pH 7.5). Cells to be subjected to
K+ depletion were pre-treated as follows: Cells were rinsed 3 times with K+-free buffer
(20 mM HEPES, pH, 140 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 5.5 mM D-glucose),
followed by incubation for 5 min in hypotonic K+-free buffer (K+-free buffer diluted 1:1
with water), washed again 3 times with K+-free buffer, and incubated in it for 15 min at
37ºC. Coverslips were then transferred to chilled binding medium (starvation medium
containing Alexa 488-conjugated with EGF at 5 µg/ml) and incubated for 1 h at 4ºC.
Cells were then washed 3 times with chilled PBS. Cells to be subjected to hypertonic
sucrose treatments were incubated in hypertonic sucrose medium (0.45 M sucrose) for 2
h and cells to be subjected to K+ depletion were incubated in warm K+-free buffer for 2 h.
Control cells were incubated in starvation medium for 2 h. At the end of the treatments,
cells were fixed and immunostained for Cx32 as described above.
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12) Treatments
Stock solutions of various reagents were prepared as follows: leupeptin at 100
mM in water; monensin at 10 mM in ethanol (Calbiochem); brefeldin at 10 mM in DMSO
(BIOMOL); Dynasore at 25 mM in DMSO (Sigma). These solutions were stored at
−20°C in small aliquots.

All solutions were appropriately diluted in the cell culture

medium at the time of treatment. Controls were vehicle treated.
13) Measurement of Gap Junctional Communication
Gap junctional communication was assayed by microinjecting fluorescent tracers
and by scrape-loading. The following fluorescent tracers were used for microinjection:
Alexa Fluor 488 (MW 570 Da; A-10436) and Alexa Fluor 594 (MW 760 Da; A-10438)
(Molecular Probes).

Alexa dyes were obtained as hydrazide sodium salts.

Stock

solutions of all Alexa dyes were prepared in water at 10 mM. These fluorescent tracers
were microinjected into test cells by Eppendorf InjectMan and FemtoJet microinjection
systems (models 5271 and 5242, Brinkmann Instrument, Inc. Westbury, NY) mounted
on a Leica DMIRE2 microscope as described previously (Chakraborty et al., 2010;
Govindarajan et al., 2010; Govindarajan et al., 2002; Johnson et al., 2013; Katoch et al.,
2015; Mehta et al., 1986). Junctional transfer of each fluorescent tracer was quantified
by scoring the number of fluorescent cells (excluding the injected one) within 5-10 min
after microinjection. Cells were scrape-loaded as described (Govindarajan et al., 2010;
Govindarajan et al., 2002). Briefly, BxPC3 cells expressing Cx32-WT or various mutants
were seeded in 35 mm dishes at a density of 5x104/well and allowed to grow to 100%
confluence. Cell culture medium from freshly confluent cells was removed and replaced
with 1 ml of medium containing rhodamine-conjugated fluorescent dextrans (10 kDa, 1
mg/ml; fixable) and Lucifer Yellow (LY) (0.25%).

Cells were scrape-loaded using a

sterile scalpel by two longitudinal scratches and then the cells were incubated for one
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minute at room temperature. Cells were washed quickly 2-3 times with warm cell culture
medium without serum and returned to the incubator at 37ºC for five minutes, after which
medium was removed, cells washed 2 times with PBS and fixed with 3.7% buffered
formalin at room temperature. The auto-fluorescence of cells was quenched with 0.1 M
glycine for five minutes and after washing once with PBS, images of the scrape-loaded
cells were captured as described above.
14) Yeast two-hybrid assay
To test for the interaction of Cx32 with the AP-1 complex, we used the yeast twohybrid assay (BD Biosciences/Clontech). Briefly, the CT of Cx32 (residues 200-283)
was cloned into the EcoRI and BamHI sites of the pGBKT7 vector to give pGBKT7Cx32-WT. Site-directed mutagenesis was then used to generate pGBKT7-Cx32-LI and
pGBKT7-Cx32-LL. pGADT7 vectors encoding the µ1, β1, y1 or y2 subunits were a gift
from Dr. Juan Bonifacino (National Institutes of Health). These plasmids were used to
co-transform Saccharomyces cerevisiae strain AH109 (BD Biosciences, Clontech) by
the lithium acetate procedure, using the Matchmaker two-hybrid kit (BD Biosciences,
Clontech) as described (Naslavsky et al., 2006). Briefly, yeast were grown on yeast
extract peptone dextrose (YPD) agar plates. A loop full of yeast was grown overnight at
30°C in liquid YPD medium with shaking at 250 rpm. Next day, transformation was done
by the lithium acetate procedure as described in the instructions for the Matchmaker
two-hybrid kit. For colony growth assays, AH109 co-transformants were streaked on
plates lacking leucine and tryptophan. Cells were then allowed to grow at 30°C for 3-4
days until the colonies were large enough to be used for the downstream assay. An
average of three to four colonies per co-transformant were selected and suspended in
water and equilibrated to the same optical density at 600 nm. They were then replated
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on plates lacking leucine and tryptophan (+His plates) as well as plates also lacking
histidine (-His). The positive control used was the interaction between p53 and SV40.
15) Cell polarization of transwell filters
MDCK cells (2x105 cells) were plated on 0.4 µm pore, 12-mm transwell filters
(Corning Life Science, MA) and grown for 5-6 days. 0.5 ml and 1.5 ml of media was
added to the upper and lower filter chambers, respectively, and changed every alternate
day. Immunocytochemical analysis was performed directly on filter-grown cells using
the same method as used for cells grown on glass coverslips (See Antibodies and
Immunostaining section). For mounting, the filters were cut with a scalpel. They were
then placed on glass slides carefully with their cell side facing up and a drop of
SlowFade antifade (Thermo Fisher Scientific) was added on top of the filter. A glass
coverslip was slowly placed on the mounting medium and pressed gently using a weight
overnight. Next day, once the slides dried, the edges were sealed with nail polish.
16) Domain Specific Biotinylation
MDCK cells polarized on 12-mm transwell filters were gown to 100% confluency.
Cells were then washed three times with cold PBS.

The biotinylation reaction was

carried out with freshly prepared EZ-LinkSulfo-NHS-SS Biotin reagent (Pierce) at 0.5
mg/ml in phosphate buffered saline (PBS) supplemented with 1 mM CaCl2 and 1 mM
MgCl2 (PBS-CM). This solution was then added to either the apical side (0.5 ml) or the
basolateral side (1.5 ml) of the filters and the filters were incubated for 30 min at 4°C.
This was followed by quenching of biotin by washing thrice and incubating for 5 min with
PBS-CM containing 20 mM glycine at 4°C. Filters were then cut out of the transwell
inserts and placed into eppendorf tubes containing 1 ml of lysis buffer supplemented
with glycine. After incubation for 30 min at 4°C, they were subjected to sonication.
Filters were then removed from the tubes.

The affinity precipitation of biotinylated
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proteins was from 150 μg of total protein using 100 µl of streptavidin-agarose beads
(Pierce) on a rotator overnight at 4°C. SDS-PAGE followed by Western blotting was
used to resolve the streptavidin-bound biotinylated proteins after elution as described
previously (Chakraborty et al., 2010; Govindarajan et al., 2010; Govindarajan et al.,
2002).
17) ABE Pulldown Assay
The Acyl Biotin Exchange (ABE) assay was carried out as described (Wan et al.,
2007) with a few modifications.

Briefly, cells were grown in six 100 mm dishes to

confluency. They were then washed with cold PBS. Lysis buffer (LB) (50 mM Tris-HCl,
pH 7.4, 5 mM EDTA, 150 mM NaCl) containing 10 mM NEM was added to the dishes to
block free thiols. Cells were then harvested, lysed and sonicated. Triton X-100 was then
added to a final concentration of 1.7% and incubated with gentle end-over-end rotation
at 4°C for 1 hr. Each cell lysate was collected by centrifugation at 14000 rpm for 15 min
at 4°C. The proteins were then precipitated with chloroform/methanol (CM) (2:5 vol/vol)
and resuspended in SB buffer (4% SDS, 50 mM Tris-HCl, pH 7.4, 5mM EDTA) with
10mM NEM and then incubated at 37°C with gentle agitation for 2-3 min until it became
clear. LB containing 1 mM NEM, 0.2 % TX100, protease inhibitor cocktail (PIC), and
phenylmethylsulfonylfluoride (PMSF) was added to each sample and the solution was
incubated overnight at 4°C with gentle mixing. NEM was removed from the samples by
three sequential CM precipitations, and the samples were finally resuspended in 300 μl
SB. The samples were then divided into two equal portions. One portion was incubated
with HA buffer (1 M hydroxylamine, pH 7.4, 150 mM NaCl, 0.2 % TX100, PIC, 1 mM
PMSF, 1 mM HPDP-biotin) and the other with the same buffer minus HPDP-biotin, as a
control, at room temperature for 1 h with gentle mixing. Then the proteins were CM
precipitated once to remove unreacted HPDP-biotin and resuspended in SB and
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incubated for 1 hr. This was followed by three sequential CMs. Finally, the protein was
dissolved in LB with 0.2 % TX-100 and incubated with gentle end-over-end rotation at
37°C for 30 min. This was followed by centrifugation at 13000 rpm for 5 min. The
supernatant was collected and used for protein estimation. 200 ug of the protein was
incubated with 30 µl of streptavidin agarose beads and mixed with gentle end-over-end
rotation at 37°C for 90 min. The beads were then washed 4 times in cold 1X TBST (10
mM Tris-HCl pH 7.5, 150 mM NaCl and 0.25% Tween 20). After the final wash, the
beads were suspended in 2X Laemmli sample buffer and incubated at 37ºC for 45 min
to elute bound proteins.

Proteins were then analyzed by SDS-PAGE and Western

blotting.
18) Statistical Analysis
Comparisons between two groups were made using Student’s unpaired twotailed t test. Data are expressed as mean ± SEM (standard error of mean). Values of p
< 0.05 were considered to be statistically significant.
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Table 2.1 : List of Antibodies

Antibody

Source

Catalogue
Number

Dilution

Farnesyl cysteine
(Polyclonal)
Calreticulin
(Polyclonal)
Clathrin Heavy Chain
(Monoclonal)
Caveolin-1
(Monoclonal)
c-myc
(Monoclonal)
Cx32 (105-123)
(Monoclonal)
Cx32 (106-124)
(Polyclonal)
Cx32
(Monoclonal)
E-cadherin (E9)
(Monoclonal)
EEA-1
(Polyclonal)
ERGIC-53
(Polyclonal)
pEzrin
(Monoclonal)
Farnesyl
(Polyclonal)
GFP
(Monoclonal)
GFP
(Polyclonal)
Giantin
(Polyclonal)
GM130
(Monoclonal)
LAMP-1
(Monoclonal)
PY20 Anti-Ptyr
(Monoclonal)
Sec31A
(Monoclonal)
Sodium/Potassium ATPase
Alpha (Monoclonal)
TGN46
(Polyclonal)

Sigma Aldrich

AB4073

Thermo Scientific

PA3-900

1:250 (IC)
1:125 (WB)
1:450 (IC)

Thermo Scientific

MAI-065

1:100 (IC)

BD Transduction
Laboratories
Covance

610058

1:100 (IC)

MMS-150P

Sigma Aldrich

C-6344

1:100 (IC);
1:500 (WB)
1:2000 (WB)

Sigma Aldrich

C-3595

1:500 (IC)

Homemade hybridoma

M12.13

1:50 (IC)

Affinity Bioreagents

PAI-063

1:10 (WB)
1:5 (IC)
1:100 (IC)

Sigma Aldrich

E1031

1:100 (IC)

Cell Signaling

3145S

1:100 (IC)

EMD Millipore

AB4073

Roche

11814460001

1:250
(IC & WB)
1:800 (WB)

Cell Signaling

2956S

1:1000 (WB)

Abcam

AB24586

1:500 (IC)

BD Transduction
Laboratories
Developmental
Hybridoma
BD Transduction
Laboratories
BD Transduction
Laboratories
Affinity Bioreagents

610822

1:250(IC)

H4A3

1:50 (IC)

P11120/L11

1:1000 (WB)

612350

1:100 (IC)

MA3928

1:125 (IC)

Abcam

AB50595

1:100 (IC)

Homemade-hybridoma
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ZO-1
(Polyclonal)
β-Actin
(Monoclonal)
β-COP
(Polyclonal)
γ-adaptin
(Monoclonal)
α-adaptin
(Monoclonal)

Zymed

61-7300

1:200 (IC)

Sigma Aldrich

A5441

Affinity Bioreagents

PAI-061

1:10000
(WB)
1:2000 (IC)

Sigma Aldrich

4200

1:3000 (IC)

Thermo Scientific

MAI-064

1:100 (IC)

55

Table 2.2 : Ligands and Inhibitors

Chemical

Source

Stock

Working

solution

solution

Brefeldin

BIOMOL

5 mg/ml

10 µM

Leupeptin

Enzo Life Science

20 mM

200 µM

Monensin

Calbiochem

10 mM

10 µM

Transferrin (Tfr) 594

Molecular Probes

2.5 mg/ml

25 µg/ml

Epidermal Growth Factor (EGF) 488

Molecular Probes

1 mg/ml

5 µg/ml

Dynasore

Sigma

25 mM

100 µM
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Table 2.3 : Primers for Site-Directed Mutagenesis

Mutation
L212A/I213A

L251A/L252A

L263A/R264A

Y211A

Primer Sequence
FP: 5’- AACGTGGCGGAGGTGGTGTACGCGGCGATCCGGGCC
TGTGCCCGC -3’
RP: 3’- GCGGGCACAGGCCCGGATCGCCGCGTACACCACCTC
CGCCACGTT -5’
FP: 5’- GCAGAATGAGATCAACAAGGCGGCGAGCGAG
CAGGATGGCTCTCTG-3’
RP: 3’- CAGCTCGCCATCCTGCTCGCTCGCCGCCTTGTT
GATCTCATTCTGG - 5’
FP: 5’- GGCTCTCTGAAAGACATAGCGGCGCGCAGTCCTGGC
ACTGGGGCC- 3’
RP: 3’- GGCCCCAGTGCCATTACTGCGCGCCGCTATGTCTTT
CAGAGAGCC – 5’
FP: 5’- TGGCGGAGGTGGTGGCCCTCATCATCCGGG -3’
RP: 5’- CCCGGATGATGAGGGCCACCACCTCCGCCA- 3’

Y243A

FP: 5’- CCGCCTCTCACCTGAAGCCAAGCAGAATGAGATC -3’
RP: 5’- GATCTCATTCTGCTTGGCTTCAGGTGAGAG GCGG -3’

C217A

FP: 5’- CTCATCATCCGGGCCGCTGCCCGCCGTGCTCA -3’
RP: 5’- TGAGCACGGCGGGCAGCGGCCCGGATGATGAG -3’

C280A

FP: 5’- GAAGAGCGACCGAGCCTCAGCCTGCTGATG
RP: 5’- CATCAGCAGGCTGAGGCTCGGTCGCTCTTC

C283A

FP: 5’- CCGATGCTCAGCCGCCTGATGCCGAGTACC
RP: 5’- GGTACTCGGCATCAGGCGGCTGAGCATCGG

Mutated bases are highlighted in red. FP: Forward primer, RP: Reverse primer.
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Table 2.4: Primers for Directional Cloning

Primer Name
Cx32-RP-Xho1(T=57.8)

Cx32-FP-EcoR1(T=60.5)

Cx32-FP-EcoR1(T=62)

Cx32-RP-Myc-Xho1

Primer Sequence
5’- ACTCTAGCACTCGAGTCAGCAGGCTGAGCATCG-3’
5’- ACTCTAGCAGAATTCACTCTAGCAGAATTCATGCG
CGCCTGTGCC-3’

5’- ACTCTAGCAGAATTCATGAACTGGACAGGTCTA
TACACCTTGCTCA-3’
5’- ACTCTAGCACTCGAGTTACAGGTCCTCTTCGGA
GATCAGCTTCTGCTCGCAGGCTGAGCATCGGTC-3’

FP: Forward primer, RP: Reverse primer; T- Melting temperature of the primer.
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Figure 2.1. Diagram of various Cx32 constructs used. The different motifs in the CT
of Cx32 are shown in blue-colored rectangular boxes. The sequences EVVYLI, EINKLL
and LKDILR represent the LI, LL and LR motifs, respectively. The mutated amino acid
residues in the sorting motifs are indicated in red.

Numbers in purple indicate the

position of the mutated amino acids. The names of the constructs containing wild-type
Cx32 (Cx32) or mutants cloned into pcDNA3.1(+) (PC) or retroviral vector LXSN (LX) are
indicated on the left. The constructs are tagged with Myc (Myc, red ovals) or monomeric
enhanced green fluorescent protein (GFP, green ovals). For the pGBKT7 vectors, only
Cx32-CT was cloned into the vector, which ranges from amino acid 200 to 283. The
amino and the carboxyl termini are indicated by N and C, respectively.
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Figure 2.1 : Cx32 Constructs Used
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Chapter III

Role of Dileucine Motifs in
Regulating the Endocytosis and
Assembly of Connexin32 into
Gap Junctions

The material presented in this chapter has been published and has been adapted
with permission from the Journal of Cell Science (Ray et al., 2018).
Ray, A., Katoch, P., Jain, N., & Mehta, P. P. (2018). Dileucine-like motifs in the Cterminal tail of connexin32 control its endocytosis and assembly into gap junctions. J
Cell Sci, 131(5). doi:10.1242/jcs.207340
http://jcs.biologists.org/content/131/5/jcs207340
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1. INTRODUCTION
Gap junctions (GJ)s are bicellular structures that are formed by the
conglomeration of several cell-cell channels at sites of cell-to-cell contact (Loewenstein,
1981; Sosinsky & Nicholson, 2005). The direct exchange of small molecules (≤ 1500Da)
between the cytoplasmic interiors of contiguous cells through these channels maintains
cytoplasmic continuity through buffering of nutrients and sharing of second messengers
(Goodenough & Paul, 2009; Loewenstein, 1981). GJs are abundant in the polarized and
well-differentiated epithelial cells of exocrine glands and sharing of second messengers
through gap junctional channels fulfills a homeostatic role by permitting the synchronous
response of cells to various physiological stimuli (Bosco et al., 2011; Macara et al., 2014;
Meda, 2017; Potolicchio et al., 2012).

The gap junctional channels are formed of

proteins called connexins (Cx)s, which are encoded by a family of 21 distinct genes in
humans (Beyer & Berthoud, 2009). While some Cxs are expressed ubiquitously, the
expression of other Cxs is tissue-specific, which suggests that gap junctional channels
composed of each type of Cx play specific roles. Credence to this notion has come from
the tissue-specific knock out of Cx genes (Dobrowolski & Willecke, 2009) and the
identification of mutations in these genes in human genetic diseases, such as
occulodentodigital dysplasia, palmoplanta keratoderma, keratitis-icthyosis-deafness
syndrome and deafness (Dobrowolski & Willecke, 2009; Laird, 2006, 2010; Xu &
Nicholson, 2013). Defects in the trafficking and assembly of Cxs into GJs often ensue
during the progression of a wide variety of carcinomas (Aasen et al., 2016; Naus & Laird,
2010). Moreover, growth factors, tumor promoters, oncogenes, and tumor suppressors
modulate the trafficking and assembly of Cxs into GJs by multiple mechanisms (Leithe,
2016; Leithe et al., 2012). Hence, investigation into the molecular mechanisms involved
in controlling the trafficking and assembly of Cxs into GJs in cancer cells may enhance
our understanding about the pathogenesis of several types of cancers.
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A gap junctional channel is formed by the collaborative efforts of two cells. The
biogenesis of a GJ — often called a GJ plaque — takes place in a stepwise manner. Six
Cxs first oligomerize to form a hexamer called a connexon, which, upon reaching the cell
surface, docks with the connexon on a contiguous cell to form a gap junctional channel.
Several channels then cluster at one particular spot to give rise to a gap junctional
plaque (Laird, 2006; Thevenin et al., 2013). The half-life of both assembled (plaqueassociated) and unassembled (non-plaque-associated) Cxs ranges from 2-5 h,
rendering GJ plaques as highly dynamic bicellular structuresFalk et al. (2009); (Gaietta
et al., 2002; Jordan et al., 2001; Laird, 2006; Piehl et al., 2007). Evidence to date
supports the notion that GJs are degraded via the endocytosis of either the entire plaque
or senescent cell-cell channels from the center of the plaque as double membrane
vesicles (Falk et al., 2009; Falk et al., 2016; Gaietta et al., 2002; Jordan et al., 2001;
Nickel et al., 2008; Piehl et al., 2007). Connexons and GJs have been shown to be
internalized by both clathrin- and non-clathrin-mediated pathways (Gumpert et al., 2008;
Lin et al., 2003; Piehl et al., 2007; Schubert et al., 2002). However, it is not clear how
the known endocytic mechanisms — utilized for the internalization of monomeric
transmembrane proteins (Traub, 2009; Traub & Bonifacino, 2013) — are adapted to
internalize oligomeric connexons or gap junctional plaques, which are conglomerations
of cell-cell channels ranging from 50-10,000 individual channels. Furthermore, GJs have
also been found to be degraded by autophagy upon internalization (Bejarano et al.,
2012; Fong et al., 2012; Hesketh et al., 2010; Lichtenstein et al., 2011).
A single cell often expresses multiple Cxs, which are localized on different
membrane domains, where they are likely subjected to distinct regulatory cues (Guerrier
et al., 1995; Laird, 2006). Connexin32 (Cx32), a 32 kDa Cx, is abundantly expressed in
the polarized cells of exocrine glands, such as prostate and pancreas, as well as in other
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well-differentiated cell types such as hepatocytes and oligodendrocytes (Bosco et al.,
2011; Laird, 2006). Our earlier studies showed that the ability of Cx32 and Cx43 to
assemble into GJs was impaired in prostate cancer cell lines and prostate tumors
(Govindarajan et al., 2002; Habermann et al., 2002; Mehta et al., 1999).

We also

showed that the cytoplasmic tail of Cx32 was not required to initiate the formation of GJs
but was essential for the growth and stability of the plaque (Katoch et al., 2015). These
findings suggest that the CT of Cx32 harbors important regulatory motifs that dictate
Cx32’s stability and/or its recruitment and incorporation into gap junctional plaques.
Previous studies also showed that a tyrosine-based sorting motif in the CT of Cx43
controlled its assembly into GJs by regulating endocytosis via the clathrin-mediated
pathway in human pancreatic cancer cells (Johnson et al., 2013) as well as in several
other cell lines (Fong et al., 2013; Gumpert et al., 2008; Piehl et al., 2007; Thomas et al.,
2003). Therefore, we searched for endocytic motifs in the cytoplasmic tail of Cx32. We
report here that the tail of Cx32 harbors tyrosine-based and dileucine-based motifs,
which regulate the trafficking, basolateral sorting, and clathrin-mediated endocytosis of
transmembrane proteins (Traub, 2009; Traub & Bonifacino, 2013). Here, we focused on
examining the role of dileucine-based motifs in regulating the trafficking and endocytosis
of Cx32. We provide evidence that these motifs have no effect on the intracellular
sorting of Cx32 but govern its ability to form GJs at the cell surface by regulating its
endocytosis via the clathrin-mediated pathway in cell lines derived from human prostate
and pancreatic tumors.
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2. RESULTS
Expression and the endocytic Itinerary of Cx32
We first explored the endocytic itinerary of Cx32 in a human pancreatic cancer
cell line, BxPC3, and a prostate cancer cell line, LNCaP, used in our previous studies
(Johnson et al., 2013; Katoch et al., 2015). Cx32 is not expressed in LNCaP and BxPC3
cells (Johnson et al., 2013; Katoch et al., 2015; Mehta et al., 1999).

We freshly

introduced Cx32 retrovirally in both cell lines and obtained pooled populations of Cx32expressing BxPC3 and LNCaP cells, hereafter referred to as Bx-32 and LN-32 cells,
respectively. In both Bx-32 and LN-32 cells, Cx32 was expressed robustly and formed
GJs (Figure 3.1). Immunocytochemical analysis by high resolution SIM showed that
Cx32 co-localized discernibly with clathrin and α-adaptin, a component of adaptor
protein complex 2 (AP-2), but not with caveolin-1, a marker for the non-clathrindependent pathway (Nichols, 2003) (Figure 3.2A). We previously showed that Cx43 did
not colocalize with clathrin and EEA1 and yet was internalized into Rab5-positive
vesicles in contacting BxPC3 cells (Johnson et al., 2013). These findings — combined
with the fact that Rab5 is involved in clathrin-mediated endocytosis (Bucci et al., 1992;
Zerial & McBride, 2001) — prompted us to examine whether Rab5 was involved in the
endocytosis of Cx32.

Therefore, we transiently expressed a constitutively active

(dominant) mutant of Rab5 tagged with EGFP (Rab5DA-GFP) in Bx-32 and LN-32 cells.
Expression of constitutively active Rab5 causes the formation of giant endocytic
vesicles, which allows unambiguous detection of proteins in Rab5-positve vesicles
(Roberts et al., 1999; Stenmark et al., 1994). Connexin32 was robustly endocytosed
into Rab5-positive vesicles (Figure 3.2B).

These findings suggest that Cx32 is

endocytosed by the clathrin-mediated pathway into Rab5-positive vesicles in LN-32 and
Bx-32 cells.
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The cytoplasmic tail of Cx32 harbors endocytic motifs
A motif search revealed that the CTs of Cx32 harbored two tyrosine-based
[YXXØ]-type and two dileucine-based [DE]XXXL[LI]-type motifs (a single letter denotes
an amino acid; X is any amino acid and Ø is a bulky hydrophobic amino acid). These
motifs mediate the basolateral sorting and endocytosis of transmembrane proteins
(Bonifacino, 2014; Traub & Bonifacino, 2013). As shown in Figure 2A, the tyrosinebased motifs in Cx32 are YTLL and YLII with Y at residue 7 and 211, respectively,
whereas the dileucine-based motifs are EVVYLI with the leucine-isoleucine pair at
residues 212 and 213 and EINKLL with the leucine-leucine pair at positions 251 and 252
(Thevenin et al., 2013). Moreover, we fortuitously discovered a non-canonical motif
LKDILR when we randomly chose to mutate leucine and arginine at positions 263 and
264 non-specifically to serve as a control (Figure 3.3A). To explore the role of these
motifs in regulating the trafficking, sorting, and endocytosis of Cx32, we constructed
mutants, where critical residues involving the pairs of leucine/leucine, leucine/isoleucine
and leucine/arginine were mutated to alanines (Figure 3.3B), which render these motifs
non-functional (Bonifacino & Traub, 2003). The mutant L212A/I213A is abbreviated as
Cx32-LI, the mutant L251A/L252A as Cx32-LL, and the mutant L263A/R264A is
abbreviated as Cx32-LR (Figure 3.3B). The dileucine motifs EVVYLI and EINKLL will
be referred to as LI and LL, respectively, whereas the putative motif LKDILR as LR.

The dileucine motifs affect the ability of Cx32 to form gap junctions
We retrovirally expressed Cx32-WT, Cx32-LI, Cx32-LL or Cx32-LR in BxPC3 and
LNCaP cells and examined the formation of GJs immunocytochemically. The results
showed that compared to Cx32-WT, mutants Cx32-LL and Cx32-LR formed larger GJs.
In contrast, Cx32-LI rarely formed GJs and remained predominantly intracellular as
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vesicular puncta (Figure 3.4A). Western blot analysis showed robust expression of
Cx32-WT and mutants Cx32-LL, Cx32-LR, and Cx32-LI in both cell types (Figure 3.4B).
To corroborate the immunocytochemical data, we measured surface areas of GJs at
several cell-cell interfaces (see Materials and Methods).

We used E-cadherin to

delineate cell-cell interfaces. The mean surface area of GJs composed of Cx32-LL or
Cx32-LR was nearly two-fold larger than Cx32-WT. In contrast, although GJ like puncta
at cell-cell interfaces were rarely seen with Cx32-LI, their mean surface area was 2 to 3fold smaller than Cx32-WT (Figure 3.4C). Moreover, there was a concomitant 2 to 3fold decrease in the number of GJs per interface in cells expressing Cx32-LL or Cx32LR (Figure 3.4D). Furthermore, Cx32-LL and Cx32-LR generally formed 1-3 large GJs
at one cell-cell interface and several small GJs at the remaining interfaces whereas
Cx32-WT formed GJs of varying sizes (Figure 3.4A). To examine whether motifs LL
and LR cooperate with each other in enhancing GJ formation, we constructed a
quadruple mutant Cx32-LL-LR in which leucines at position 251, 252 and 263 and
arginine at position 264 were mutated to alanines (Figure 3.3B). When expressed
retrovirally in BxPC3 and LNCaP cells, the quadruple mutant Cx32-LL-LR was also
robustly expressed (Figure 3.4B, right blots) and formed large GJs like Cx32-LL and
Cx32-LR (Figure 3.4A, right panels) but the mean surface area of GJs composed of
Cx32-LL-LR was not significantly different from Cx32-LL or Cx32-LR alone (Figure
3.4C).
To substantiate immunocytochemical data, we examined the GJ forming ability of
Cx32-WT, Cx32-LI, Cx32-LL and Cx32-LR biochemically by the detergent-solubility
assay and upon in situ extraction with 1% Triton X-100 (TX100) as well as functionally.
Analyses of total as well as TX100-soluble and –insoluble fractions from cells expressing
Cx32-WT or mutants by Western blotting showed that GJs composed of Cx32-WT,
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Cx32-LL, and Cx32-LR were detergent-insoluble, while Cx32-LI puncta were detergentsoluble (Figure 3.5A). As determined by quantifying total, TX100-soluble and -insoluble
fractions from four separate experiments, between 35-45% of Cx32-WT, 70-75% of
Cx32-LL, and 55-65% of Cx32-LR was insoluble and only 5-10% soluble. In contrast,
50-75% of Cx32-LI was soluble and only 5-10% insoluble (Figure 3.5B).
To explore the function of GJs, we examined the permeability of GJs composed
of Cx32-WT, Cx32-LI or Cx32-LL by microinjecting GJ-permeable fluorescent tracers
and by scrape-loading of Lucifer Yellow (LY) (El-Fouly et al., 1987). Consistent with the
immunocytochemical data, we observed that LNCaP cells expressing Cx32-LI
communicated poorly compared to those expressing Cx32-WT. However, we did not
observe any significant difference in the junctional transfer of Alexa 488 and Alexa 594
between LNCaP cells expressing Cx32-WT or Cx32-LL (Figure 3.6A). We failed to
substantiate the data — obtained by microinjecting LNCaP cells with various GJ
permeable tracers — by the scrape-loading assay because these cells detached from
the substrate upon scrape-loading. Intriguingly, measurement of GJ permeability by the
scrape-loading assay in BxPC3 cells expressing Cx32-WT, Cx32-LI, Cx32-LL or Cx32LR also showed no consistent, discernible difference (Figure 3.6B). There may be
several explanations for these intriguing findings.

One plausible explanation is that

BxPC3 cells express Cx43 endogenously, which, although is inefficiently assembled into
GJs (Johnson et al., 2013), may be sufficient to allow the passage of LY even in cells
expressing Cx32-LI. On the other hand, LNCaP cells are Cx-null (Mehta et al., 1996;
Mehta et al., 1999). Together, the results in Figures 3.4, 3.5 and 3.6 suggest that the GJ
forming ability of Cx32 is regulated differently by the LI and the LL or LR motifs.
Rendering the LL or LR motif nonfunctional enhances whereas rendering the LI motif
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nonfunctional inhibits GJ formation. Moreover, the LL and LR motifs do not cooperate
with each other in enhancing the formation of GJs.

Trafficking and degradation of Cx32-WT and mutants
Besides regulating endocytosis, dileucine motifs have been shown to govern the
trafficking of transmembrane proteins from the trans-Golgi Network (TGN) to the cell
surface, retrograde transport from endosomes to the TGN, as well as transport from the
TGN to the cell surface (Bonifacino & Traub, 2003; Traub & Bonifacino, 2013). We used
a cell surface biotinylation assay to determine whether differential trafficking and/or
degradation from the cell surface might account for the difference in the ability of Cx32WT, Cx32-LI, Cx32-LL, and Cx32-LR to form GJs. As postulated by Van Slyke et al.,
(VanSlyke & Musil, 2000), only Cx32 in hemichannels is expected to be biotinylated due
to the small space of 2-4 nm at the GJ plaque between contiguous cells and the large
size of biotin (2.24 nm). The results showed that Cx32-WT, Cx32-LL, and Cx32-LR
were robustly biotinylated whereas Cx32-LI was not (Figure 3.7A).

There was no

difference in the biotinylation of E-cadherin, a cell surface protein, which was used as a
positive control. We next examined the kinetics of degradation of Cx32-WT and the
mutants at various times after cell surface biotinylation to determine whether the
degradation of mutants from the cell surface was affected. Compared to Cx32-WT,
mutants Cx32-LL and Cx32-LR degraded with slower kinetics (Figure 3.7B). As shown
in Figure 3.7C, we found that 50% of Cx32-WT was degraded within 2-3 h while
degradation rates of Cx32-LL and Cx32-LR were profoundly slower. Taken together,
these data suggest that Cx32-WT, Cx32-LL, and Cx32-LR traffic normally to the cell
surface whereas Cx32-LI either traffics poorly to the cell surface or mis-sorts to other
vesicular compartments. Moreover, these data rule out the involvement of the LL and
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LR motifs in regulating the transport of Cx32 from the TGN to the cell surface or between
different endosomal compartments. Furthermore, these data hint that motifs LL and LR
regulate the level of Cx32 at the cell surface possibly by promoting endocytosis.

Regulation of endocytosis of Cx32 by motifs LL and LR
To examine the involvement of motifs LL and LR in regulating the endocytosis of
Cx32, we undertook the following experimental approaches. First: we knocked down the
heavy chain of clathrin using siRNA in LNCaP cells expressing Cx32-WT, Cx32-LL or
Cx32-LR.

Knockdown of clathrin has been shown to inhibit endocytosis of GJs

composed of Cx43 (Gumpert et al., 2008). Knockdown of clathrin enhanced the
formation of GJs composed of Cx32-WT but had no effect on the formation of GJs
composed of Cx32-LL (data not shown).

Second: we transiently expressed

constitutively active Rab5DA-GFP in LNCaP cells expressing Cx32-WT, Cx32-LL or
Cx32-LR. Compared to Cx32-WT, mutants Cx32-LL and Cx32-LR were less frequently
internalized into Rab5-positive vesicles (Figure 3.8A).

For example, Rab5-positive

vesicles containing Cx32-WT were 3 times more abundant than those containing Cx32LL or Cx32-LR (Figure 3.8B). Moreover, Cx32-WT was more robustly internalized into
Rab5-positive vesicles compared to Cx32-LL or Cx32-LR as assessed by counting the
number of Cx32-positive puncta (Figure 3.8C).

Furthermore, Cx32-LL or Cx32-LR

colocalized neither with clathrin and AP-2 nor with caveolin-1 (data not shown). These
data suggest that Cx32-WT is endocytosed by the clathrin-mediated pathway whereas
Cx32-LL or Cx32-LR are not significantly endocytosed by this pathway.
To examine if dileucine motifs LL and LR govern GJ formation directly by
regulating the endocytosis of Cx32, we retrovirally expressed Cx32-WT, Cx32-LL or
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Cx32-LR in another human pancreatic cancer cell line Capan-1.

In Capan-1 cells,

retrovirally-expressed Cx32-WT fails to form GJs because of endocytosis prior to GJ
formation (Johnson et al., 2013).

As is evident from immunocytochemical analysis,

Cx32-LL and Cx32-LR formed GJs whereas Cx32-WT did not (Figure 3.8D). To test if
Cx32-WT is endocytosed via the LL or LR motifs by the clathrin-mediated pathway, we
transiently expressed the mEGFP-tagged µ2 subunit of the AP-2 complex (μ2-GFP) in
HEK293T cells, which do not express Cx32, along with Cx32-WT, Cx32-LI, Cx32-LL,
Cx32-LR or Cx32-LL-LR.

Results showed that µ2-GFP coimmunoprecipitated with

Cx32-WT, Cx32-LI, Cx32-LL or Cx32-LR but not with Cx32-LL-LR (Figure 3.8E). These
data suggest that both the LL and LR motifs interact with the AP-2 complex directly or
indirectly and mediate the endocytosis of Cx32, and rendering these motifs
nonfunctional inhibits endocytosis. Collectively, the data shown in Figure 3.8 document
that the motifs LL and LR regulate the endocytosis of Cx32, whereas motif LI does not,
and that inhibition of endocytosis induces the formation of larger GJs.

The secretory itinerary of the dileucine mutant Cx32-LI
Dileucine motifs govern not only the endocytosis of transmembrane proteins but
also their intracellular sorting (Bonifacino, 2014; Bonifacino & Traub, 2003; Traub &
Bonifacino, 2013).

Because Cx32-LI largely remained in the cytoplasm as discrete

vesicular puncta (Figure 3.4A) and was biotinylated poorly (Figure 3.7A), we
investigated whether it was mis-sorted. Hence, we examined the secretory itinerary of
Cx32-WT and Cx32-LI.

We used the following markers for various subcellular

compartments: Calreticulin, an ER resident protein (Sonnichsen et al., 1994); ERGIC53,
an ERGIC marker; β-cop and Sec31A, markers for COPI and COPII containing vesicles,
respectively (Brandizzi & Barlowe, 2013; Hauri et al., 2000); GM130, a cis-Golgi marker
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(Nakamura et al., 1995); and TGN46, a marker for the TGN (De Matteis & Luini, 2008).
Neither Cx32-WT nor Cx32-LI colocalized discernibly with any of the secretory markers
under steady-state conditions both in LNCaP and BxPC3 cells (Figure 3.9AB). One
plausible explanation might be the rapid transit of Cx32 along the secretory pathway.
Hence, we used pharmacological approaches to define their secretory itinerary. We
used brefeldin A to block trafficking between ER and Golgi (Klausner et al., 1992) and
monensin to block trafficking between TGN and cell surface (Tartakoff, 1983).

We

observed a significant colocalization of Cx32-WT or Cx32-LI with TGN46 upon monensin
treatment (Figure 3.10A).

Measurement of Pearson’s colocalization coefficient

corroborated the immunocytochemical data (Figure 3.10B).

Neither Cx32-WT nor

Cx32-LI colocalized discernibly with calreticulin and GM130 upon treatment with
brefeldin A and monensin, respectively (Figure 3.10C,D).

For these experiments,

retention of E-cadherin in the ER, cis-Golgi, and TGN upon treatment with brefeldin and
monensin served as a positive control (Figure 3.11).
Previous studies showed that Cx43 was directly sorted from early secretory
compartments to lysosomes for degradation (Qin et al., 2003).

Hence, we tested

whether Cx32-LI was preferentially sorted to lysosomes. To test this notion, we first
examined the colocalization of LAMP-1 with Cx32-WT, Cx32-LI, Cx32-LL or Cx32-LR
immunocytochemically under steady-state conditions as well as upon treatment with 100
µM leupeptin, which inhibits the degradation of proteins in the lysosomes. Our results
showed that discernible colocalization was observed only upon treatment with leupeptin,
and there was no difference in the extent of colocalization between Cx32-WT or mutants
with LAMP1 (Figure 3.12AB). Next, we examined the degradation of Cx32-WT and
mutants by Western blot analysis (Figure 3.12C). The results showed that leupeptin
inhibited the degradation of Cx32-WT, Cx32-LI, Cx32-LL, and Cx32-LR equally,
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suggesting that Cx32-LI was not degraded preferentially in the lysosomes. Altogether,
the data in Figures 3.9, 3.10 and 3.12 suggest that Cx32-LI traffics normally to the TGN
and is not preferentially sorted to lysosomes.

Inhibition of endocytosis induces assembly of Cx32-LI
Since Cx32-LI did not mis-sort along the secretory pathway, we examined
whether it was rapidly endocytosed by the clathrin-mediated pathway into Rab5-positive
vesicles.

Immunocytochemical analysis showed that Cx32-LI colocalized discernibly

with clathrin in both LNCaP and BxPC3 cells (Figure 3.13A). Moreover, we observed
more Cx32-LI in Rab5-positive vesicles compared to Cx32-WT upon expressing
Rab5DA-GFP in LNCaP cells (Figure 3.13B). The mean number of Cx32-LI puncta per
Rab5-positive vesicle was 4 to 5-fold higher than the mean number of Cx32-WT puncta
(Figure 3.13C). These data suggested that Cx32-LI was endocytosed more robustly by
the clathrin-mediated pathway into Rab5-positive vesicles.

Therefore, we examined

whether inhibiting endocytosis would enhance the assembly of Cx32-LI into GJs. To test
this notion, we subjected cells to potassium (K+) depletion or hypertonic sucrose. Both
treatments inhibit clathrin-mediated endocytosis (Hansen et al., 1993; Heuser &
Anderson, 1989; Larkin et al., 1986). Alexa 488-conjugated epidermal growth factor
(EGF) was used as a positive control for endocytosis. Depletion of K+ or treating cells
with hypertonic sucrose for 2 h induced the assembly of Cx32-LI into GJs as assessed
immunocytochemically by the appearance of GJ like puncta at cell-cell interfaces, with a
concomitant 2-3 fold decrease in the number of intracellular puncta (Figure 3.13DFG).
As expected, Alexa 488-conjugated EGF was internalized in control cells but not in cells
subjected to K+ depletion or hypertonic sucrose (Figure 3.13D). Next, we used the cell
surface biotinylation assay to corroborate the immunocytochemical data. Hypertonic
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sucrose treatment or K+ depletion increased the cell surface expression of Cx32-LI
profoundly.

The biotinylation of E-cadherin was not discernibly affected in cells

expressing Cx32-LI (Figure 3.13.E). Quantification of the data from three independent
experiments showed that K+ depletion or hypertonic sucrose treatment increased cell
surface expression of Cx32-LI by 2 to 5-fold (data not shown). We also independently,
treated the above cells with 100 µM dynasore. Dynasore is a small molecule inhibitor of
dynamin, a GTPase essential for clathrin-dependent coated-vesicle formation (Damke et
al., 1994; Macia et al., 2006). We observed similar results as above, where treatment
with dynasore induced the assembly of Cx32-LI into GJs (Figure 3.14). These findings
suggest that Cx32-LI traffics normally to the cell surface but is endocytosed prior to GJ
formation by the clathrin-mediated pathway.

The LL and LR motifs regulate the endocytosis and assembly of Cx32-LI into gap
junctions
Our previous studies showed that expression of an endocytosis-defective Cx43
mutant restored the defective GJ assembly of endogenously-expressed Cx43 in BxPC3
cells (Johnson et al., 2013). Moreover, restoration of the defect in assembly occurred
through inhibition of endocytosis upon formation of heteromers between endogenously
expressed Cx43 and endocytosis-defective Cx43 mutant (Johnson et al., 2013). We
used a similar experimental approach to determine whether expression of endocytosisdefective Cx32-LL and Cx32-LR would inhibit the endocytosis of Cx32-LI. First, we
determined whether expression of Cx32-LL or Cx32-LR in trans would inhibit the
endocytosis of Cx32-LI. To test this notion, we engineered Myc-tagged Cx32-LI (Cx32LI-myc) and GFP-tagged Cx32-WT (Cx32-WT-GFP), Cx32-LI (Cx32-LI-GFP), Cx32-LL
(Cx32-LL-GFP) and Cx32-LR (Cx32-LR-GFP) constructs (Figure 3.15A).

Transient

74
expression of Cx32-LI-myc along with Cx32-LL-GFP or Cx32-LR-GFP, but not with
Cx32-LI-GFP, induced the assembly of Cx32-LI-myc into GJs in HEK293T cells.
Transient expression of Cx32-WT-GFP induced the assembly of Cx32-LI-myc partially
and only in cells where it was expressed in large excess of Cx32-LI-myc (Figure 3.15B,
top right panel). Moreover, Cx32-LI-myc co-localized nearly completely with Cx32-LIGFP, Cx32-WT-GFP, Cx32-LL-GFP or Cx32-LR-GFP (Figure 3.15B).

We used

HEK293T cells for these studies because of the poor transfection efficiency of BxPC3
and LNCaP cells. By expressing GFP-tagged Cx32-WT or various mutants in HEK293T
cells, we found that addition of GFP had no effect on the ability of various mutants to
assemble into larger GJs (except Cx32-LI) compared to Cx32-WT (data not shown). To
test whether Cx32-LI-myc formed heteromers with GFP-tagged Cx32-WT, Cx32-LL or
Cx32-LR, we transiently co-expressed Cx32-LI-myc along with Cx32-WT-GFP, Cx32-LIGFP, Cx32-LL-GFP or Cx32-LR-GFP in HEK293T cells. The results showed that Cx32LI-myc and GFP-tagged Cx32-WT, Cx32-LL or Cx32-LR co-immunoprecipitated with
each other (Figure 3.15C). Altogether, these data suggest that Cx32-LI-myc likely forms
heteromeric connexons with GFP-tagged Cx32-WT, Cx32-LL or Cx32-LR and motifs LL
and LR promote its endocytosis. Inhibiting endocytosis permits Cx32-LI to form GJs.
In the next series of experiments, we directly examined whether Cx32-LI is
endocytosed by the LL or the LR motif. Hence, we created a quadruple mutant Cx32-LILL in which leucine and isoleucine in the LI motif and both leucines in the LL motif were
mutated to alanines. Similarly, we also created the quadruple mutant Cx32-LI-LR in
which leucine and isoleucine in the LI motif and leucine and arginine in the LR motif
were mutated to alanines (Figure 3.16A). We then expressed Cx32-WT, Cx32-LI or
these quadruple mutants retrovirally in LNCaP and BxPC3 cells in parallel, and
assessed their expression by Western blotting (Figure 3.16B) and their ability to form
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GJs by immunocytochemical analysis (Figure 3.16C).

The results showed that

rendering the LL or LR motif alone nonfunctional overrode the effect of motif LI in
inducing the endocytosis of Cx32, conferring upon it the ability to form GJs.

As

assessed by the decrease in the number of intracellular puncta, motif LL appeared to be
more effective in inducing the endocytosis of Cx32 compared to motif LR (Figure
3.16D). To test whether motifs LL and LR collaborate in inducing the endocytosis of
Cx32, we created a mutant Cx32-LI-LL-LR in which all leucines as well as isoleucine and
arginine were mutated to alanines (Figure 3.16A). We expressed Cx32-LI-LL-LR or
Cx32-WT retrovirally in LNCaP and BxPC3 cells and examined GJ formation and
expression. We found that the Cx32-LI-LL-LR formed the largest GJs (Figure 3.16C).
The mean area of GJs formed of Cx32-LI-LL-LR was 1.5 times larger than those formed
by Cx32-WT, Cx32-LI-LL, and Cx32-LI-LR but was not larger than those formed of
Cx32-LL and Cx32-LR alone (Figure 3.16E). Taken together, the data shown in Figures
3.14 and 3.15 document that motifs LL and LR regulate the endocytosis of Cx32-LI.
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3. DISCUSSION

Defective trafficking and endocytosis of cell junctions, such as tight junctions and
adherens junctions, has emerged as a key event that triggers the initiation of a wide
variety of cancers (Mellman & Yarden, 2013; Scita & Di Fiore, 2010). Cell junctions
maintain the polarized and well-differentiated state of epithelial cells of exocrine glands,
such as prostate and pancreas (Rodriguez-Boulan & Macara, 2014). The polarized
acinar cells of these glands are also enriched in GJs, composed of Cx32, at their
basolateral domains (Meda, 2018), and are the primary target cell type that gives rise to
tumors (Shen & Abate-Shen, 2010). Hence, we explored which motifs in the carboxyl
tail of Cx32 regulate its endocytosis in human pancreatic and prostate cancer cell lines.
We discovered one tyrosine-based [YXXØ]-type and two dileucine-based [DE]XXXL[LI]type motifs in the CT of Cx32 (Thevenin et al., 2013). The tyrosine- and dileucine-based
motifs mediate not only the endocytosis but also the basolateral sorting of
transmembrane proteins (Bonifacino & Traub, 2003; Traub & Bonifacino, 2013). Here,
we explored the role of two dileucine-based motifs in regulating the trafficking,
endocytosis, and assembly of Cx32 into GJs in human pancreatic and prostate cancer
cell lines. One motif designated as LI was located near the juxtamembrane domain in
the CT of Cx32 whereas the other motif designated as LL was located distally (Figure
3.3C). Moreover, we fortuitously discovered an additional putative motif, designated
here as LR, when we randomly mutated leucine and arginine at position 263 and 264 to
serve as a control for examining the role of the LI and LL motifs in regulating the
intracellular sorting and assembly of Cx32 into GJs (Figure 3.3C). Our results showed
that rendering the LL or LR motif nonfunctional enhanced the formation of GJs
profoundly whereas rendering the LI motif nonfunctional had the opposite effect (Figure
3.4). Moreover, these motifs played no discernible role in governing the intracellular
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sorting of Cx32 or its transport from the TGN to the cell surface. Furthermore, rendering
the LL or LR motif nonfunctional, facilitated the formation of larger GJs by preventing the
endocytosis of Cx32 by the clathrin-mediated pathway into Rab5-positive vesicles
whereas rendering the LI motif nonfunctional, inhibited GJ formation by augmenting its
endocytosis via the LL and LR motifs.
The dileucine mutant Cx32-LL and the mutant Cx32-LR formed larger GJs
compared to Cx32-WT (Figure 3.4AC), with a concomitant decrease in the number of
GJs per cell-cell interface (Figure 3.4D). The cell surface biotinylation data suggested
that Cx32-LL and Cx32-LR trafficked normally to the cell surface (Figure 3.7A) but were
degraded with slower kinetics (Figure 3.7BC). These findings rule out a role of the LL
and LR motifs in controlling the trafficking of Cx32 from the TGN to the cell surface, and
implicate their role in regulating the endocytosis and/or degradation of Cx32 at the cell
surface to affect GJ formation. How GJs nucleate remains poorly understood (Falk et
al., 2016; Thevenin et al., 2013). However, it is well-established that after nucleation the
subsequent growth of a GJ plaque occurs upon recruitment of connexons to its
periphery by diffusion (Gaietta et al., 2002; Lauf et al., 2002; Simek et al., 2009; Thomas
et al., 2005) or upon direct delivery of connexons to its vicinity (Shaw et al., 2007).
Therefore one plausible explanation for the formation of large GJs by Cx32-LL and
Cx32-LR might be that they are less efficiently endocytosed — both as connexons from
non-junctional membranes, which allows them to diffuse to the plaque periphery and
incorporate into the plaque to increase its size, and as cell-cell channels from the center
of the plaque. Three independent lines of evidence support this line of thought. First,
compared to Cx32-WT, which colocalized discernibly with clathrin and was robustly
internalized into Rab5-positive vesicles (Figure 3.2), mutants Cx32-LL and Cx-LR did not
colocalize with clathrin, and were rarely seen in Rab5-positive vesicles (Figure 3.8ABC).
Second, knockdown of clathrin in cells expressing Cx32-WT increased the size of GJs
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whereas knockdown had no discernible effect on the size of GJs composed of Cx32-LL
or Cx32-LR (data not shown). Earlier studies also showed that knockdown of clathrin
reduced endocytosis of Cx43 (Gumpert et al., 2008).

Finally, when expressed

retrovirally in Capan-1 cells, Cx32-LL or Cx32-LR formed GJs, whereas Cx32-WT did
not (Figure 3.8D).

These findings suggest that the LL or LR motif govern the

endocytosis of Cx32 by the clathrin-mediated pathway, and inhibiting endocytosis is
sufficient to induce the formation of GJs.
Previous studies showed that two distinct tyrosine-based motifs controlled the
assembly of Cx43 into GJs cooperatively (Fong et al., 2013). Our results with Cx32
showed that rendering the LL or LR motif nonfunctional enhanced the assembly of Cx32
into GJs equally; and there seemed to be no cooperativity between the LL and the LR
motifs. In contrast, rendering the LI motif non-functional inhibited the formation of GJs
profoundly (Figure 3.4AC). Moreover, our results with quadruple mutants Cx32-LI-LL
and Cx32-LI-LR showed that mutating the LL or LR motif alone was sufficient to override
the effect of LI motif in inhibiting assembly of Cx32 into GJs. Furthermore, mutant Cx32LI-LL-LR in which all motifs were rendered nonfunctional formed the largest GJs (Figure
3.16E), suggesting that both the LL and the LR motifs are likely used cooperatively to
regulate endocytosis when the LI motif is rendered non-functional.

Thus, our data

implicate a complex cross talk among the LI, LL and LR motifs in regulating the
endocytosis of Cx32 and its subsequent ability to form GJs, and imply that mechanisms
must exist to selectively activate or inactivate these motifs. Our ongoing studies are
exploring the mechanisms involved in activating or inactivating these motifs in response
to various physiological stimuli in LNCaP and BxPC3 cells.
The most surprising findings regarding the role of motif LI in controlling the
trafficking and endocytosis of Cx32 was the failure of Cx32-LI to assemble into GJs and
its detergent solubility (Figure 3.4A and Figure 3.5A).

Moreover, Cx32-LI was also
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biotinylated poorly (Figure 3.7A). The dileucine-based [DE]XXXL[LI]-type motifs not only
interact with the AP-2 complex to govern endocytosis but also with the AP-1, AP-3 and
AP-4 complexes to regulate sorting from the TGN to cell surface, sorting from the TGN
to lysosomes and retrograde transport from endosomes to the TGN, respectively
(Bonifacino & Traub, 2003; Traub & Bonifacino, 2013). Previous studies demonstrated
direct sorting of Cx43 from the early secretory compartment to lysosomes (Qin et al.,
2003) and showed multiple routes by which different Cxs trafficked to the cell surface
(George et al., 1999; Martin et al., 2001). However, our results showed that Cx32-LI
trafficked normally to the TGN (Figure 3.10) and was trapped neither in secretory
vesicles (Figures 3.9 and 3.10) nor was preferentially sorted to lysosomes (Figure 3.12).
Moreover, inhibiting endocytosis with K+ depletion or hypertonic sucrose increased its
amenability to cell surface biotinylation and induced its assembly into GJs as assessed
immunocytochemically (Figure 3.13DE).

These findings suggest that the dileucine-

based LI motif in Cx32 neither acts as an endocytic motif nor controls its trafficking from
ER to lysosomes, from TGN to lysosomes, and from TGN to cell surface. However, we
found that the LL and LR motifs act in concert to induce endocytosis of Cx32 by the
clathrin-mediated pathway into Rab5-positive vesicles.

Several lines of evidence

support this interpretation. First, Cx32-LI colocalized significantly with clathrin (Figure
3.10A) and was internalized robustly into Rab5-positive endosomes compared to Cx32WT (Figure 3.10BC). Second, coexpression of Cx32-LI-myc along with Cx32-WT-GFP,
Cx32-LL-GFP or Cx32-LR-GFP in HEK293T cells resulted in the assembly of Cx32-LImyc into GJs whereas coexpression of Cx32-LI-GFP had no effect (Figure 3.15). Third,
rendering the LL or LR motif nonfunctional in Cx32-LI, as in mutants Cx32-LI-LL and
Cx32-LI-LR, restored GJ formation (Figure 3.16C, compare column 2 with columns 3
and 4). Fourth, rendering both the LL and LR motifs nonfunctional, as in mutant Cx32LI-LL-LR, not only enhanced the formation of GJs profoundly (Figure 3.16C, column 5)
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but also reduced intracellular accumulation of the mutant (Figure 3.16D), suggesting that
this mutant was barely endocytosed. Fifth, when expressed retrovirally in Capan-1 cells,
in which Cx32-WT does not form GJs, Cx32-LL and Cx32-LR were assembled into
distinct GJs (Figure 3.8D).

Finally, only Cx32-LL-LR failed to interact directly or

indirectly with µ2-GFP (Figure 3.8E).
In essence, our studies have shown that multiple motifs govern the endocytosis
of Cx32 and its ability to form GJs. The two canonical dileucine-based motifs LI and LL
play no discernible role in regulating intracellular trafficking of Cx32 or its transport from
the TGN to cell surface but regulate its endocytosis directly or indirectly. The motif LL is
the endocytic motif whereas motif LI is not. We have explored the various possible roles
of the LI motif, which is discussed in subsequent chapter IV. Our studies have also
identified the non-canonical motif LR fortuitously, and have shown it to be an endocytic
motif. The assembly of Cx32 into GJs is profoundly enhanced upon rendering the LL or
LR motif nonfunctional whereas rendering the LI motif non-functional facilitates
endocytosis via the LL or LR motif. Our studies have shown that these dileucine-based
motifs play distinct as well as overlapping roles in regulating the endocytosis of Cx32.
How these motifs are utilized to regulate endocytosis of Cx32 to induce the formation of
GJs in response to hormones and other physiological stimuli in various cell types,
including polarized cells, remains to be explored.
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Figure 3.1. Retroviral expression of Cx32 in LNCaP and BxPC3 cells. BxPC3 and
LNCaP cells were infected with control retrovirus, which confers resistance to neomycin
(Neo)
and
Cx32-harboring
retrovirus. Cx32
expression
was
assessed
immunocytochemically (A) and by Western blotting (B). Note that in LNCaP (LN-32) and
BxPC3 (Bx-32) cells infected with the Cx32 retrovirus, Cx32 (red) is detected at cell-cell
interfaces, delineated by E-cadherin (E-Cad, green) staining at cell-cell contact areas but
not in cells infected with the control retrovirus (LN-Neo, Bx-Neo). Note also robust
expression of Cx32 in LN-32 and Bx-32 cells. LN-WT and Bx-WT are the parental
LNCaP and BxPC3 cells, respectively. Scale bar = 30 μm.
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Figure 3.2. Cx2 is endocytosed by the clathrin-mediated pathway in Rab5-positive
endosomes. A. Bx-32 and LN-32 cells were immunostained for Cx32 (red) and
clathrin, AP-2, or caveolin-1 (Cav-1) (green). The enlarged images of boxed areas in the
panels are shown towards right of each panel. Note discernible colocalization of Cx32
with clathrin or AP-2 and lack of colocalization with Cav-1. Scale bar = 20 μm. B. Cells
were transfected with EGFP-tagged dominant active Rab5 (Rab5DA-GFP) and
immunostained for Cx32. The enlarged images of boxed areas in the panels are shown
below each panel. Note the presence of Cx32 (red) in large Rab5-positive (green)
vesicles. Scale bar = 30 µm (top panels) and 2 µm (enlarged boxed areas).
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Figure 3.3. A schematic diagram showing the topology of Cx32 and the location
of sorting motifs. A. Topology of Cx32. The position of sorting motifs is indicated by
the numbered arrows pointing towards the encircled areas. Tyrosine-based [YXXØ]type motifs are: YTLL (1) and YLII (3, red circle). The two dileucine-based
[DE]XXXL[LI]-type motifs are: EVVYLI (2) and EINKLL (4). An additional putative motif
LKDILR (5) is also shown. TM1-TM4 are the transmembrane domains. EC1 and EC2
are the extracellular loop domains. The NH2 and COOH are the amino and the carboxyl
termini, respectively. A single letter denotes an amino acid. B. Top: Position of sorting
motifs in wild-type Cx32’s CT. The numbers on left and right indicate amino and
carboxyl termini, respectively. The motifs are circumscribed in dashed rectangles and
the critical amino acids in motifs are shown in red. The numbers in blue below the
circumscribed rectangles indicate the position of amino acids that were mutated.
Bottom: Mutants generated. The mutated amino acids in circumscribed rectangles are
indicated in red. The names of mutants are also shown in brackets. L=leucine;
I=Isoleucine; and A=alanine. In L212A/I213A (Cx32-LI), leucine at position 212 and
isoleucine at position 213 were mutated to alanines. In L251A/L252A (Cx32-LL),
leucines at positions 251 and 252 were mutated to alanines. In mutant L263A/R264A
(Cx32-LR), leucine at position 263 and arginine at position 264 were mutated to alanine
whereas in mutant Cx32-LL-LR all four critical residues were mutated.
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Figure 3.4. The dileucine motifs regulate gap junction size. A. Cells expressing
Cx32-WT or mutants were immunostained for Cx32 (red) and E-cadherin (green). Note
that Cx32-LL, Cx32-LR, and Cx32-LL-LR form larger GJs whereas Cx32-LI remains
largely cytosolic. Nuclei are in blue. B. Western blot analysis of total cell lysates from
cells expressing Cx32-WT or mutants, showing robust and near equal expression. C.
GJ areas of cells expressing Cx32-WT or mutants. Areas (Mean ± SEM) of 350 distinct
GJ puncta, from 3-5 microscopic fields from 3 independent experiments were
determined using the measurement module of Volocity. The surface area (SA) is
represented in µm2. Note 2 to 3-fold increase in the mean GJ area in cells expressing
mutants. D. The number of GJs per cell-cell interface in cells expressing Cx32-WT or
mutants. GJs from 45-65 randomly chosen cell-cell interfaces were chosen from 3
independent experiments and the mean number of GJ puncta per cell-cell interface was
plotted. The difference in the mean number of puncta per cell-cell interface between
cells expressing Cx32-WT or mutants was statistically highly significant (p < 0.001). LI =
Cx32-LI, LL= Cx32-LL, and LR = Cx32-LR.

88

89
Figure 3.5. Detergent-solubility of Cx32-WT and mutants. A. Western blot analysis of
Cx32 in Total (T), TX100-soluble (S), and TX100-insoluble (I) fractions from LNCaP (left)
and BxPC3 (right) cells expressing Cx32-WT, Cx32-LI, Cx32-LL or Cx32-LR. Note a
significant detergent-soluble fraction in cells expressing Cx32-LI. B. Quantitation of the
Western Blot data in LNCaP cells, shown here as percentages of the total protein
amount. IS = Insoluble fraction, S = soluble fraction.
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Figure 3.6. Gap junctional communication of BxPC3 cells expressing Cx32-WT,
Cx32-LI, Cx32-LL or Cx32-LL. A. Junctional transfer of Alexa 488 and Alexa 594 in
LNCaP cells expressing Cx32-WT or various mutants. Mean number of fluorescent cell
neighbors within 5-10 minutes after microinjection of Alexa 488 or Alexa 594 into test
cells are shown. The total number of injection trials is shown above the bars. The
differences in the numbers of communicating cells (showing dye transfer) between
Cx32-WT and Cx32-LI as well as between Cx32-LL and Cx32-LI were statistically
significant with p<0.001. There was no statistically significant difference in the numbers
of communicating cells between Cx32-WT and Cx32-LL. B. Cells were scrape-loaded
with rhodamine-conjugated dextran (R-DEX) and Lucifer Yellow (LY). Note the lack of
discernible difference in the junctional transfer of LY between BxPC3 cells expressing
Cx32-WT (WT), Cx32-LI (LI), Cx32-LL (LL) or Cx32-LR (Ullrich et al.). Scale bar = 120
μm.
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Figure 3.7. Kinetics of degradation of Cx32-WT and mutants. A. LNCaP cells
expressing Cx32-WT, Cx32-LI, Cx32-LL orCx32-LR were cell-surface biotinylated (Biotin
+). Biotinylated proteins were pulled down by streptavidin (Pull) and immunoblotted for
Cx32 and E-cadherin (E-cad). A non-biotinylated dish was kept as a control (Biotin -).
B. Cell-surface-associated mutants degrade with a slower kinetics in LNCaP cells.
Kinetics of degradation was determined by incubating cells for 0-6 h at 37°C after cell
surface biotinylation. For input, 10 µg of total protein was used and immunoblotted for
Cx32. C. The blots were quantified and values from three independent experiments
were plotted graphically as best-fit curve after normalization of the input for each time
point. Note that nearly 50% Cx32-WT is degraded within 2-3 h whereas Cx32-LL and
Cx32-LR are degraded at a much slower rate.
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Figure 3.8. Motifs LL and LR regulate the endocytosis of Cx32. A. Cx32-LL and
Cx32-LR are less efficiently endocytosed in Rab5-positive vesicles compared to Cx32WT. LNCaP cells expressing Cx32-WT, Cx32-LL or Cx32-LR were transfected with
Rab5DA-GFP and immunostained for Cx32. The enlarged images of boxed areas in the
panels are shown above. Note the presence of abundant Cx32 (red) in large Rab5positive (green) vesicles in cells expressing Cx32-WT compared to cells expressing
Cx32-LL or Cx32-LR. Scale bar = 30 μm (bottom panels) and 2 μm (enlarged boxed
areas). B. Number of Rab5-positive vesicles, containing at least one Cx32-positive
punctum, was quantitated in cells transfected with Rab5DA-GFP in three independent
experiments. In each experiment between 10-20 vesicles in three separate fields were
counted. The number of vesicles scored was 112 for Cx32-WT (range 30-50), 121 for
Cx32-LL (range 30-55), and 128 for Cx32-LR (range 40-52) including all experiments.
C. Intracellular Cx32 puncta in Rab5-positive vesicles were quantified in cells transfected
with Rab5DA-GFP. Cx32 puncta from 10-15 cells, with 2-3 Rab5-positive vesicles per
cell, were counted from three separate experiments. The number of puncta per vesicle
ranged from 2-19 in different vesicles. Values are significantly different from the control
(p≤0.001) as assessed by the two-tailed unpaired Student’s t test. D. Cx32-LL and
Cx32-LR form GJs in Capan-1 cells. Cx32-WT, Cx32-LL or Cx32-LR were retrovirally
expressed in Capan-1 cells and immunostained for Cx32 (red) and β-catenin (β-cat,
green). Note that only mutants Cx32-LL or Cx32-LR are assembled into GJs (white
arrows in the middle and right panels). Nuclei are shown in blue. Scale bar = 30 μm. D.
HEK293T cells (in 10-cm dishes) were transfected with Cx32-WT and Cx32-LL, Cx32LR, Cx32-LI or Cx32-LL-LR along with mEGFP-tagged μ2 subunit of AP2 complex (μ2GFP). After 24 h, Cx32 was pulled down from the whole cell lysates and the
immunoprecipitates were immunoblotted with anti-GFP antibody (GFP). The inputs (20
μg) were immunoblotted with Cx32 antibody (Cx32). Note a significant decrease in
interaction of Cx32-LL-LR with μ2-GFP.
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Figure 3.9. The secretory itinerary of Cx32-WT and Cx32-LI in LNCaP and BxPC3
cells. (A) LNCaP or (B) BxPC-3 cells expressing Cx32-WT (upper two panels) or Cx32LI (lower two panels) were immunostained for Cx32 (red) and calreticulin, ERGIC53,
Sec31A, β-cop, GM130 or TGN46 (green). The enlarged images of boxed areas in the
panels are shown towards right. Note the lack of discernible colocalization of Cx32-WT
or Cx32-LI with the indicated markers. Calret = calreticulin; β-Cop = β-cop.
Scale bar = 20 μm.

98

99
Figure 3.10. Cx32-LI traffics normally till the trans-Golgi network A. LNCaP cells
expressing Cx32-WT (LN-32-WT) or Cx32-LI (LN-32-LI) were treated with vehicle
(Control) or 10 µM monensin (Monensin) for 8 h and immunostained for Cx32 (red) and
TGN46 (green). The enlarged images of boxed areas in the panels are shown at the top
right. Note there is discernible colocalization of Cx32-WT and Cx32-LI with TGN46 upon
monensin treatment.
B. Pearson’s colocalization coefficient (PCC). PCC was
determined from 9 different microscopic fields from three independent experiments.
Three fields were chosen from each experiment and between 4-5 cells were chosen in
each field. The difference in the mean PCC values between control and monensintreated cells was statistically highly significant (p ˂ 0.001). Scale bar = 30 µm. C and D.
Cx32-WT and Cx32-LI colocalize poorly with calreticulin and GM130 upon brefeldin and
monensin treatment. LNCaP cells expressing Cx32-WT (LN-32-WT) or Cx32-LI (LN-32LI) were treated with vehicle (Control) or 10 μM brefeldin (C) or monensin for 8 h (D).
Cells were immunostained for Cx32 (red) and calreticulin (Calret, green) or GM130
(green). The enlarged images of boxed areas in the panels are shown at the top right.
Note the lack of discernible colocalization of both Cx32-WT and Cx32-LI with calreticulin
and GM130. Scale bar = 30 μm.
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Figure 3.11. Brefeldin A and monensin inhibit the trafficking of E-cadherin. LNCaP
cells expressing Cx32-WT were treated with vehicle (Control) or 10 μM brefeldin A
(Brefeldin) or 10 μM monensin (Monensin) for 8 h. Cells were immunostained for Ecadherin (E-cad, green) and calreticulin (Calret, red), GM130 (red) or TGN46 (red). The
enlarged images of boxed areas in the panels are shown at the bottom right. Note
discernible colocalization of E-cad with calreticulin and GM130 upon brefeldin treatment
and with TGN46 upon monensin treatment. Scale bar = 30 μm.
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Figure 3.12. Cx32-WT and mutants are routed to lysosomes for degradation.
BxPC3 cells expressing Cx32-WT or mutants were either treated with vehicle (Control)
or 100 μM leupeptin for 8 h. Cells were immunostained for Cx32 (red) and Lamp-1
(green). A. BxPC3 cells expressing Cx32-WT (Bx-32-WT) or Cx32-LI (Bx-32-LI). The
enlarged images of boxed areas in the panels are shown at the top right. Scale bar = 20
μm. B. BxPC3 cells expressing Cx32-LL (Bx-32-LL) or Cx32-LR (Bx-32-LR). Note there
is discernible colocalization of Cx32-WT and mutants with Lamp1. Scale bar = 20 μm.
C. Confluent BxPC3 cells expressing Cx32-WT (WT), Cx32-LI (LI), Cx32-LL (LL) and
Cx-32-LR (Ullrich et al.) were treated as described above. Expression level of Cx32 and
mutants was determined by Western blot analysis. Note the inhibition of degradation of
Cx32-WT and the mutants upon treatment with leupeptin.
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Figure 3.13. Cx32-LI is endocytosed by the clathrin-mediated pathway and
inhibition of endocytosis induces its assembly into gap junctions. A. LNCaP and
BxPC3 cells expressing Cx32-LI were immunostained for Cx32 (red) and clathrin
(green). The enlarged images of boxed areas in the panels are shown towards right.
Note the discernible colocalization of Cx32-LI with clathrin. B. LNCaP cells expressing
Cx32-WT or Cx32-LI were transfected with Rab5DA-GFP and immunostained for Cx32
(red). The enlarged images of boxed areas in the panels are shown towards right. Note
copious internalization of Cx32-LI in Rab5-positive vesicles. Scale bar = 30 µm. C. The
number of Cx32-positive puncta in LNCaP cells expressing Cx32-WT (WT) or Cx32-LI
(LI) in 30-35 Rab5-positive vesicles was counted from 2 independent experiments. Note
a nearly 3-fold increase in the number of Cx32-LI puncta per Rab5-positive vesicle
compared to Cx32-WT. The two-tailed p value is less than 0.0001. D. Potassium
depletion or hypertonic sucrose treatment induces the assembly of Cx32-LI into GJs.
BxPC3 cells expressing Cx32-LI were labeled with Alexa 488-conjugated EGF and were
left untreated or subjected to K+ depletion (K+) or hypertonic sucrose treatment (Suc) for
2 hours. Cells were immunostained for Cx32 (red). Note formation of GJs at cell-cell
contact areas. Note internalization of Alexa 488-conjugated EGF in control cells but not
in cells subjected to K+ depletion or hypertonic sucrose treatment. Scale bar = 20 µm.
E. BxPC3 and LNCaP cells expressing Cx32-LI were subjected to K+ depletion or
hypertonic sucrose treatment as in D and cell surface biotinylated. Note enhancement
of cell surface biotinylation of Cx32-LI in cells subjected to K+ depletion or hypertonic
sucrose treatment. F. Mean ± SEM of GJs per cell-cell interface were counted in
control cells (C) or cells subjected to K+ (K) or hypertonic sucrose (S) treatment and
plotted. The number of cell-cell interfaces examined were 27, 36 and 26 for C, K and S,
respectively. G. Mean ± SEM of intracellular puncta per cell in control cells (C) or cells
subjected to K+ (K) or hypertonic sucrose (S) treatment were counted and plotted. The
number of cells counted were 27, 35 and 30 for C, K and S, respectively. The data were
obtained from 3 different microscopic fields from three independent experiments. The
treatments were for 2 h at 37ºC. * indicates p<0.001 in C,F and G.
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Figure 3.14. Dynasore treatment induces the assembly of Cx32-LI into gap
junctions. A. BxPC3 cells expressing Cx32-LI were labeled with Alexa 594-conjugated
Transferrin (Tfr) and were left untreated or subjected to dynasore treatment (100 µM) for
the indicated times. Cells were immunostained for Cx32 (green). Note formation of GJs
at cell-cell contact areas. Note internalization of Alexa 594-conjugated Tfr in control
cells but less in cells subjected to dynasore treatment. B. These cells were parallely
treated with dynasore (100 µM) for 1 h, 2h and 4h and fixed and immunostained with
Cx32 (green) and β-catenin (β-cat, red). Note that in treated cells as compared to
control, Cx32-LI formed GJs at the cell-cell interfaces.
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Figure 3.15. Expression of Cx32-LL and Cx32-LR induces assembly of Cx32-LI
into gap junctions. A. A schematic diagram showing the various constructs used.
HEK293T cells seeded in six well clusters (B) or 10-cm dishes (C) were transiently
transfected with pcDNA3.1 vectors (PC) encoding Cx32-LI-myc (LI-myc) along with PC
vectors encoding Cx32-WT-GFP (WT-GFP), Cx32-LI-GFP (LI-GFP), Cx32-LL-GFP (LLGFP) or Cx32-LR-GFP (LR-GFP). After 24 h, cells were immunostained for Myc (B) or
EGFP-tagged proteins were pulled down with immobilized anti-GFP antibody and
immunoblotted with anti-Myc and anti-GFP antibodies (C). Note that coexpression of
Cx32-WT, Cx32-LL or Cx32-LR induced the assembly of Cx32-LI-myc (red) into GJs (B).
Note that Cx32-LI-myc co-immunoprecipitates with Cx32-WT, Cx32-LL and Cx32-LR
(C). Scale bar = 20 μm.
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Figure 3.16. The dileucine mutant Cx32-LI is endocytosed via the LL and LR
motifs. A. A schematic diagram showing the location of the amino acids mutated in the
sorting motifs of Cx32. In the mutant LI-LL, only the LR motif (green) is functional. In
mutant LI-LR, only the LL motif (green) is functional whereas in mutant LI-LL-LR, all
motifs are non-functional. The mutated residues are shown in red. The numbers in
black indicate the positions of the mutated amino acid residues. Slanted blue lines
indicate missing residues between amino acids 220 and 246. B. Western blot analysis
of total cell lysates from cells expressing Cx32-WT or mutants. Lanes corresponding to
mutants LI-LL and LI-LL-LR are labeled as 4M and 6M, respectively. Lanes indicating
the expression of mutant LI-LR are not shown. C. BxPC3 and LNCaP cells expressing
Cx32-WT (WT), Cx32-LI (LI), Cx32-LI-LL (LI-LL), Cx32-LI-LR (LI-LR) or Cx32-LI-LL-LR
(LI-LL-LR) were immunostained for Cx32 (red) and β-catenin (green). Note that Cx32-LI
fails to form GJs whereas other mutants form GJs. Note also that Cx32-LI-LL-LR forms
the largest GJs. Nuclei are in blue. Scale bar = 20 µm. D. The dileucine mutant Cx32LI is endocytosed via the LL and LR motifs. Mean ± SEM of intracellular puncta in cells
expressing Cx32-WT and various mutants. For each mutant, intracellular puncta from
30-35 cells were counted from 5 different microscopic fields from two independent
experiments. The difference in the number of intracellular puncta between Cx32-LI and
Cx32-WT, Cx32-LI-LL, Cx32-LI-LR or Cx32-LI-LL-LR in LNCaP cells is statistically
significant, with p< 0.0001, as determined by Student’s t-test (unpaired). The difference
in number of intracellular puncta between Cx32-LI and Cx32-LI-LR in BxPC3 cells was
statistically significant with p< 0.001. E. The LL and LR motifs cooperate to restore
defective assembly of Cx32-LI. Mean ± SEM of surface areas of 30-150 individual GJ
puncta were measured in two independent experiments. The difference in surface areas
between Cx32-LI and the mutants is statistically significant with p<0.0001. The
difference between Cx32-LI and Cx32-LI-LR in BxPC3 cells is statistically significant with
p<0.001.
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Chapter IV

Role of the LI Dileucine Motif
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1. INTRODUCTION
Epithelial cells are morphologically and functionally polarized. The apical and
basolateral surfaces have distinct composition of cell surface proteins and lipids. This
polarity is achieved and maintained through proper sorting and targeting of newly
synthesized proteins to apical or basolateral membrane domains (Rodriguez-Boulan &
Macara, 2014). Both apical and basolateral sorting depends on recognition of specific
motifs on the cargo proteins. In contrast to basolateral sorting determinants, apical
sorting determinants are highly diverse and remain poorly defined. Basolateral sorting is
determined by specific amino acids motifs in the cytoplasmic domains of membrane
proteins (Bonifacino & Traub, 2003). Correct sorting of Cxs to the basolateral domain is
essential in maintaining the architecture and functioning of the highly polarized cells of
exocrine glands as mis-sorted Cxs could disrupt the intracellular milieu by allowing the
leakage of important metabolites and signaling molecules (Michon et al., 2005). To
date, no studies have been aimed at elucidating the basolateral sorting determinants for
Cxs.
Dileucine-based motifs mediate endocytosis and basolateral sorting

of

transmembrane proteins by interaction with different clathrin adaptor protein (AP)
complexes (Bonifacino & Traub, 2003; Traub & Bonifacino, 2013) (Figure 4.1). Many
studies using polarized epithelial cell systems have reported dileucine motif-mediated
basolateral targeting of various membrane proteins.

A dileucine-based motif in the

cytoplasmic tail of E-cadherin targets it to the basolateral domain in polarized cells
(Miranda et al., 2001). The cytosolic domain of the IgG Fc receptor harbors a dileucinebased motif, which is responsible for its basolateral targeting (Hunziker & Fumey, 1994).
A dileucine-based sorting motif in the cytoplasmic tail of the nucleotide-pyrophosphatase
NPP1 regulates its basolateral targeting but not endocytosis (Bello et al., 2001). From
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our findings reported in Chapter III, we identified two dileucine-based motifs (referred to
as LI and LL) and one non-canonical motif (referred to as LR) in the CT of Cx32. While
the LL and LR motifs controlled endocytosis of Cx32, the role of the LI motif was not
elucidated.

This LI

motif (sequence EVVYLII) (Figure 3.3) neither acted as an

endocytic motif for Cx32 nor controlled its trafficking from ER to lysosomes, from TGN to
lysosomes, and from TGN to cell surface in LNCaP and BxPC3 cells. Therefore, in this
study, we sought to explore the role of the LI motif in regulating the basolateral sorting of
Cx32 in polarized cells.
The most surprising finding of our studies presented in Chapter III with regard to
role of dileucine-based motifs in controlling the trafficking and endocytosis of Cx32 was
that the mutant Cx32-LI failed to form GJs, remained predominantly intracellular as
discrete vesicular puncta that were detergent-soluble (Figures 3.4 and 3.5), and was
biotinylated poorly (Figure 3.7). Our results showed that Cx32-LI trafficked normally till
the TGN like Cx32-WT (Figure 3.10) and neither was mis-sorted to other subcellular
compartments (Figure 3.9) nor sorted to the lysosomes preferentially (Figure 3.12).
Moreover, inhibiting endocytosis with K+ depletion or hypertonic sucrose treatment
increased its amenability to cell surface biotinylation and restored assembly (Figure
3.13). We showed that rendering the LI motif nonfunctional induced rapid endocytosis of
Cx32 by clathrin-mediated pathway via the LL or LR motifs (Figure 3.16). Therefore, we
reasoned that the lack of assembly of Cx32-LI into GJs and its rapid endocytosis may be
related to the fact that the LI motif is a hybrid motif where the tyrosine-based YLII motif
(consensus sequence YXXɸ), which mediates the endocytosis of transmembrane
proteins by the clathrin-mediated pathway, overlaps with the dileucine-based motif LI
(sequence EVVYLI) (Figure 4.10A) (Bonifacino, 2014; Bonifacino & Traub, 2003;
Carvajal-Gonzalez et al., 2012; Traub & Bonifacino, 2013).
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Tyrosine-based motifs conform to the sequence YXXɸ in which the tyrosine (Y) is
separated by two random amino acids (X) from an amino acid with a bulky hydrophobic
side chain (ɸ). The Y residue is the most critical for function of YXXɸ motif and mutating
it to any other amino acid abrogates its function.

The YXXɸ motif mediates rapid

internalization of receptors, such as the transferrin receptor, from the cell surface as well
targets them to various endosomal compartments: the lysosomes (for example,
lysosomal membrane proteins like LAMP-1), the TGN (for example, TGN proteins like
TGN38) and the basolateral surface of polarized epithelial cells, (for example, prestin, a
motor protein in outer hair cells) (Bonifacino & Traub, 2003; Collawn et al., 1993; Zhang
et al., 2015). Our findings reported in this chapter suggest that the dileucine-based motif
LI is a hybrid motif with an embedded tyrosine-based endocytic motif YLII. They further
suggest that the LI motif plays distinct role in non-polarized and polarized cells in
regulating basolateral sorting of Cx32.
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2. RESULTS
Role of the LI motif in polarized sorting
Our previous results showed that in non-polarized or tumor cells, the dileucinebased LI motif did not function as an endocytic motif (Chapter III).

Earlier studies

showed that dileucine-based motifs mediated basolateral sorting in polarized cells as
discussed before (Bello et al., 2001; Hunziker & Fumey, 1994; Miranda et al., 2001).
Hence, we rationalized that the LI motif might regulate the basolateral sorting of Cx32 in
polarized cells. To test this notion, we chose MDCK-II (Madin-Darby Canine Kidney)
cells. MDCK cells are one of the most well characterized systems to study mechanisms
regulating polarity, membrane trafficking, and cell-cell adhesion (Bryant & Mostov,
2008). The first report establishing MDCK as a suitable cell line to study polarized
trafficking came from studies of asymmetric budding of viruses, where influenza virus
was seen to bud exclusively from the free (apical) surface of infected cells, while
vesicular stomatitis virus acquired its envelope from the basolateral PM (Rodriguez
Boulan & Sabatini, 1978).

MDCK-II cells do not express Cx32 as confirmed

immunocytochemically by us (data not shown). We thus freshly introduced Cx32-WT,
Cx32-LI or Cx32-LL retrovirally in MDCK-II cells and obtained pooled populations
expressing Cx32-WT, Cx32-LI or Cx32-LL (See Materials and Methods). In Cx32-LI, the
LI motif (EVVYLI) is non-functional whereas in Cx32-LL, the LL motif (EINKLL) is nonfunctional (Figure 3.3). Cx32-LL was used as an additional control for deciphering the
LI motif’s role in basolateral sorting.

These pooled populations of MDCK-II cells

expressing Cx32-WT, Cx32-LI or Cx32-LL were heterogeneous. Therefore, we isolated
several individual clones (approximately 10 for each pooled population). Each individual
clone was immunostained for Cx32 (red) and β-catenin (green) to examine GJ formation
and only those clones expressing Cx32 homogenously were used (Figure 4.2A).
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Immunocytochemical analysis showed that Cx32-LI failed to form GJs in MDCK-II cells
grown on plastic, whereas Cx32-WT and Cx32-LL formed GJs. However, in MDCK-II
cells, Cx32-LL did not form larger GJs compared to Cx32-WT as was observed in
LNCaP and BxPC3 cells (Figure 3.4). Total cell lysate from each clone was used for
western blot analysis to assess Cx32 expression (Figure 4.2B).

Based on

immunocytochemical and western blot data, clones A8, B9 and D7, representing Cx32WT, Cx32-LI and Cx32-LL, respectively, were chosen for further studies. To assess if
Cx32-WT and mutants trafficked normally to the cell surface in MDCK-II cells grown on
plastic, we performed a cell surface biotinylation assay. The results showed that Cx32WT and Cx32-LL were robustly biotinylated whereas Cx32-LI was poorly biotinylated as
was observed previously with LNCaP cells (Figure 3.7). There was no difference in the
biotinylation of E-cadherin, a cell surface protein, which was used as a positive control
(Figure 4.3).
Next, we examined the localization of Cx32 and the dileucine mutants in
polarized MDCK-II cells. We grew the selected clones of MDCK-II cells expressing
Cx32-WT, Cx32-LI or Cx32-LL on transwell filters for 5-6 days to induce polarization.
Acquisition of polarized phenotype was verified with specific markers for the apical and
basolateral domains.

Apical markers used were ZO-1, a tight-junction associated

protein (Stevenson et al., 1986), and Ezrin, a linker protein between the cytoskeleton
and the cell membrane (Huang et al., 2003).

Basolateral markers used were E-

cadherin, an adherens junction associated protein (Miranda et al., 2001) and Na+-K+
ATPase, an ATP-driven proton pump (Caplan et al., 1986).

Immunocytochemical

analysis showed a distinct localization of the apical markers at the top edge and the
basolateral markers at the bottom edge of each X-Z panel (Figure 4.4A). The X-Z
panels demonstrate the delineation of apical from the basolateral domain.

These

observations confirmed that the MDCK-II cells grown on transwell filters were polarized.
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Next, we examined localization of Cx32 and the dileucine mutants. Immunostaining for
Cx32 showed a basolateral localization pattern for both Cx32-WT and Cx32-LL.
However, Cx32-LI appeared to localize at neither the apical nor the basolateral surface
(Figure 4.4B). To corroborate our immunocytochemical observations, we performed a
domain-specific cell surface biotinylation of Cx32-WT and its mutants in polarized
MDCK-II cells. This assay can differentially biotinylate proteins localized at the apical or
basolateral domain. MDCK-II cells expressing Cx32-WT, Cx32-LI or Cx32-LL were cellsurface biotinylated in a domain-specific manner (described in Materials and Methods).
E-cadherin was used as a control for the basolateral biotinylation. Results from four
independent experiments are shown (Figure 4.5). Intriguingly, we observed that Ecadherin was partially apically biotinylated although majority of it was biotinylated
basolaterally.

Similarly, Cx32-WT and Cx32-LL localized to the basolateral domain

predominantly. However, for Cx32-LI, results showed it to be present variably in both
the apical and basolateral domains in different experiments. Moreover, the signal for
biotinylation was very weak as compared to Cx32-WT and Cx32-LL, possibly suggesting
poor trafficking of this mutant to the apical and basolateral domains. These results
hinted a role of the LI motif in regulating the basolateral sorting of Cx32 in polarized
cells. To substantiate this notion, we examined the secretory itinerary of Cx32-WT and
the dileucine mutants in polarized MDCK-II cells. We immunostained MDCK-II cells
expressing Cx32-WT, Cx32-LL or Cx32-LI with the trans-Golgi marker TGN46 (De
Matteis & Luini, 2008). Our results showed that as compared to Cx32-WT and Cx32-LL,
Cx32-LI showed robust colocalization with TGN46 (Figure 4.6). This hinted that Cx32-LI
was trapped in the TGN, suggesting a possible role of the LI motif in mediating sorting
from the TGN to the cell surface in polarized cells.
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The dileucine-based [DE]XXXL[LI]-type motifs not only interact with the AP-2
complex to govern endocytosis but also with the AP-1 complex to regulate sorting from
the TGN to the cell surface (Bonifacino & Traub, 2003). These motifs bind to conserved
sites on the both the y1 and σ1 subunits of the AP-1 complex (Mattera et al., 2011)
(Figure 4.7A). If the LI motif plays a role in basolateral sorting, we expect Cx32-LI (in
which the LI motif is mutated and rendered non-functional) not to bind to AP-1 complex.
We tested this notion directly by examining the interaction of Cx32-WT and Cx32-LI with
the subunits of the AP-1 complex in a yeast two-hybrid assay, which is used to detect
protein-protein interactions. The CTs of Cx32-WT and Cx32-LI (residues 200-283) were
cloned into pGBKT7 vector. pGADT7 plasmids encoding the various subunits of the AP1 complex [β1, γ1, γ2 (isoforms) and μ1], were co-transformed in yeast along with the
pGBKT7 plasmids, described above. Interactions were screened by plating on selective
media (See Materials and Methods). Results showed that, while the CT of Cx32-WT
interacted with the y1 subunit of AP-1, Cx32-LI did not (Figure 4.7B). This suggested a
possible role of the LI motif in mediating sorting from the TGN to the cell surface via
interaction with the AP-1 complex. Next, we examined if the interaction of Cx32 with AP1 was lost upon mutating the LI motif in MDCK-II cells. AP-1 is localized in the TGN and
endosomes (Wang et al., 2003).

We co-immunostained polarized MDCK-II cells

expressing Cx32-WT and Cx32-LI with Cx32 and y-adaptin. We observed colocalization
of y-adaptin with Cx32-WT but not with Cx32-LI in polarized MDCK-II cells (Figure 4.8).
Collectively, our data with yeast two-hybrid and polarized MDCK-II cells suggest that the
LI motif controls the basolateral sorting of Cx32 from the TGN to the cell surface in
polarized cells and rendering this motif non-functional blocks this sorting by abrogating
its interaction with AP-1.
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Role of the LI motif in the recycling pathway
The recycling pathway is responsible for recycling endocytosed cargo back to the
cell surface.

Endocytosed cargo can recycle back to the cell surface via a rapid

recycling pathway that sorts cargo directly from the early endosome to the cell surface or
via the slow recycling pathway which sorts cargo from the early endosome to the
endocytic recycling complex and back to the cell surface (Grant & Donaldson, 2009).
Earlier studies with Cx43 showed that under conditions of cytosolic stress, postendocytic trafficking to lysosomes was reduced and recycling of endocytosed Cx43 back
to the cell surface for its assembly into GJs was facilitated (VanSlyke & Musil, 2005). In
another study, Cx43 was found to colocalize with the small GTPases Rab4 and Rab11
that are involved in the recycling pathway (Gilleron et al., 2011). Our earlier results
showed robust localization of Cx32-LI in Rab5-positive early endosomes (Figure 3.13B)
as well as in the TGN in polarized MDCK cells (Figure 4.6). Hence, we considered the
possible involvement of the LI motif in regulating the recycling of Cx32 between the cell
surface and the endosomes and/or the TGN in non-polarized cells.

Therefore, we

examined whether Cx32 recycles via the fast or slow recycling pathways and whether
the LI motif is involved in regulating the recycling of Cx32. To test this, we used Rab4
and Rab11, which are used to identify the fast and slow recycling pathways, respectively
(Ullrich et al., 1996; van der Sluijs et al., 1992). LNCaP and BxPC3 cells expressing
Cx32-WT or Cx32-LI were transfected with GFP-tagged versions of wild-type Rab4
(Rab4-WT-GFP) or dominant-active Rab4 (Rab4-DA-GFP) or GFP-tagged versions of
wild-type Rab11 (Rab11-WT-GFP) or dominant-active Rab11 (Rab11-DA-GFP). Cells
were immunostained for Cx32 after 24 h. Results showed that neither Cx32-WT nor
Cx32-LI colocalized with Rab4 and Rab11 (Figure 4.9). This suggested that Cx32 did
not recycle to the cell surface, and that the LI motif does not regulate the recycling of
Cx32 via the fast or slow recycling pathways.
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The LI motif as a hybrid motif
Our findings from Chapter III suggested that the dileucine-based LI motif neither
regulated Cx32’s trafficking from the TGN to cell surface and/or lysosomes, nor acted as
an endocytic motif.

Moreover, rendering the LI motif nonfunctional induced rapid

endocytosis of Cx32 by the clathrin-mediated pathway via the LL or LR motifs (Figure
3.16). Therefore, we conjectured that the lack of assembly of Cx32-LI into GJs and its
rapid endocytosis may be due to the fact that the LI motif is a hybrid motif with an
embedded endocytic motif. Our analysis revealed that the LI motif indeed is a hybrid
motif where the tyrosine-based YLII motif overlaps with the dileucine-based motif
EVVYLI (Figure 4.10A). Tyrosine-based motifs conform to the consensus sequence
YXXɸ, and are known to mediate the endocytosis of transmembrane proteins by the
clathrin-mediated pathway (Bonifacino & Traub, 2003). We hypothesized that mutating
leucine and isoleucine in the LI motif activates the tyrosine-based motif, which acts in
concert with either LL or LR endocytic motifs to induce rapid endocytosis of Cx32.
Therefore, we mutated the critical tyrosine residue (Y) in the YLII motif to alanine (A) in
Cx32 (Figure 4.10B). We also mutated a second tyrosine residue at position 243 in
Cx32 to serve as control. The mutants thus created were referred to as Cx32-Y211A
and Cx32-Y243A. We also created a double mutant where both tyrosines at position
211 and 243 were mutated to alanines, which was referred to as Cx32-YYAA (Figure
4.10B). These tyrosine mutants were retrovirally expressed in LNCaP cells and their
ability to form GJs was assessed immunocytochemically (Figure 4.10C).

Results

showed that all mutants formed GJs. However, Cx32-Y211A formed the largest GJs.
The mean area of GJs formed by Cx32-Y211A was nearly 1.5 times larger than those
formed by Cx32-WT (Figure 4.10D). These results suggested that the YLII motif acts as
a possible endocytic motif in Cx32.
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Cx32 is tyrosine phosphorylated at position 243
The availability of the sorting motifs to AP complexes to modulate endocytosis
and sorting is governed by the direct phosphorylation of serine and tyrosine residues in
or near the sorting motifs (Bonifacino and Traub, 2003; Traub, 2009; Bonifacino, 2014).
Our previous studies with Cx43 showed that phosphorylation of serine 279 and 282 near
the sorting-motif controlled its endocytosis (Johnson et al., 2013). Hence, we examined
the phosphorylation status of tyrosine 211 and 243 in Cx32-CT as they lay near the
dileucine motifs LI and LL respectively. To examine this, we expressed Cx32-WT or its
tyrosine mutants in HEK293T cells. Cx32 was pulled down from total cell lysates using a
Cx32 antibody and probed with an anti-phosphotyrosine antibody to detect the
phosphorylation status. Results showed that Cx32 is not phosphorylated at Y211 as a
phosphorylation signal was detected when only Y211 was mutated to alanine but not
when Y243 was mutated (Figure 4.11).
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3. DISCUSSION
Cell junctions maintain the polarized state of epithelial cells of exocrine glands,
such as the prostate and the pancreas. This polarized phenotype is achieved by proper
segregation of membrane proteins to their respective apical or basolateral membrane
domains (Rodriguez-Boulan & Macara, 2014).

GJs are basolaterally localized in

polarized epithelial cells (Meda, 2018). Basolateral determinants of membrane proteins
include sorting motifs in their cytoplasmic domains (Bonifacino & Traub, 2003). For Cxs,
no such motifs have yet been defined. Based on our findings, as discussed in Chapter
III, we found that one of the dileucine-based motifs in Cx32, EVVYLI, referred to as the
LI, neither acted as an endocytic motif nor controlled its trafficking from ER to
lysosomes, from TGN to lysosomes, or from TGN to cell surface in LNCaP and BXPC3
cells. Dileucine-based motifs are known to regulate endocytosis as well as basolateral
sorting of transmembrane proteins in polarized cells (Bonifacino & Traub, 2003). Hence,
we explored the possibility that the LI motif regulated the trafficking and basolateral
sorting of Cx32 from the TGN to the cell surface only in polarized cells. Our data with
MDCK-II cells showed no significant sorting of Cx32-LI to the apical surface as evident
from our immunocytochemical analysis (Figure 4.4B) and domain-specific biotinylation
(Figure 4.5). Possible explanations for detecting E-cadherin, Cx32-WT, Cx32-LI and
Cx32-LL, which are basolaterally localized, in the apical domain, are as follows. Initially,
under non-polarized condition (where there is no delineation of apical and basolateral
domains) these proteins are targeted to the cell surface. As cells gradually acquire a
polarized phenotype on transwell filters, those proteins directed to that part of the cell
membrane which now becomes the apical domain, are unable to diffuse to the
basolateral side due to the presence of tight junctions. Secondly, the size of the biotin
moiety is 607 Daltons (Da), well below the cut-off size limit of 1500 Da, which can
permeate GJs.

Hence, it is possible that when biotin is added apically, the biotin
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molecules permeate through open hemichannels present at the apical surface and enter
the cell to biotinylate the basolaterally localized proteins, thereby giving an erroneous
apical localization. Hemichannels are undocked connexons on the surface of cells and it
is possible that some of them remain open (Goodenough & Paul, 2003).
We observed that Cx32-LI remained in the TGN in polarized MDCK–II cells
compared to Cx32-WT and Cx32-LL, which trafficked normally to the cell surface (Figure
4.6).

Our yeast two-hybrid study showed that rendering the LI motif non-functional

abrogated its interaction with the γ1 subunit of AP-1 (Figure 4.7). Loss of interaction of
Cx32 with AP-1 will prevent its transport from the TGN to the cell surface. Consistent
with this notion, we also observed a lack of colocalization of Cx2-LI with γ-adaptin in
polarized MDCK cells (Figure 4.8). These results suggest that in polarized MDCK-II
cells, the motif LI regulates basolateral sorting from the TGN via interaction with AP-1.
Our data also ruled out a role of LI motif in regulating recycling of Cx32 to the cell
surface via the slow or the fast recycling routes (Figure 4.9) in non-polarized cells.
The LI motif is a hybrid motif where the tyrosine-based YLII motif overlaps with
the dileucine-based motif EVVYLI (Figure 4.10A). The tyrosine-based motifs mediate
rapid internalization from the cell surface into endosomes as well as intracellular sorting
to lysosomes and lysosome-related organelles (Marks et al., 1997; Marks et al., 1996;
Traub & Bonifacino, 2013). Our results showed that mutating the tyrosine residue at
position 211 to alanine alone enhanced the assembly of Cx32 into GJs in LNCaP cells
even when the LI, LL and LR motifs remained intact (Figure 4.10CD). This indicates that
YLII motif is an endocytic motif.

Additional experiments to examine whether the

intracellular accumulation of Cx32-LI could be rescued when Y211 in Cx32-LI is mutated
to alanine will lend further credence to this notion. Therefore, we propose that rendering
the LI motif non-functional activates the tyrosine-based YLII motif which acts in concert
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with the LL or LR motif to induce endocytosis of Cx32 by the clathrin-mediated pathway
into Rab5-positive vesicles (Figure 3.2). Tyrosine phosphorylation has been shown to
inhibit or induce the endocytosis of many integral membrane proteins. For example,
studies with CTLA-4 showed that tyrosine phosphorylation of Y165 of a YXXɸ motif in its
cytoplasmic region abrogated its interaction with the µ2 subunit of the AP-2 complex and
reduced its internalization from the cell surface (Shiratori et al., 1997). On the other
hand, studies with GluN3A showed that tyrosine phosphorylation of YXXɸ in its Cterminal tail promoted endocytosis by allowing its direct interaction with the AP-2
complex (Chowdhury et al., 2013).

Our results showed abolition of tyrosine

phosphorylation by the phosphoinhibiting mutant Y243A but not with Y211A (Figure
4.11), which suggests that Y211 is not phosphorylated whereas Y243 is. This further
hints that the Y211 remains buried and hence is not available for phosphorylation or
interaction with AP-2 when the LI motif is intact. Collectively, these data raise several
intriguing questions with regard to the role of YLII and EVVYLII motif in controlling the
endocytosis of Cx32 in non-polarized cells. It is possible that mutating leucine and
isoleucine in the motif EVVYLII to alanines induces a conformational change in the CT of
Cx32, which enables phosphorylation of Y211 to induce rapid endocytosis of Cx32 in
non-polarized cells. Thus, additional studies to see if Y211 is phosphorylated when the
LI motif is mutated will be interesting. Lack of phosphorylation of Y211 in Cx32-LI will
indicate that tyrosine phosphorylation of Y211 in the motif YLII plays no role in regulating
endocytosis of Cx32.

On the other hand, phosphorylation of Y211 in Cx32-LI will

suggest that phosphorylation facilitates its interaction with the AP-2 complex. Further
studies are required to dissect out the role of this hybrid motif in regulating basolateral
sorting and endocytosis of Cx32.
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It is noteworthy to mention that the cytoplasmic tail of aquaporin 4 also harbors
both tyrosine-based and dileucine-based sorting signals.

The tyrosine-based motif

regulates endocytosis of aquaporin 4 whereas the dileucine-based motif regulates its
trafficking from endosomes to lysosomes (Madrid et al., 2001). Also, clathrin-mediated
endocytosis of activated epidermal growth factors is regulated by multiple mechanisms
that are both redundant and cooperative (Goh et al., 2010). Elegant studies by Jenkins
et al. have shown how a conserved 21-amino acid stretch in the juxtamembrane domain
of E-cadherin behaves as a hybrid motif, as it harbors both ankyrin G-binding as well as
a dileucine motif.

They reported that distinct residues within this motif conferred

restricted mobility in the lateral membrane through interaction with ankyrin-G, whereas
the dileucine residues conferred apical-lateral transcytosis via a clathrin-dependent
process that functioned as an editing pathway (Jenkins et al., 2013).
In summary, the dileucine-based LI motif controls the transport of Cx32 from the
TGN to the cell surface in polarized cells only. In non-polarized cells, the LI motif plays
no role in intracellular sorting or transport of Cx32 from the TGN to the cell surface. We
propose that in non-polarized cells, rendering the LI motif non-functional activates the
embedded YLII motif, which induces the rapid endocytosis of Cx32 via the clathrindependent pathway.
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Figure 4.1. Schematic diagram showing the role of various clathrin adaptor
protein (AP) complexes in sorting pathways in polarized cells. A. Subunit
heterogeneity of the different AP complexes. Individual subunits for each heteromeric
complex are shown. The schematic depicts a core comprising the large subunits (y, α or
δ and β1-β3 for AP-1,-2, or -3, respectively) together with the corresponding medium (µ)
and small subunits (σ). The function of each AP complex is described below. All the
above three AP complexes interact with both tyrosine-based (YXXΦ) and dileucinebased ([DE]XXXL[LI]) sorting motifs. B. Protein sorting events mediated by the AP
complexes. Shown is a polarized epithelial cell with distinct apical and basolateral
domains. The AP-1 complex is localized to the TGN and REs and mediates bidirectional
transport between them, as well as mediates basolateral sorting in polarized epithelial
cells. The AP-2 complex plays a role in clathrin-dependent endocytosis from the cell
surface. The AP-3 complex mediates the trafficking of proteins from the TGN or
endosomes to lysosomes. TJ: Tight Junctions; AJ: Adherens Junctions; RE: Recycling
Endosomes; EE: Early Endosomes.
Figure Courtesy: Dr. Mehta

129

A

B

130
Figure 4.2. Characterization of isogenic clones of MDCK-II cells. MDCK-II cells
were infected with Cx32-WT, Cx32-LI or Cx32-LL harboring retroviruses. Several single
clones of MDCK cells expressing Cx32-WT or the dileucine mutants were isolated from
pooled populations and further characterized by immunocytochemical and western blot
analyses. A. Five clones expressing Cx32-WT (A1, A2, A6, A7, A8), five clones
expressing Cx32-LL (D2, D5, D6, D7, D8) and 3 clones expressing Cx32-LI (B4, B9,
B10) are shown. The clones were immunostained for Cx32 (red) and β-catenin (β-cat,
green). B. Expression level of Cx32 in different clones was determined by Western
Blotting. The blots were also probed for E-cadherin (E-cad). β-actin was used as a
loading control. For further studies, clones A8, B9 and D7, representing Cx32-WT,
Cx32-LI and Cx32-LL, respectively, were chosen based on homogenous expression. In
the selected clones, Cx32-WT and Cx32-LL form GJs whereas Cx32-LI remains largely
cytosolic.
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Figure 4.3. Trafficking of Cx32-WT and mutants in MDCK-II cells. MDCK-II cells
expressing Cx32-WT, Cx32-LI or Cx32-LL were cell-surface biotinylated (Biotin +).
Biotinylated proteins were pulled down by streptavidin (Pull) and immunoblotted for Cx32
and E-cadherin (E-Cad). A non-biotinylated dish was kept as a control (Biotin -). Note
that as compared to Cx32-WT and Cx32-LL, which are robustly biotinylated, Cx32-LI is
poorly biotinylated. For the input, 10 μg of total protein was used and immunoblotted for
Cx32.
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Figure 4.4. Localization of Cx32-WT and the dileucine mutants in polarized MDCKII cells. MDCK-II cells expressing Cx32-WT or mutants were plated on transwell filters
and grown for 5-6 days to induce polarization. The filter-grown cells were immunostained
with various markers (green). The serial z-sections (0.5 µm) were collected and
analyzed with image-processing software Volocity. The X-Z cross-sectional images
were generated by Volocity. A. Acquisition of polarization in MDCK cells was verified by
using different apical (ZO-1, p-Ezrin) and basolateral (Na+-K+ ATPase, E-cadherin)
markers. Note the distinct localization of the apical markers at the top and basolateral
localization of the basolateral markers at the bottom of each X-Z panel. The sections
demonstrate the delineation of different polarized domains. B. MDCK-II cells grown on
transwell filters expressing Cx32-WT, Cx32-LI or Cx32-LL. Immunostaining with Cx32
(red) revealed basolateral localization of Cx32-WT and Cx32-LL. This pattern is not
evident for Cx32-LI.
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Figure 4.5. Domain-specific biotinylation of Cx32-WT and mutants in polarized
MDCK-II cells. MDCK-II cells expressing Cx32-WT, Cx32-LI or Cx32-LL were cellsurface biotinylated in a domain-specific manner (See Materials and Methods).
Biotinylated proteins were pulled down by streptavidin (Pull) and immunoblotted for Cx32
and E-cadherin (E-Cad). E-cadherin was used as a control for basolateral biotinylation.
AP=Apical biotinylation, BL=Basolateral biotinylation. Results from 4 blots are shown.
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Figure 4.6. Cx32-LI accumulates in the trans-Golgi Network in polarized MDCK-II
cells. MDCK-II cells expressing Cx32-WT, Cx32-LI or Cx32-LL were grown on transwell
filters for 5-6 days and immunostained for Cx32 (red) and TGN46 (green). Nuclei are
stained with DAPI (blue). The enlarged images of boxed areas in the panels are shown
on the right. Note discernible colocalization of Cx32-LI with TGN46 (middle row panels),
compared to Cx32-WT (top row panels) and Cx32-LL (bottom row panels).
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Figure 4.7. Cx32-CT interacts with the γ1 subunit of AP-1 in the yeast two-hybrid
assay. A. A schematic diagram showing the different subunits of the clathrin adaptor
complex AP-1. B. S. cerevisiae (yeast) was cotransformed with pGBKT7 plasmids
encoding the following GAL4-binding domain fusion constructs: p53 (control), Cx32-WT
and Cx32-LI and pGADT7 plasmids encoding the following GAL4 transcription activation
domain fusion constructs: PTD1, γ1, γ2, β1, µ1. Co-transformants were plated on nonselective (+His) and selective (-His) agar plates. Interaction between PVA3 (p53) and
PTD1 (large T-antigen) served as a positive control. Note lack of interaction of Cx32-LI
with γ1. (His = histidine).
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Figure 4.8. Cx32-LI traffics normally till the trans-Golgi Network. Cx32-LI
colocalizes poorly with γ-adaptin. MDCK-II cells expressing Cx32-WT (WT) or Cx32-LI
(LI) were grown on transwell filters for 5-6 days and immunostained for Cx32 (green)
and γ-adaptin (red). The enlarged images of boxed areas in the panels are shown at the
top right. Note lack of discernible colocalization of Cx32-LI with γ-adaptin compared to
Cx32-WT.
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Figure 4.9. Cx32-WT and Cx32-LI do not recycle. LNCaP and BxPC3 cells
expressing Cx32-WT or Cx32-LI were transfected with Rab4-WT-GFP and Rab4-DAGFP (A), or Rab11-WT and Rab11-DA-GFP (B). Cells were immunostained for Cx32.
The enlarged images of boxed areas in the panels are shown towards the top right. Note
the lack of colocalization of Cx32 (red) with Rab4- and Rab11-positive (green) vesicles
in both cell lines expressing Cx32-WT or Cx32-LI.
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Figure 4.10. The different tyrosine mutants of Cx32 and their expression. A. The
hybrid motif in Cx32’s CT is shown. The location of the amino acid residues in the
[YXXØ]-type (YLII) motif and the [DE]XXXL[LI]-type (EVVYLI) motif, circumscribed by
rectangles is shown. Note that the amino acid residues in YLII and EVVYLI overlap. The
numbers on left and right indicate amino and carboxyl termini, respectively. B. Left:
Position of the two tyrosine residues in wild-type Cx32’s CT. The residues are
circumscribed in rectangles. The numbers in blue below the circumscribed rectangles
indicate the position of the tyrosine residues that were mutated. Right: Mutants
generated. The mutated tyrosines are indicated in red. The names of mutants are also
shown in red above the mutated residues. Y=tyrosine, A=alanine. In Y211A (Cx32Y11A), tyrosine at position 211 was mutated to alanine. In Y243A (Cx32-Y243A),
tyrosine at position 243 was mutated to alanine. In mutant YYAA (Cx32-YYAA), both
tyrosines at positions 211 and 243 were mutated to alanines. C. Cells expressing Cx32WT or mutants were immunostained for Cx32 (red) and β-catenin (β-cat, green). Note
that all the mutants formed GJs at cell-cell interfaces (as indicated by white arrows).
Note the larger size of GJs formed by Cx32-Y211A. Nuclei are in blue. D. Cx32-Y211A
assembles into larger GJs. Mean ± SEM of surface areas of 40-70 individual GJ puncta
at cell-cell interfaces were measured in two independent experiments using the
Measurement module of Volocity. The surface area of GJs formed by Cx32-Y211A was
larger than those by Cx32-WT and this difference was statistically significant (* p<0.05).
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Figure 4.11. Tyrosine phosphorylation of Cx32-CT. HEK293T cells seeded in 6-cm
dishes were transiently transfected with 5 μg of plasmids encoding Cx32-WT, Cx32Y211A, Cx32-Y243A or Cx32-YYAA. After 24 h, cell lysates were harvested. Cx32 was
pulled down from 200 μg of cell lysates and immunoblotted with phospho-tyrosine
antibody. Cx32-WT served as a positive control and Cx32-YYAA as a negative control
for the co-immunoprecipitation. Note lack of tyrosine phosphorylation in the Cx32Y243A pulldown lane, indicating that tyrosine 211 is not phosphorylated.
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Chapter V

Role of Cysteines in Regulating
the Trafficking of Connexin32
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1. INTRODUCTION
The functional properties of GJ channels mainly depend on the composition of
the different Cx isoforms (Bevans et al., 1998).

However, channel function is also

regulated by the location, type, extent, and combination of different post-translational
modifications (PTMs).

Cxs may undergo different types of PTMs, which includes

phosphorylation, hydroxylation, acetylation, glutamation, nitrosylation, palmitoylation,
and prenylation (Locke et al., 2006).

The most well studied of these Cx PTMs is

phosphorylation. The majority of Cxs are phosphoproteins. Phosphorylation of serines
and tyrosines in Cxs have been shown to be essential for proper assembly and function
of GJ channels (Lampe & Lau, 2004). To date, none of the other common PTMs have
been studied in much details for Cxs. Studies aimed at identifying these different PTMs
may be instrumental in understanding important aspects of channel trafficking and
molecular mechanisms of channel regulation as well as GJ assembly.
The first study describing the covalent modification of proteins with lipids in brain
tissue was undertaken almost 70 years ago (Folch & Lees, 1951). Lipid modifications
help to modulate the association of the modified proteins with cellular membranes by
increasing the hydrophobicity of a protein and thus its affinity for membranes. Lipidation
is a method to target proteins to membranes in organelles (ER, Golgi apparatus,
mitochondria), vesicles (endosomes, lysosomes) and the PM. Apart from facilitating
membrane association of soluble proteins, the covalent attachment of lipids plays an
important role in their localization and function, such as protein-protein interactions,
protein trafficking, subcellular targeting, partitioning of proteins into specific membrane
domains, changes in structure and regulation of protein stability (Resh, 2004). Proteins
are covalently modified with a great variety of lipids: octanoic acid, myristic acid, palmitic
acid, palmitoleic acid, stearic acid, a farnesyl or geranylgeranyl group, cholesterol, etc.
Most of these modifications take place in the cytoplasm or on the cytoplasmic face of
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membranes. The different types of lipidation are also not mutually exclusive, in that, two
or more lipids can be attached to a given protein (Aicart-Ramos et al., 2011).
Some studies have highlighted the association of Cxs with lipids, which are most
likely to have structural and/or functional roles. Channels composed of Cx26 or Cx32
have been found to be tightly associated with endogenous phospholipids, suggesting
that such association might have Cx-specific regulatory and/or structural interactions
with lipid membranes (Locke & Harris, 2009). Studies have also shown that though GJ
plaques are not associated with lipid rafts, nonjunctional channels, formed by Cx26 or
Cx32, were raft associated (Locke et al., 2005). Nonjunctional channels, also known as
hemichannels, are undocked connexons, present on the surface of cells (Goodenough &
Paul, 2003). These connexons diffuse laterally to pre-existing GJ plaques (Gaietta et al.,
2002). However, it remains unknown how unpaired Cx hemichannels are recruited to
GJs. Lipid rafts are specialized microdomains in the PM enriched in sphingolipids and
cholesterol (Simons & Ikonen, 1997). Lipid rafts have been proposed to be involved in
protein sorting at various places in the cell (Helms & Zurzolo, 2004). A role for rafts in
protein sorting in the Golgi was described for apical as well as basolateral sorting of GPIanchored proteins in polarized epithelial cells (Brown & Rose, 1992). Recently, a study
showed that mutating the cysteine residues in the CT of Cx32 and Cx43 decreased the
stability of the GJ plaque by resulting in very fluidly arranged GJs (Stout & Spray, 2017).
The above studies indicate that association of lipids with Cx32 may have structural
and/or functional implications and cysteines in Cx32-CT might play an important role in
regulating this.
Studies using mass spectrometric analysis of Cx32 and Cx26 in HeLa cells and
rodent livers have identified new PTMs of Cx32.

These modifications included

hydroxylation and/or phosphorylation in the amino-terminal domain of both Cx32 and
Cx26, γ-carboxyglutamation in the cytoplasmic loop of both Cxs, phosphorylation in the

153
CT and palmitoylation of the CT of Cx32 (Locke et al., 2006).

Studies have also

identified a prenylation motif in the CT of Cx32 and demonstrated that Cx32 was
prenylated in COS7 cells (Huang et al., 2005). These PTMs are likely to be involved in
regulation of Cx trafficking and assembly or functional modulation.
Protein palmitoylation, also known as S-Palmitoylation, is a reversible posttranslational lipid modification which involves the addition of 16-carbon fatty acid
(palmitate) moiety to cysteine residues via a thioester linkage. Palmitoylation has no
sequence requirement except a cysteine residue, normally found in the proximity of
transmembrane helices. Addition of palmitate is catalyzed by palmitoyl acyltransferases
(PATs) and removal by acyl-palmitoyl thioesterases (APTs). Palmitoylation is an
important mechanism for regulating protein subcellular localization, trafficking,
translocation to lipid rafts, and stability (Blaskovic et al., 2013; Linder & Deschenes,
2007).

The most well studied example of palmitoylation is the Ras-family of small

GTPases, particularly H-Ras and N-Ras. Palmitoylation of these proteins at the Golgi
regulates their trafficking between the Golgi and the cell surface by increasing their
affinity for the cell membrane (Rocks et al., 2005). Apart from the Ras family of proteins,
palmitoylation has been shown to affect several other proteins. Palmitoylation on two
cysteine residues in the juxtamembrane domain of Dsg2, a desmosomal cadherin,
affected its trafficking to the cell surface as well as its stability (Roberts et al., 2016).
Palmitoylation of two cysteine residues in the β-chain of the tyrosine kinase receptor cmet, was required for its egress from the Golgi for transport to the cell surface (Coleman
et al., 2016). Palmitoylation was also shown to play a role in regulating protein turnover
as evident from the reduced stability of palmitoylation-defective mutants of the HIV
receptor CCR5 (Percherancier et al., 2001).
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Prenylation, a PTM, involves the addition of a 15 or 20-carbon isoprenoid
farnesylpyrophosphate (FPP) or geranylgeranylpyrophosphate (GGPP), respectively, to
the cysteine residue of the target protein via a thioether bond (Zhang & Casey, 1996).
The isoprenylated cysteine is part of a C-terminal CAAX box (where “C” is cysteine, “A”
is usually an aliphatic residue and “X” is usually Ser, Met, Cys, Gln, Leu, Ile or Asn. The
identity of this final amino acid determines if the protein becomes farnesylated (if X is
Ser, Met, Cys, Gln) or geranylgeranylated (if X is Leu, Ile or Asn) (Reid et al., 2004).
Prenylation involves a three step process.

A protein farnesyltransferase (FT) or

geranylgeranyltransferase (GGT) couples the prenyl group to the cysteine via a thioether
linkage, then a CAAX protease then removes the AAX tripeptide, and finally a prenylcysteine methyltransferase methylates the terminal carboxyl group of the prenylated
cysteine. The latter two enzymes are present in the ER membrane (Zhang & Casey,
1996).

This modification then promotes the interaction of the modified protein with

cellular membranes. Most of the time, a subsequent palmitoylation can occur in cysteine
residues adjacent to the farnesylated or geranylgeranylated cysteine of the CAAX box.
In all cases tested, mutating the cysteine residue in the CAAX box, which abrogated
farnesylation or geranylgeranylation resulted in the absence of palmitoylation, as seen in
Ras and RhoB family of small GTPases (Aicart-Ramos et al., 2011). The most well
established function of prenylation is to direct CAAX proteins to cellular membranes.
Apart from this, prenylation plays an important role in cellular trafficking and proteinprotein interactions as well.

Attachment of a farnesyl moiety to the γ-subunit of

heterotrimeric G proteins like transducin is indispensible for its GTP binding activity
(Fukada et al., 1990). A double prenylation (geranylgeranylation) modification of Rab
proteins is an important feature in the function of this small GTPase as it allows these
Rab proteins to correctly localize to their characteristic organelle membrane (Calero et
al., 2003). All Ras proteins are prenylated on their CAAX motif which allows specific
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association with the ER and Golgi membranes which is required for further processing
and allows engagement of a transport pathway to the PM (Choy et al., 1999).
Our studies here were focused on elucidating the role of cysteine residues
present in the CT of Cx32 in regulating GJ assembly, as palmitoylation and prenylation
occur on cysteine residues. Our findings showed that Cx32 is palmitoylated at C217,
near the juxtamembrane domain of TM4. However, this palmitoylation did not affect the
trafficking of Cx32 or its ability to form GJs at the cell surface. We found that mutating
C280 and C283 in combination caused robust accumulation of Cx32 in the Golgi and
failure to assemble into GJs. Our results further showed that this accumulation was due
to a trafficking defect of this mutated protein from the Golgi to the cell surface. Further
studies are ongoing to elucidate the molecular mechanism responsible for defective
trafficking of Cx32 and the role played by C280 and C283.
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2. RESULTS
Single cysteine mutants of Cx32 form gap junctions
The CT of Cx32 harbors three cysteine residues. These cysteines are located at
residues 217, 280 and 283 (Figure 5.1A). To explore the role of these cysteines in
regulating assembly of Cx32 into GJs, we constructed mutants where the cysteine
residues were mutated to alanines (Figure 5.1B). These mutants are Cx32-C217A,
where C217 is mutated to alanine, Cx32-C280A, where C280 is mutated to alanine, and
Cx32-C283A, where C283 is mutated to alanine (Figure 5.1B).

We retrovirally

expressed Cx32-WT, Cx32-C217A, Cx32-280A or Cx32-C283A in LNCaP cells and
examined the formation of GJs immunocytochemically. The results showed that similar
to Cx32-WT, all mutants formed GJs (Figure 5.2A).

To substantiate the

immunocytochemical data, we measured the surface areas of GJs at several cell-cell
interfaces (see Materials and Methods).

We used β-catenin to delineate cell-cell

interfaces. We found significant difference between the mean surface area of Cx32-WT
and Cx32-C280A and Cx32-C283A (p<0.01).

However, no such difference was

observed between Cx32-WT and Cx32-C217A (Figure 5.2B). Western blot analysis
showed robust expression of Cx32-WT and the mutants (Figure 5.2C).
To corroborate the immunocytochemical data, we examined the GJ forming
ability of Cx32-WT, Cx32-C217A, Cx32-280A and Cx32-C283A biochemically by the
detergent-solubility assay using 1% TX100. Analyses of total as well as TX100-soluble
and –insoluble fractions from cells expressing Cx32-WT or the mutants by Western
blotting showed that GJs composed of Cx32-WT, Cx32-C217A, Cx32-280A or Cx32C283A appeared predominantly in the detergent-insoluble fraction (Figure 5.2D),
suggesting that Cx32-WT and the mutants assembled into GJs.
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To assess whether Cx32-WT and the mutants trafficked normally to the cell
surface in LNCaP cells, we performed a cell surface biotinylation assay. The results
showed that Cx32-WT and the mutants were robustly biotinylated.

There was no

difference in the biotinylation of E-cadherin, a cell surface protein, which was used as a
positive control (Figure 5.3). Taken together, these results suggested that mutating
C217, C280 or C283 singly to alanines, affected neither the trafficking of Cx32 to the cell
surface nor the ability of Cx32 to assemble into GJs.

The triple cysteine mutant of Cx32 fails to assemble into gap junctions
Because single cysteine mutants of Cx32 assembled into GJs (Figure 5.2) and
multiple cysteines could be lipidated in a given protein, we sought to observe the effect
of mutating all three cysteines on GJ assembly. Hence, we constructed a mutant Cx32
where C217, C280 and C283 were mutated to alanines. This triple mutant is referred to
as Cx32-3CA (Figure 5.4A).

Cx32-WT or Cx32-3CA were retrovirally expressed in

LNCaP cells. Pooled polyclonal cultures were next analyzed to assess GJ assembly.
Surprisingly, immunocytochemical analysis revealed that as compared to Cx32-WT,
which formed large GJs, Cx32-3CA did not and instead accumulated intracellularly. The
pattern of intracellular accumulation seemed to resemble a Golgi-localized pattern
(Figure 5.4B). Moreover, Western blot analysis showed that the expression level of
Cx32-3CA was lower than that of Cx32-WT (Figure 5.4C).

To substantiate the

immunocytochemical data, we examined the GJ forming ability of Cx32-WT and Cx323CA biochemically by the detergent-solubility assay using 1% TX100. Analyses of total
as well as TX100-soluble and -insoluble fractions from cells expressing Cx32-WT or
Cx32-3CA by Western blotting showed that while GJs composed of Cx32-WT were
found in the detergent-insoluble fraction, those formed of Cx32-3CA were found
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predominantly in the soluble fraction (Figure 5.4D). This suggested that Cx32-3CA fails
to assemble into GJs and the intracellular puncta were not detergent-insoluble
denatured aggregates of Cx32-3CA.

Palmitoylation of Cx32 plays no apparent role in regulating gap junction assembly
Palmitoylation plays an important role in influencing protein trafficking, protein
stability, and protein subcellular localization (Linder & Deschenes, 2007). Earlier studies
using mass spectrometric analysis using mouse Cx32 had detected a palmitoylated Cterminal peptide (residues 277–283) where either C280 or C283 or both could

be

palmitoylated (Locke et al., 2006). We performed a database search using SwissPalm
to assess the palmitoylation state of Cx32.

SwissPalm is a protein palmitoylation

database which integrates predictions of S-palmitoylated cysteine scores, orthologs and
isoform multiple alignments to predict the palmitoylation status of a protein (Blanc et al.,
2015). Analysis using SwisssPalm showed a high prediction confidence for C217 and
C280 to be palmitoylated (Figure 5.5). We thus examined if Cx32 was palmitoylated
and what role it could have in trafficking and assembly into GJs. We examined if Cx32
was palmitoylated and which cysteines were involved. To investigate this, we did the
Acyl Biotin Exchange (ABE) pulldown assay, which is a well established method to
detect protein palmitoylation (Wan et al., 2007) (Figure 5.6A)

(See Materials and

Methods). In this assay, we used Cx32-3CA as our negative control, which would not be
palmitoylated as all the cysteines in the CT are mutated to alanines. We used p120 as a
positive control, which is known to be palmitoylated (Dr. Keith Johnson, Personal
communication).

Our results showed that Cx32-WT, Cx32-C280A and Cx32-C283A

were palmitoylated whereas Cx32-C217A and Cx32-3CA were not (Figure 5.6B).
These data suggested that Cx32 is palmitoylated at C217. Because C217A formed GJs

159
(Figure 5.2) and trafficked normally (Figure 5.3), these data suggest that palmitoylation
does not play any role in regulating the trafficking of Cx32 and/or its assembly into GJs.

Intracellular accumulation is due to double mutation at C280 and C283
Our previous results showed that the single cysteine Cx32 mutants trafficked to
the cell surface and assembled into GJs (Figure 5.2 and 5.3), whereas Cx32-3CA,
where all cysteines were mutated, accumulated intracellularly with a Golgi-like pattern of
localization (Figure 5.4). Therefore, we further explored which of the three cysteines, in
combination of two were responsible for intracellular accumulation. To assess this, we
created a series of double cysteine mutants of Cx32. We constructed the following
double cysteine mutants: Cx32-C217A/C280A in which cysteine residues at positions
217 and 280 were mutated to alanines, Cx32-C217/C283A in which cysteine residues at
positions 217 and 283 were mutated to alanines, and Cx32-C280A/C283A in which
cysteine residues at positions 280 and 283 were mutated to alanines (Figure 5.7A).
These double mutants were then retrovirally expressed in LNCaP cells in parallel. Their
ability to form GJs was assessed immunocytochemically whereas their expression was
assessed by Western blotting. Immunocytochemical analysis showed that both Cx32C217A/C280A and Cx32-C217/C283A formed GJs at cell-cell interfaces, whereas Cx32C280A/C283A did not, and accumulated intracellularly (Figure 5.7B, top panels), like
Cx32-3CA (Figure 5.4B). To substantiate the immunocytochemical data, we expressed
these mutants in another cell line HEK293T. Cx32-WT or the double cysteine mutants
were transiently transfected into HEK293T and immunostained for Cx32 after 24 h. As
was observed in LNCaP cells, we found that the mutant Cx32-C280A/C283A
accumulated intracellularly whereas the other mutants were assembled into GJs like
Cx32-WT (Figure 5.7B, bottom panels). As was observed with Cx32-3CA (Figure
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5.4C), western blot analysis showed a reduced expression level of Cx32-C280A/C283A
compared to Cx32-WT (Figure 5.7C). Henceforth, the mutant Cx32-C280A/C283A will
be referred to as Cx32-2CA.

To substantiate the immunocytochemical data, we

examined the GJ forming ability of Cx32-WT and Cx32-2CA biochemically by the
detergent-solubility assay using 1% TX100. Analyses of total as well as TX100-soluble
and -insoluble fractions from cells expressing Cx32-WT or Cx32-2CA by Western
blotting showed that Cx32-WT was found predominantly in the detergent-insoluble
fraction, whereas Cx32-2CA occurred predominantly in the soluble fraction (Figure
5.7D). Thus, the detergent solubility assay confirmed that Cx32-2CA is not aggregated
into detergent-insoluble puncta.

Intracellular accumulation of Cx32-2CA and Cx32-3CA is due to impaired
trafficking
The intracellular accumulation of Cx32-2CA and Cx32-3CA could be caused by
their defective trafficking from the TGN to the cell surface or rapid endocytosis from the
cell surface prior to assembly. To test this, we first did a cell surface biotinylation assay
to determine whether impaired trafficking of Cx32-2CA and Cx32-3CA compared to
Cx32-WT might account for their failure to form GJs. We found that compared to Cx32WT, Cx32-2CA and Cx32-3CA were poorly biotinylated (Figure 5.8). There was no
difference in the biotinylation of E-cadherin, a cell surface protein, which was used as a
positive control. Altogether, these data suggest that both the mutants traffic to the cell
surface poorly.
Since Cx32-2CA and Cx32-3CA showed predominantly a Golgi pattern of
localization, we immunostained LNCaP cells expressing Cx32-2CA or Cx32-3CA with
Golgi markers, GM130, a cis-Golgi marker (Nakamura et al., 1995); and TGN46, a
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marker for the TGN (De Matteis & Luini, 2008). We observed robust colocalization of
Cx32-2CA and Cx32-3CA with the above markers as compared to Cx32-WT (Figure
5.9A). To support our observation, we confirmed this phenotype in another cell line
HEK293T. We transiently expressed Cx32-WT or Cx32-3CA in HEK293T cells. After
24h, we immunostained cells for Cx32 and GM130 or TGN46 to examine colocalization.
Similar to our findings in LNCaP cells, we observed an intracellular staining pattern of
Cx32-3CA which showed robust colocalization with GM130 and TGN46 (Figure 5.9B).
To further confirm our results, we examined the localization pattern of Cx32-2CA and
Cx32-3CA after blocking their trafficking from the ER to the Golgi using brefeldin A
(Fujiwara et al., 1988).

For these experiments, we treated LNCaP cells expressing

these mutants with brefeldin (10 μM) for 8 h and observed that the distinct Golgi pattern
of localization was entirely lost upon treatment (Figure 5.9C). These results suggested
that Golgi-localization pattern was caused by the trafficking of Cx32-2CA and Cx32-3CA
from ER to Golgi and a block in their transport from the TGN to the cell surface
Our earlier studies with mutant Cx32-LI (See Chapter III) showed that it was
poorly biotinylated because of its rapid endocytosis prior to assembly into GJs. Hence,
we examined whether this lack of cell-surface biotinylation and Golgi accumulation of
Cx32-2CA and Cx32-3CA was caused by the rapid endocytosis followed by retrograde
transport back to the Golgi or by a forward trafficking defect from the Golgi. If the former
was true, inhibiting endocytosis would induce the assembly of these mutants into GJs.
To test this notion, we subjected cells to potassium (K+) depletion or hypertonic sucrose
(Suc). Both treatments inhibit clathrin-mediated endocytosis (Hansen et al., 1993; Larkin
et al., 1986). Alexa 594-conjugated transferrin receptor (Tfr) was used as a positive
control for endocytosis. Depletion of K+ or treating cells with hypertonic sucrose for 2 h
did not induce the assembly of Cx32-2CA and Cx32-3CA into GJs as assessed
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immunocytochemically (Figure 5.10AB, bottom panels).

As expected, Alexa 594-

conjugated Tfr was internalized in control cells but not in cells subjected to K+ depletion
or hypertonic sucrose (Figure 5.10AB, top panels).

Taken together our results

suggested that the Golgi accumulation of Cx32-2CA and Cx32-3CA was caused by
impaired trafficking from the Golgi to the cell surface, and not by their endocytosis.

Cx32 is farnesylated at the CAAX motif
Prenylation is known to direct CAAX-motif containing proteins to cellular
membranes. It also plays an important role in regulating protein trafficking and proteinprotein interactions (Calero et al., 2003; Fukada et al., 1990). A sequence search from
GenBank revealed that Cx32 was the only cloned mammalian Cx with a CAAX-motif at
position C280 in its CT (Figure 5.11A). This CAAX motif of Cx32 is phylogenetically
conserved among its orthologs (Huang et al., 2005). More than 270 different mutations
of the GJB1 gene affecting different portions of Cx32 have been described for CMTX.
Two of these mutations affect this potential prenylation motif: a Cys to Gly substitution at
280 (C280G) and a Ser to stop mutation at 281 (S281x) (Bergoffen et al., 1993). Cx32
was shown to be prenylated in COS7 cells, however, prenylation was not required for
proper trafficking of Cx32 or its function in myelinating Schwann cells in mice (Huang et
al., 2005).
We analyzed the amino acid sequence of Cx32 using the software PrepPS, an
amino acid sequence-based predictor for various types of protein prenylation, which is
based on the refinement of descriptions of sequence motifs recognized by the three
enzymes

[Farnesyltransferase

(FT),

Geranylgeranyltransferase

I

(GGT1),

and

Geranylgeranyltransferase II (GGT2)] in substrate proteins (Maurer-Stroh & Eisenhaber,
2005). Our analysis indicated a high prediction score for recognition of C280 by FT
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(Figure 5.11B). We also found Cx32 listed in PRENbase, a database of prenylated
proteins (Maurer-Stroh et al., 2007). Our previous results showed that mutating Cx32 at
C280 and C283 inhibited GJ assembly (Figure 5.7A) and we also identified that these
residues were critical for Cx32 trafficking to the cell surface (Figure 5.8 and 5.9).
Hence, we hypothesized that Cx32 is farnesylated at the CAAX motif and loss of this
modification by mutating C280 and C283 in combination impedes its trafficking to the cell
surface. To test this notion, we first co-immunoprecipitated Cx32 from LNCaP cells
expressing Cx32-WT using an anti-Cx32 antibody and blotted with an anti-farnesyl
antibody. Additionally, we also expressed Cx32-WT transiently in HEK293T cells and
did a similar co-immunoprecipitation assay.

Our results showed that Cx32-WT is

farnesylated in both LNCaP and HEK293T cells (Figure 5.11C). Collectively, these data
indicate that Cx32 is prenylated.
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3. DISCUSSION
Connexins are subjected to a wide variety of PTMs. However, not much has
been studied about how different PTMs, except phosphorylation, can regulate Cx
trafficking and assembly. Most of these PTMs occur in the CT of Cxs. Previous studies
showed that Cx32-CT is palmitoylated and prenylated (Huang et al., 2005; Locke et al.,
2006). Palmitoylation and prenylation occur on cysteine residues. Hence, we explored
if the cysteines present in Cx32-CT are critical for its ability to assemble into GJs.
Our findings show that mutating Cx32 on single cysteine residues did not affect
its trafficking or ability to assemble into GJs (Figure 5.2 and 5.3). In contrast, our results
with the triple cysteine mutant of Cx32, Cx32-3CA, showed that it did not assemble into
GJs and was localized intracellularly (Figure 5.4). We made a series of double cysteine
mutants, out of which Cx32-C280A/C283A (Cx32-2CA) accumulated intracellularly
similar to Cx32-3CA (Figure 5.6). These data attribute this intracellular accumulation to
lack of modification, possibly prenylation, at C280 and C283. We also found that Cx32
is palmitoylated at residue C217 (Figure 5.6), and this palmitoylation is not required for
trafficking of Cx32 or its assembly into GJs because Cx32-C217A formed GJs like Cx32WT (Figure 5.2). We found that the intracellular accumulation of Cx32-2CA and Cx323CA was due to a block in trafficking from the Golgi to the cell surface as evident from
the inability of these mutants to get cell-surface biotinylated (Figure 5.8) and their robust
colocalization with Golgi markers (Figure 5.9). Moreover, intracellular accumulation was
not caused by endocytosis (Figure 5.10). Since residues C280 and C283 are part of the
CAAX motif of Cx32, we tested if farnesylation of Cx32 was required for its normal
trafficking. Bioinformatic analysis and co-immunoprecipitation experiments showed that
Cx32 is farnesylated (Figure 5.11). Experiments are ongoing to address if farnesylation
occurs at the CAAX motif and whether this farnesylation is required for its normal
trafficking.
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It is known that Cxs oligomerize in the ERGIC or in the TGN (Diez et al., 1999;
Musil & Goodenough, 1993), however, the underlying mechanisms regarding how
connexons exit from the Golgi remain unknown. If farnesylation is responsible for Cx32
trafficking, then it will imply that this lipid modification of Cx32 is required for its
association with lipid rafts in the Golgi, and that this association directs its sorting to the
cell surface. Additional experiments to test if farnesylation of Cx32 at the CAAX motif is
required for its trafficking from the Golgi to the cell surface are in progress. This includes
co-immunoprecipitation studies with LNCaP cells expressing Cx32-2CA or Cx32-3CA,
where Cx32 will be pulled down using an anti-Cx32 antibody and blotted with a farnesyl
antibody. Farnesylation at this motif is expected to result in a lack of signal when pulling
down Cx32-2CA or Cx32-3CA and blotting with the farnesyl antibody.
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Figure 5.1. A schematic diagram showing the topology of Cx32 and the location
of cysteine residues in its CT.
A. Topology of Cx32.
TM1-TM4 are the
transmembrane domains. EC1 and EC2 are the extracellular loop domains. NH2 and
COOH are the amino and the carboxyl termini, respectively. A single letter denotes an
amino acid. The position of cysteine residues in the CT is indicated by the numbered
arrows pointing towards them. Note also that there are six additional cysteines (3 in
EC1 and 3 in EC2), which are not accessible to enzymatic modifications. They are
indicated by the red arrowheads. B. Top: Position of cysteine residues that are likely to
be lipidated in Cx32’s CT. The numbers on left and right indicate amino and carboxyl
termini, respectively. The cysteine residues are shown in green. The numbers in black
above the cysteine residues indicate their positions. Bottom: Mutants generated. The
mutated amino acids are indicated in red. The names of mutants are shown in purple on
the left. C=cysteine and A=alanine. In Cx32-C217A, cysteine at position 217 was
mutated to alanine. In Cx32-C280A, cysteine at positions 280 was mutated to alanine
and in mutant Cx32-C283A, cysteine at position 283 was mutated to alanine.
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Figure 5.2. Single cysteine mutants form gap junctions. A. LNCaP cells
expressing Cx32-WT or the mutants were immunostained for Cx32 (red) and β-catenin
(β-cat, green). Note that the mutants efficiently assembled into GJs at cell-cell interfaces
as pointed by white arrows. Nuclei are in blue. B. GJ areas of cells expressing Cx32WT or the mutants. Surface areas (Mean ± SEM) of 50-90 distinct GJ puncta at cell-cell
interfaces from 2 independent experiments were determined using the measurement
module of Volocity. The area is represented in µm2. Note a significant decrease in the
mean GJ area in cells expressing the mutants C280A or C283A. p values are indicated
above the bars. C. Western blot analysis of total cell lysates from cells expressing
Cx32-WT or the mutants, showing robust and near equal expression. D. Detergentsolubility of Cx32-WT and the mutants. Western blot analysis of Cx32 in Total (T),
TX100-soluble (S), and TX100-insoluble (I) fractions from LNCaP cells expressing Cx32WT or the mutants, shows a predominantly insoluble fraction for all.
Figure Courtesy: Dr. Mehta

169

170
Figure 5.3. Trafficking of Cx32-WT and single cysteine mutants. LNCaP cells
expressing Cx32-WT, Cx32-C217A, Cx32-C280A or Cx32-C283A were cell-surface
biotinylated (Biotin +). Biotinylated proteins were pulled down by streptavidin (Pull) and
immunoblotted for Cx32 and E-cadherin (E-Cad). A non-biotinylated dish was kept as a
control (Biotin -). Note that like Cx32-WT, all the mutants were efficiently biotinylated.
For the input, 10 μg of total protein was used and immunoblotted for Cx32.
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5.4. The triple cysteine mutant of Cx32 (Cx32-3CA) accumulates intracellularly
and does not assemble into gap junctions. A. The position of the cysteine residues
in the CT of Cx32-WT. The numbers on left and right indicate amino and carboxyl
termini, respectively. The cysteine residues (C) are shown in purple in the CTs of Cx32WT. The numbers in black above the cysteine residues indicate the position of the
amino acids. Bottom: Mutant Cx32-3CA. The mutated amino acids (mutated to alanine,
A) are indicated in red. B. LNCaP cells expressing Cx32-WT or Cx32-3CA were
immunostained for Cx32 (red) and β-catenin (β-cat, green). Note that Cx32-3CA did not
assemble into GJs whereas Cx32-WT did (indicated by white arrows) and was localized
intracellularly. Nuclei are in blue. C. Western blot analysis of total cell lysates from
cells expressing Cx32-WT or Cx32-3CA. D. Detergent-solubility of Cx32-WT and Cx323CA. Western blot analysis of Cx32 in total (T), TX100-soluble (S), and TX100-insoluble
(I) fractions from LNCaP cells expressing Cx32-WT or Cx32-3CA. Note that Cx32-WT
formed GJs whereas Cx32-3CA did not, and instead was localized intracellularly.
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Figure 5.5. Cx32 is predicted to be palmitoylated at C217A and/or C280A. A
search using the SwissPalm database indicated a high confidence prediction score for
palmitoylation at C217 and C280, both of which are cytosolic and present in the CT of
Cx32. Code for cysteine position E=Extracellular, T=Transmembrane, C-Cytosolic.
Color code for prediction: High confidence, Medium confidence, Low confidence, Not
predicted. Note for C217 and C280 show a high confidence prediction.
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Figure 5.6. Cx32 is palmitoylated at C217. A. A schematic overview of the ABE
pulldown assay. Outlined are the different steps of this assay in the presence (+HA) and
absence (-HA) of hydroxylamine (HA). (1) Blockade of free thiols with NEM; (2) HA
treatment to release thioester-linked palmitoyl moieties, restoring the modified cysteine
to thiols; (3) Biotinylation of thiols using a thiol-reactive biotinylation reagent (HPDPbiotin); (4) followed by pulldown of the biotinylated proteins with streptavidin agarose
(SA). Figure adapted with modified from (Rodriguez-Walker & Daniotti, 2017). B.
Lysates from LNCaP cells expressing Cx32-WT, Cx32-C217A, Cx32-C280A, Cx32C283A or Cx32-3CA were split into two halves and treated with HA (+) or left untreated
(-). After the streptavidin-agarose pull-down, the captured proteins were resolved by
SDS-PAGE and immunoblotted for Cx32 and p120. (See Materials and Methods). For
the input, 10 μg of total protein was used and immunoblotted for Cx32. Note that only
the C217A mutant is palmitoylated.
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Figure 5.7. The double cysteine mutants of Cx32 affect gap junction assembly. A.
Different double cysteine mutant constructs of Cx32. The numbers on left and right
indicate amino and carboxyl termini, respectively. The cysteine (C) residues are shown
in purple in the CT of Cx32-WT. The numbers in black above the cysteine residues
indicate the position of the amino acids. The names of the mutants generated are
shown in green on the left. The mutated amino acids (mutated to alanine, A) are
indicated in red. B. LNCaP cells (top panels) and HEK293T cells (bottom panels)
expressing Cx32-WT and the mutants were immunostained for Cx32 (red) and β-catenin
(β-cat, green). Note that Cx32-WT, Cx32-C217A/C280A and Cx32-C217A/C283A
assembled into GJs (indicated by white arrows), whereas Cx32-C280A/C283A did not,
and was localized intracellularly in both LNCaP and HEK293T cells. Nuclei are shown in
blue. C. Western blot analysis of total cell lysates from cells expressing Cx32-WT and
Cx32-C280A/C283A. Note reduced expression level of Cx32-C280A/C283A compared
to Cx32-WT and other mutants. D. Detergent-solubility of Cx32-WT and Cx32C280A/C283A. Western blot analysis of Cx32 in Total (T), TX100-soluble (S), and
TX100-insoluble (I) fractions from LNCaP cells expressing Cx32-WT or Cx32-3CA. Note
a significant detergent-soluble fraction in cells expressing Cx32-3CA.
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Figure 5.8. Trafficking of Cx32-WT, Cx32-2CA and Cx32-3CA. LNCaP cells
expressing Cx32-WT, Cx32-2CA or Cx32-3CA were cell-surface biotinylated (Biotin +).
Biotinylated proteins were pulled down by streptavidin (Pull) and immunoblotted for Cx32
and E-cadherin (E-Cad). A non-biotinylated dish was kept as a control (Biotin -). Note
that compared to Cx32-WT, mutant Cx32-2CA and Cx32-3CA were poorly biotinylated.
Note also that E-cadherin was equally biotinylated in cells expressing Cx32-WT, Cx322CA or Cx32-3CA. Note also reduced expression level of Cx32-2CA and Cx32-3CA
compared to Cx32-WT.
For the input, 10 μg of total protein was used and
immunoblotted for Cx32.
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Figure 5.9. Cx32-2CA and Cx32-3CA are predominantly Golgi-localized. A. LNCaP
cells expressing Cx32-WT, Cx32-2CA or Cx32-3CA were immunostained for Cx32 (red)
and GM130 or TGN46 (green). The enlarged images of boxed areas in the panels are
shown at the bottom right. Note robust colocalization of the mutants with the indicated
markers as compared to Cx32-WT. B. HEK293T cells transfected with Cx32-WT or
Cx32-3CA were immunostained for Cx32 (red) and GM130 or TGN46 (green). The
enlarged images of boxed areas in the panels are shown at the bottom right. Note
robust colocalization of Cx32-3CA with the indicated markers as compared to Cx32-WT.
C. LNCaP cells expressing Cx32-2CA or Cx32-3CA were treated with vehicle (Control)
or 10 μM brefeldin A (Brefeldin) for 8 h. Cells were then immunostained for Cx32 (green)
and GM130 (red). Note loss of Golgi localization pattern of Cx32-2CA and Cx32-3CA
upon brefeldin treatment.
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Figure 5.10. Golgi-localized pattern does not result from the retrograde transport
of endocytosed Cx32-2CA and Cx32-3CA to Golgi. LNCaP cells expressing (A)
Cx32-2CA or (B) Cx32-3CA were subjected to K+ depletion (K+) or hypertonic sucrose
(Suc) treatment for 2 h. Cells were then fixed and immunostained for Cx32 (red). As a
control, these cells were labeled with Alexa Fluor 594-conjugated transferrin (Tfr) and
were left untreated (Control) for 0 or 15 minutes or subjected to K+ depletion or Suc
treatment for 0 or 15 minutes (0’ or 15’). Note internalization of Alexa Fluor 594conjugated Tfr in control cells but not in cells subjected to K+ depletion or Suc treatment.
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Figure 5.11. Cx32-WT is farnesylated. A. The CAAX motif for Cx32 is located at
position C280 of its CT, circumscribed within a blue rectangle. B. A snapshot of the
prediction obtained using the PrePS software. Note that as compared to GGT1
(Geranylgeranyltransferase I) and GGT2 (Geranylgeranyltransferase II), the prediction
score of FT (Farnesyltransferase) acting on position C280 is the highest. C. Whole cell
lysates from LNCaP cells and HEK293T cells expressing Cx32-WT were pulled down
using an anti-Cx32 antibody and immunoblotted with an anti-farnesyl antibody. For the
input, 10 μg of total protein was used and immunoblotted for Cx32.
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Chapter VI

Major Conclusions and
Future Directions
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Our current understanding of how connexons are delivered to the cell surface,
primed to form a nascent GJ plaque, recruited to the plaque, and endocytosed is
incomplete. Cxs have a short half-life of 2-5 h whereas the average half-life of GJ
plaques is nearly 12-16 h (Falk et al., 2016; Gumpert et al., 2008; Holm et al., 1999;
Jordan et al., 1999; Lauf et al., 2002; Thomas et al., 2005). This discrepancy between
the half-life of a Cx and a GJ plaque imposes temporal and spatial constraints with
respect to how connexons traffic to the cell surface to prime the assembly of a GJ
plaque, how a GJ plaque grows, and how it is disassembled. The key determinants that
determine the assembly of Cxs to give rise to a nascent plaque remain unexplored. Also
complex mechanisms must exist to maintain a plaque in a steady state as well as allow it
to remodel in response to physiological stimuli. Why do some specialized cell types
have very large GJs, consisting of more than 10,000 channels, while other cell types
have very small plaques consisting of only 10-100 channels?
The above findings imply that the size of a GJ plaque may be intimately tied to
some specific function in a cell-context and differentiation-state specific manner. One
possible function might be that larger GJ plaques may permit rapid assembly and
disassembly of signaling complexes at the areas of cell-cell contact through recruitment
of scaffolding proteins or alterations in local ionic concentrations at the areas of cell-cell
contact due to rapid and larger fluxes of ions or signaling molecules between contiguous
cells. If so, molecular mechanisms must exist to control the initiation of the plaque, its
growth and dynamics, and its size. The carboxyl termini of Cxs differ widely in length
and sequence homology, suggesting that they are intimately involved not only in
regulating cell type specific assembly of Cxs but also in determining the size of the
plaque, its subsequent growth, and dynamics. The results reported in this dissertation
with regard to trafficking of Cx32 to the cell surface, its assembly into GJs, and its
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endocytosis have identified regulatory mechanisms that might be used to assemble and
disassemble GJs. The major conclusions of this study are as follows:
1. One tyrosine-based [YXXØ]-type motif, two dileucine-based [DE]XXXL[LI]-type
motifs, and one newly discovered non-canonical motif in the CT of Cx32
regulates its assembly into GJs. These motifs affect the assembly of Cx32 into
GJS differently.

In non-polarized cells, one dileucine-based motif, the LL

[EINKLL] motif, and the non-canonical motif [LKDILR], the LR motif, which is
located distal to the transmembrane domain, control the endocytosis of Cx32 by
the clathrin-mediated pathway whereas the other dileucine-based motif
[EVVYLI], the LI motif, which is located near the juxtamembrane domain, does
not.
2. The LL, LR and the LI motifs do not regulate the intracellular sorting of Cx32 in
non-polarized cells.

However, in polarized cells, the LI motif controls the

intracellular sorting of Cx32 from the TGN to the cell surface.
3. The LL, the LR, and LI motifs do not regulate the recycling of Cx32 in nonpolarized cells.
4. The cysteines located in the CT of Cx32 regulate the trafficking of Cx32 from the
Golgi to the cell surface.
5. Out of three cysteines in the CT of Cx32, only cysteine 217 is palmitoylated and
inhibiting palmitoylation at this residue has no significant effect on the assembly
of Cx32 into GJs.
6. Mutating cysteines 280 and 283 in combination as well as cysteines 217, 280,
and 283 together to alanines blocks the transport of Cx32 from the Golgi to cell
surface.
7. Cysteine 280 in the CT of Cx32 may be farnesylated, which may impact the
intracellular sorting of Cx32 from the Golgi to the cell surface.
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Our earlier studies showed that Cx32 and Cx43 are endocytosed by the clathrinmediated pathway (Johnson et al., 2013; Ray et al., 2018) . The function of sorting
motifs can be governed by phosphorylation of nearby serine and tyrosine residues
(Bonifacino, 2014; Bonifacino & Traub, 2003; Moore et al., 2007; Traub, 2009). We
showed that phosphorylation on serine 279 or 282 by MAP kinase near the sorting motif
of Cx43 enhanced its endocytosis and attenuated GJ formation whereas inhibiting
phosphorylation of these residues enhanced GJ formation (Johnson et al., 2013).
Hence, we searched for tyrosines and serines that lay near the sorting motifs of Cx32.
We have discovered a tyrosine and several serines in the CT of Cx32, which could be
potentially phosphorylated by protein kinases (PK)s (Figure 6.1). In contrast to Cx43
(Solan & Lampe, 2009), not much is known about which PKs phosphorylate Cx32
(Axelsen et al., 2013). In vitro studies with specific peptides showed that the CT of Cx32
was phosphorylated by cAMP-dependent PKA and PKC at serine 233 (Saez et al.,
1990). Other studies detected phosphorylation on serines 229 and 240 (Locke et al.,
2006; Saez et al., 1990). Based on the data from PhosphoSitePlus, phosphorylation of
S266 is most frequently observed, followed by phosphorylation of S258, Y243, S233,
and S240.

In future studies we will investigate whether phosphorylation of Cx32

regulates its endocytosis and assembly into GJs.

In particular, we will test the

hypothesis that phosphorylation of serines 253, 258 and 266 and tyrosine 243 near the
sorting motifs LL and LR regulates the endocytosis of Cx32 and modulates GJ
formation.
Cx32 is expressed in the polarized acinar cells of the pancreas and prostate
(Meda, 2017). In polarized cells, the dileucine motifs of transmembrane proteins interact
with three adapter protein (AP) complexes (AP-1 to AP-3) which control their
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endocytosis as well as apical and basolateral sorting (Bonifacino, 2014; Janvier et al.,
2003; Traub & Bonifacino, 2013) (Figure 4.1B).

Our results with pancreatic and

prostate cancer cell lines showed that rendering the LL or LR motif nonfunctional
enhanced GJ formation by inhibiting Cx32’s endocytosis, whereas rendering the LI motif
nonfunctional inhibited GJ formation by augmenting its endocytosis (Figure 3.4). It is
now well-established that connexons, often called hemichannels, also permit the
bidirectional exchange of small molecules less than 1500 Da between the cytoplasmic
interior and the extracellular space (Esseltine & Laird, 2016). Mis-sorted hemichannels
may distort the intracellular metabolic milieu, alter acinar structure, and trigger tumor
initiation by permitting the leakage of essential metabolites and signaling molecules to
the extracellular space or vice versa.

Although we showed that in pancreatic and

prostate cancer cell lines motifs LL, LR, and LI had no effect on the trafficking of Cx32 to
cell surface (Ray et al., 2018), it is possible that polarized and well-differentiated acinar
cells utilize the LI, LL or LR motifs differently as evidenced by our studies with respect to
the role of LI motif in regulating trafficking of Cx32 form the TGN to the cell surface in
MDCK-II cells. MDCK-II cells are derived from the kidney where Cx32 is not expressed
(Laird, 2006). Future studies will be aimed at investigating which sorting motifs dictate
the basolateral sorting of Cx32 in polarized prostate cancer cell lines. For these studies
we will use immortalized RWPE-1 cells, which polarize and undergo acinar
differentiation when grown in three-dimensional (3-D) cultures in Matrigels.
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Figure 6.1. Location of phosphorylatable serines and tyrosines in the CT of Cx32.
A. The dileucine motifs, LI and LL, and a non-canonical motif LR are encircled. The
phosphorylatable serine (S) and tyrosine (Y) residues are numbered in red. B. Cx32CT from residue 221 to 270. The position of phosphorylatable Ys and Ss are indicated
by the numbers below. The sorting motifs are delineated by rectangles. Other Ss
known to be phosphorylated in vitro or Ys are also indicated.
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